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Jérôme Husson and Laurent Guyard
4′-(N-(Propan-1,2-dienyl)pyrrol-2-yl)-2,2′: 6′, 2′′-terpyridine
Reprinted from: Molbank 2020, 2020, M1142, doi:10.3390/M1142 . . . . . . . . . . . . . . . . . . . 79
Peter W. R. Corfield and Joseph R. Dayrit
Poly[1,3-Dimethyltetrahydropyrimidin-2(1H)-iminium [tri-μ2-cyanido-κ6C:N-dicuprate(I)]]
Reprinted from: Molbank 2020, 2020, M1170, doi:10.3390/M1170 . . . . . . . . . . . . . . . . . . . 85
vi
About the Editor
Stefano D’Errico studied Organic Chemistry at the University of Naples Federico II. He finished
his doctoral studies in 2009 with a thesis entitled “Synthesis and Structural Characterization of
Quadruplex Forming Oligonucleotides and Studies on Solid Phase Synthesis of Nucleoside and
Nucleotide Analogues”. Between 2009 and 2015, he conducted his research at the Department of
Pharmacy of University of Naples Federico II. Since 2016, he has been a Technologist at the same
University. In 2017, he obtained qualification as Associate Professor in Organic Chemistry. His current
research activities mainly focus on the development of innovative synthetic methodologies for
the preparation of novel bioactive modified nucleosides and nucleotides, and on the solid-phase





Editorial: Special Issue “Molecules from
Side Reactions”
Stefano D’Errico
Department of Pharmacy, University of Naples Federico II, via D. Montesano, 49, 80131 Naples, Italy;
stefano.derrico@unina.it
Received: 24 November 2020; Accepted: 27 November 2020; Published: 30 November 2020
Organic synthesis is a powerful tool that allows researchers to express their scientific creativity.
Its fundamental role in obtaining drugs and creating new materials is irrefutable evidence.
However, a chemical process may often take a side route, generating novel unexplored products.
Most chemical reactions produce side products, which are often set aside and even thrown away.
If the side product is formed in large amounts or if its presence makes difficult the chromatographic
purification procedures, the desire to throw it away is even stronger. Let us suppose that a chemist is
in the middle of a total synthesis made up of several synthetic steps and that, during a key step, he or
she notes on thin layer chromatography (TLC)the formation of an intense spot with Rf that, in their
knowledge, cannot belong to the target compound. At first glance, this side product, generated by a
side reaction, could be discouraging and frustrating; however, the isolation and characterization of
that product could give the possibility to better investigate the mechanism of reaction. The obtainment
of a side product cannot fail to fascinate a chemist that works in the field of synthesis as (i) novel
reactions may be discovered and (ii) novel molecular scaffolds may be achieved. The purpose of
the Special Issue “Molecules from Side Reactions” was to collect papers reporting on the synthesis
and characterization of those products that could be useful building blocks for the whole scientific
community. The Special Issue was launched in July 2019 and collected 13 contributions by the end of
2020. The authors contributing to this Special Issue, whom the Guest Editor sincerely thanks, described
the science elegantly and rationally; in addition, they characterized the side products according to
the rigorous standards of Molbank. The published papers cover the following aspects of the organic
chemistry field:
• Synthesis of Heterocycles
• Synthesis of Carbohydrates
• Synthesis of Modified Nucleosides
• C-H Bond Functionalization
• Mechanisms of Reactions
In the first paper, an oxidative ring opening reaction was reported to convert a disubstituted
furan ring to isoxazole [1]. This reaction could be useful for the construction of linked isoxazoles and
other new complex structures containing an isoxazole subunit. In the second paper, the nitration of
pyridine-imidazolium salt was described. It proceeded with the oxidative cleavage of a N–C bond
between imidazolium ring and methylene group, with the formation of two side products [2]. In the third
paper, the authors described the access to the rare d- and l-psicose derivatives via hydroxy methylation
of the ribono lactone [3]. The fourth paper dealt with the synthesis of an intriguing side product
obtained during the 5′-ribose fluorination of the nucleoside 6-chloropurine riboside [4]. This reaction
occurred during the preparation of a valuable, more lipophilic, analogue of the imidazo-nucleoside
AICAR [5]. In the fifth paper, the synthesis of a N-(2-hydroxy-1,1-dimethylethyl)-3-methylbenzamide
was accomplished. The importance of the compound lies in its potential reactivity as an
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N,O-bidentate directing group in metal-catalyzed C–H bond functionalization reactions [6]. In the
sixth paper, an interesting and unexpected obtainment of N′-acetylhydrazides from hydrolysis of the
3-acetyl-2,3-dihydro-1,3,4-oxadiazole derivatives of 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine nucleus
was presented [7]. In the seventh paper, an unexpected epoxide-oxetane rearrangement was observed
during the synthesis of symmetrical dodeco-6,7-diuloses, that are potential candidates for inhibition
of glycosidases [8]. In the eighth paper, a novel glycosyl sulfoxide was synthesized from a S-phenyl
thioglycoside for the preparation of alginate oligosaccharides [9]. In the ninth paper, the authors
discovered that the incorporation of 8-fluoro-N-2-isobutyryl-2′-deoxyguanosine into oligonucleotides
through the phosphoramidite chemistry-based solid phase synthesis failed to give the desired products.
These results prompted the authors to explore an alternative N-protecting group and to modify the solid
phase synthetic cycle conditions [10]. In the tenth paper, the authors focused on the synthesis of peptidyl
nucleosides as antibacterial agents. During their study to prepare an intermediate to be attached to a
solid support, they found an interesting side product with a seven-membered ring [11]. In the eleventh
paper, the formation of an isomeric mixture of dienynes, instead of a diallene, was detected during
a reduction reaction performed on the 1,1,2,2,7,7,8,8-octaethoxyocta-3,5-diyne [12]. In the twelfth
paper, the authors reported on the synthesis of a new pyrrole-substituted terpyridine derivative that
possessed an allene moiety. It was obtained as an unexpected sole product during attempts to alkylate
the N-atom of pyrrole [13]. In the last paper, the serendipitous formation of the cyclic guanidinium
complex poly[1,3-dimethyltetrahydropyrimidin-2(1H)-iminium [tri-μ2-cyanido-κ6C:N-dicuprate(I)]]
was found during an X-ray analysis of the crystals obtained after an attempted synthesis of a copper
cyanide polymer involving the diamine N,N′-1,3-dimethyldiaminopropane [14]. All this research
confirms the importance of isolating, characterizing and always preserving all the products formed
during a reaction. A side product obtained from a side reaction could be as useful an intermediate as a
novel pharmaceutical lead. Finally, special thanks go also to all the reviewers, who always helped the
Guest Editor to make clear and final decisions, maintaining the high-quality standards of Molbank.
Conflicts of Interest: The author declares no conflict of interest.
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Abstract: (E)-4-(3-Phenylisoxazol-5-yl)but-3-en-2-one was synthesized via the oxidative ring
opening reaction of 2-(5-methylfuran-2-yl)-1-phenylethanone oxime, followed by the iodine
mediated isomerization.
Keywords: oxazole; furan; RORC reaction; (E,Z)-isomerization
1. Introduction
The isoxazole ring is a structural motif of numerous bioactive compounds, including several
marketed drugs [1]. Substituted isoxazoles are known as promising anticancer [2–5], antifungal [6],
antidepressant [7], antioxidant [8], and antituberculous agents [9]. Additionally, some of the isoxazoles
demonstrate herbicidal [10] and insecticidal [11] properties.
In 2017, Pinho e Melo et al. described a new synthesis of isoxazoles from tetrahydrofurooxazines
via the intermediate formation of oximes (Scheme 1) [12]. Main products of this acid-catalyzed reaction
were substituted 4-(isoxazol-5-yl)butan-2-ones 3. On the other hand, minor isoxazolylvinyl ketones
(E)-4 are of special interest, due to an active enone fragment, which can be utilized for the construction





Scheme 1. Acid-catalyzed formation of isoxazolylvinyl ketones as minor products.
Herein, we describe an easy approach to (E)-4-(3-phenylisoxazol-5-yl)but-3-en-2-one 4c, and its
characterization by 1D and 2D NMR spectroscopy.
2. Results and Discussion
Oxime 2c was synthesized via the reaction of furfuryl ketone 5 with hydroxylamine hydrochloride,
and sodium acetate in ethanol. The subsequent furan ring opening–isoxazole ring closure reaction of
2c under oxidative conditions [15,16] provided the target 4-(3-phenylisoxazol-5-yl)but-3-en-2-one 4c in
high yield as a mixture of (E,Z)-isomers (Scheme 2).
Molbank 2019, 2019, M1081; doi:10.3390/M1081 www.mdpi.com/journal/molbank5
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Scheme 2. Synthesis of compound 4c.
Isoxazole (E)-4c was obtained in a pure form through iodine-mediated isomerization [17] and
fully characterized (Scheme 3).
 
Scheme 3. Isomerization (E,Z)-4c→(E)-4c.
The structure of compound 4c was confirmed by 1H and 2D nuclear magnetic resonance
spectroscopy: 1H-1H correlation spectroscopy (COSY), 1H-13C heteronuclear single-quantum
correlation spectroscopy (HSQC), and 1H-13C heteronuclear multiple-bond correlation spectroscopy
(HMBC) (Figures 1–3). In the 1H NMR spectrum of (E)-4c, signals of the vinyl protons α-H and β-H
are observed at δH = 6.95 and 7.40 ppm, respectively, and have a coupling constant of 16.2 Hz, which
indicates a (E)-configuration (Figure S1). In the 1H-13C HMBC spectrum, there are cross-peaks between
the α-H proton and C-atom of the methyl group (δC 28.5 ppm) and isoxazole C(5) atom (δC 166.3 ppm).
The β-H proton correlates with carbonyl carbon atom at δC 197.0 ppm and isoxazole C(4) atom at δC
104.5 ppm. Cross-peaks between the proton H(4) at δH 6.80 ppm and β-C atom of the acetyl vinyl
fragment at δC 125.4 ppm, and between protons of the methyl group at δH 2.41 ppm and α-C atom of
the acetyl vinyl fragment at δC 130.8 ppm are observed as well. All key cross-peaks are presented in
Table 1.
Table 1. Cross-peaks in heteronuclear single-quantum correlation and heteronuclear multiple-bond





7.40 (β-H) 125.4 104.5, 130.8, 166.3, 197.0 (C=O)
6.95 (α-H) 130.8 28.5, 125.4, 166.3, 197.0 (C=O)
6.80 (HIso) 104.5 125.4, 163.1, 166.3
2.41 (CH3) 28.5 130.8, 197.0 (C=O)
In summary, we have suggested an effective route to (E)-4-(3-phenylisoxazol-5-yl)but-3-en-2-one
employing oxidative RORC reaction of furfuryl ketone oxime. The exploration of the reaction scope is
underway in our laboratory.
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Figure 1. Data of 1H-1H correlation spectroscopy for compound (E)-4c (CDCl3).
 
Figure 2. Data of 1H-13C heteronuclear multiple-bond correlation spectroscopy for compound
(E)-4c (CDCl3).
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Figure 3. Data of 1H-13C heteronuclear single-quantum correlation spectroscopy for compound
(E)-4c (CDCl3).
3. Materials and Methods
All commercial products and solvents were used without further purification (Fisher Scientific,
Loughborough, UK). All reactions were run under the air unless noted otherwise.
The reactions under microwave irradiation were conducted in Microwave Synthesis Reactor
«Biotage® Robot Eight» (Biotage AB, Uppsala, Sweden) using sealed microwave reaction vessels.
TLC analyses were performed on Merck 60 F254 aluminum plates in combination with UV detection
(254 nm). Flash chromatography was performed on silica gel 200–300 mesh (Merck, Darmstadt,
Germany) using mixture EtOAc/i-hexane as eluents. Melting points were determined on a Mel-Temp
II Laboratory Devices apparatus (Triad Scientific Manasquan, Manasquan, NJ, USA); the values are
uncorrected. NMR spectra were recorded on a Bruker AV-600 (1H NMR at 600 MHz and 13C NMR at
151 MHz,) and Bruker AV-400 (1H NMR at 400 MHz and 13C NMR at 101 MHz) spectrometers (Bruker
GmbH, Mannheim, Germany). Proton chemical shifts (δ) are reported in parts per million (ppm)
relative to tetramethylsilane (TMS), with the solvent resonance employed as the internal standard
(CDCl3 δ= 7.26 ppm). Data are reported as follows: chemical shift, multiplicity (s= singlet, d = doublet,
t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, dt = doublet of triplets), coupling
constants (J) and integration. Coupling constants (J) are reported in Hertz (Hz). Carbon chemical shifts
are reported in ppm from tetramethylsilane (TMS), with the solvent resonance as the internal standard
(CDCl3 δ = 77.16 ppm).
IR spectra were measured on PerkinElmer Spectrum BX spectrophotometer (NaCl plates,
PerkinElmer LAS GmbH, Rodgau, Germany). HRMS-ESI spectra were recorded at The Mass Spectroscopy
Laboratory, Chair of Organic Chemistry, Friedrich-Alexander University of Erlangen-Nuremberg.
Starting furfuryl ketone 5 was obtained according to the published procedure [18].
2-(5-Methylfuran-2-yl)-1-phenylethan-1-one oxime (2c)
8
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Hydroxylamine hydrochloride (2 mmol) and anhydrous NaOAc (4 mmol) were added to a
solution of furfuryl ketone 5 (2 mmol) in ethanol (5 mL), and the mixture was stirred for 24 h at 80 ◦C
(TLC and LC-MS control). Then, the reaction mixture was poured into H2O (100 mL) and extracted
with EtOAc (4 × 25 mL). The combined organic phases were washed with brine, dried over anhydrous
Na2SO4, filtered, and evaporated under reduced pressure. The resulting crude product was purified
by flash chromatography using EtOAc/i-Hex as eluents.
Yield 0.61 g (100%). White solid. M.p. 90–92 ◦C. 1H NMR (600 MHz, CDCl3): δ = 7.69–7.67 (m,
2H), 7.37–7.36 (m, 3H), 5.92 (d, J = 3.0 Hz, 1H), 5.83 (m, 1H), 4.13 (s, 2H), 2.24 (s, 3H) ppm. 13C NMR
(101 MHz, CDCl3): δ = 155.2, 150.9, 147.9, 135.3, 129.4, 128.5, 126.4, 107.5, 106.3, 25.5, 13.6 ppm. IR
(NaCl): 3241, 2922, 1568, 1495, 1461, 1321, 1168, 1016, 960 cm−1. HRMS (ESI): m/z calcd. for C13H13NO2
[M-H]+: 214.0868; found: 214.0862.
(E,Z)-4-(3-Phenylisoxazol-5-yl)but-3-en-2-one ((E,Z)-4c)
m-CPBA (77% w/w, 0.135 g, 0.6 mmol) was added to a solution of oxime 2c (0.5 mmol) in DCM
(2 mL) at 0 ◦C. The reaction mixture was stirred at the same temperature for 1 h. Then TFA (0.038 mL,
0.05 mmol) was added. The reaction mixture was allowed to reach room temperature and stirred for
20 h. Once the reaction was complete, the mixture was washed with Na2S2O3 solution three times, and
then with brine. DCM was dried over anhydrous Na2SO4, filtered, and evaporated under reduced
pressure to give a pure (E,Z)-4.
(Z)-4-(3-Phenylisoxazol-5-yl)but-3-en-2-one ((Z)-4c)
In a mixture with (E)-isomer. 1H NMR (600 MHz, CDCl3): δ = 7.87–7.86 (m, 2H), 7.69 (s, 1H),
7.48–7.44 (m, 3H), 6.74 (d, J = 12.8 Hz, 1H), 6.43 (d, J = 12.8 Hz, 1H), 2.37 (s, 3H) ppm. 13C NMR
(101 MHz, CDCl3): δ = 197.8, 166.0, 163.2, 130.8, 130.4, 130.1, 128.9, 126.8, 123.5, 106.0, 31.5 ppm.
Isomerization (E,Z)-4→(E)-4
Microwave reaction vessel was charged with (E,Z)-4c (0.2 mmol), I2 (0.0034 g, 0.013 mmol), and
toluene (5 mL). The reaction mixture was stirred at 140 ◦C in a microwave reactor for 2 h. After
completion of the reaction, toluene and iodine were removed under reduced pressure to afford
pure (E)-3a.
(E)-4-(3-Phenylisoxazol-5-yl)but-3-en-2-one) (E)-4c)
Yield 0.034 g (80%). White solid. M.p. 130–132 ◦C. 1H NMR (600 MHz, CDCl3): δ = 7.83–7.81
(m, 2H), 7.49–7.47 (m, 3H), 7.40 (d, J = 16.2 Hz, 1H), 6.95 (d, J = 16.2 Hz, 1H), 6.80 (s, 1H), 2.41 (s, 3H)
ppm. 13C NMR (151 MHz, CDCl3): δ = 197.0, 166.3, 163.1, 130.8, 130.4, 129.1, 128.4, 126.8, 125.4, 104.5,
28.5 ppm. IR (NaCl): 1664 (C=O), 1560, 1439, 1268, 983, 952, 769 cm−1. HRMS (ESI): m/z calcd. for
C13H11NO2 [M + H]+: 214.0868; found: 214.0861.
Supplementary Materials: The following are available online, Figure S1: 1H NMR spectrum of compound 2c,
Figure S2: 13C NMR spectrum of compound 2c, Figure S3: 1H NMR spectrum of compound (E)-4c, Figure S4: 13C
NMR spectrum of compound (E)-4c, Figure S5: 1H NMR spectrum of compound (Z)-4c, Figure S6: 13C NMR
spectrum of the compound (Z)-4c.
Author Contributions: N.S.—synthesis, A.A.K.—NMR data analysis, writing the manuscript, O.V.S.—
conceptualization, supervision, data analysis, writing the manuscript, funding acquisition. All authors read and
approved the final manuscript.
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Abstract: Azaheterocycles derivatives with pyridine-imidazole skeleton are compounds of
great value for medicinal chemistry. We report herein the nitration of 1,1′-(pyridine-2,6-
diylbis(methylene))bis{3-[2-(4-nitrophenyl)-2-oxoethyl]-1H-imidazol-3-ium} bromide using a typical
mixture of nitric and sulphuric acid. The nitration occur with the oxidative cleavage of N–C bond
between imidazolium ring and methylene group.
Keywords: nitration; azaheterocycles; N–C bond cleavage; pyridine-imidazolium
1. Introduction
In the past decades five and six member ring azaheterocycles compounds, especially imidazole
and (di)azine, became invaluable scaffolds in drug designing because of their large variety of biological
activities, such as anticancer, antimicrobial (antibacterial, antifungal, antitubercular), antimalarial,
anti-inflammatory, antidepressant, analgesic, antihypertensive etc. [1–7].
Taking into consideration our expertise in the area of obtaining new biologically active compounds
with antimicrobial activity [8–14] using cycloimmonium ylides chemistry [15–21], we decided to study
the reactions of pyridine-imidazolium salts with nitric acid.
2. Results and Discussion
In this respect, we perform the nitration of 1,1′-[pyridine-2,6-diylbis(methylene)]bis{3-[2-(4-
nitrophenyl)-2-oxoethyl]-1H-imidazol-3-ium} bromide 1, using a typical mixture of nitric and sulphuric
acid, Figure 1.
Figure 1. The nitration of 1,1′-[pyridine-2,6-diylbis(methylene)]bis{3-[2-(4-nitrophenyl)-2-oxoethyl]-1H-
imidazol-3-ium} bromide.
Our expectation was to have a nitration in the 3-position of pyridine ring or in the 4-position of the
imidazole moiety. Instead of this an unexpected oxidative cleavage N–C bond between imidazolium
ring and methylene group took place, with the formation of 2,6-bis[(1H-imidazol-1-yl)methyl]pyridine
Molbank 2019, 2019, M1095; doi:10.3390/M1095 www.mdpi.com/journal/molbank11
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2 and 4-nitrobenzoic acid 3. The structures of compounds were proven by spectroscopic analysis:
1H-NMR, 13C-NMR, and two-dimensional experiments 2D- COSY, 2D-HMQC, 2D-HMBC.
In conclusions, nitration of 1,1′-[pyridine-2,6-diylbis(methylene)]bis{3-[2-(4-nitrophenyl)-2-
oxoethyl]-1H-imidazol-3-ium} bromide occur with the oxidative cleavage of N–C bond between
imidazolium ring and methylene group, with the formation of two side products 2,6-bis[(1H-
imidazol-1-yl)methyl]pyridine 2 and 4-nitrobenzoic acid 3.
3. Materials and Methods
3.1. Instrumentation
All the reagents and solvents were purchased from commercial sources (Sigma Aldrich and Merck,
Darmstadt, Germany) and used without further purification. Melting points were recorded on an
Electrothermal MEL-TEMP (Barnstead International, Dubuque, IA, USA) apparatus in open capillary
tubes and are uncorrected. Analytical thin-layer chromatography was performed with commercial
silica gel plates 60 F254 (Merck) and visualized with UV light. The NMR spectra were recorded on a
(Bruker, Vienna, Austria) Advance III 500 MHz spectrometer operating at 500 MHz for 1H and 125
MHz for 13C. Chemical shifts were reported in delta (δ) units, part per million (ppm) and coupling
constants (J) in Hz.
2,6-Bis[(1H-imidazol-1-yl)methyl]pyridine 2, was initially synthetized by Garrison and Co [22];
in the supporting information of the paper all the data concerning the compound can be found
for comparison.
4-Nitrobenzoic acid 3, is a commercially available compound and relevant data can be found in
the Sigma-Aldrich catalog [23].
3.2. Nitration of Pyridine-Imidazolium Salts
Concentrated nitric acid (HNO3 65%, p.a.) (4.89 mmol, 9.78 equiv., 0.22 mL) was added dropwise
over the undissolved quaternary salt 1 (0.5 mmol, 1 equiv., 0.36 g) at 0 ◦C (ice bath) under vigorous
stirring, until the entire precipitate has been dissolved (10 min) completely. Concentrated sulfuric
acid (H2SO4 98%) (3.825 mmol, 7.65 equiv., 0.21 mL) was added dropwise, at 0 ◦C (ice bath), over the
reaction mixture. The resulting solution was stirred at room temperature for 30 min, and after that
heated at 130 ◦C for 2 h. The nitrogen oxides released were bubbled into a water bath. The reaction
was processed by neutralization with a saturated NaHCO3 solution (0.95 mL). The formed precipitate
was collected by filtration, washed with distilled H2O (5–7 mL), and dried in vacuum, obtaining
2,6-bis[(1H-imidazol-1-yl)methyl]pyridine 2 as a white powder.
From the aqueous phase the extraction was performed with ethyl acetate (3 × 20 mL), the phase
was separated and the organic layer was dried over sodium sulphate. After filtration, the solution was
left overnight, resulting in the formation of a yellow acicular precipitate, 4-nitrobenzoic acid.
2,6-Bis[(1H-imidazol-1-yl)methyl]pyridine (2). White powder, m.p. 106–107 ◦C. Yield 32%. 1H-NMR
(500 MHz, DMSO) (ppm): 7.78 (t, 1H, 3J = 8.0 Hz, H4), 7.74 (s, 2H, 2H2′), 7.19 (as, 2H, 2H5′), 7.03 (d,
2H, 3J = 8.0 Hz, 2H3), 6.92 (as, 2H, 2H4′), 5.28 (s, 4H, 2(-CH2-). 13C-NMR (125 MHz, DMSO) (ppm):
156.7 (2C2), 138.5 (C4), 137.7 (2C2′ ), 128.6 (2C4′ ), 120.4 (2C3), 119.8 (2C5′ ), 51.13 (2(-CH2-)).
4-Nitrobenzoic Acid (3). Yellow acicular crystals, m.p. 237–238 ◦C. Yield 41%. 1H-NMR (400 MHz,
DMSO) (ppm): 13.67 (brs, 1H, -COOH), 8.30 (d, 2H, 3J = 7.6 Hz, 2H3), 8.15 (d, 2H, 3J = 7.6 Hz, 2H2).
13C-NMR (100 MHz, DMSO) (ppm): 165.8 (-COOH), 150.0 (C4), 136.3 (C1), 130.7 (2C3), 123.7 (2C2).
Supplementary Materials: 1H- and 13C-NMR spectra for compounds 2 and 3 are available online.
Author Contributions: Conception and writing were performed by V.M. Experimental work and structure
elucidation were performed by D.C. and V.M. All authors reviewed and approved the final version.
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Abstract: 2,3,5-Tri-O-benzyl- and 2,3,5-tri-O-methyl-d-ribono-γ-lactone were converted with
(methoxyethoxymethoxy)methyl and benzyloxy tributylstannane into the corresponding
protected d-psicoses as mixtures of anomers in 31%–72% yield. Treatment of
2,3,5-tri-O-methyl-l-ribono-γ-lactone with benzyloxy tributylstannane afforded the corresponding
l-psicose derivative as an anomeric mixture in 72% yield. Both methylated psicoses were further
converted into 1,2-O-isopropylidene-3,4,6-tri-O-methyl-d- and l-psicofuranosides, the respective α-
and β-anomers of which could be separated and characterized.
Keywords: ribose; psicose; ketose; rare sugar; hydroxy methylation
1. Introduction
Only a few ketoses occur in nature in significant amounts. d-Fructose is the only ketose that
occurs in large quantities in nature and can be isolated from plant material [1]. Other ketoses like
psicose (Figure 1) are rare carbohydrates which cannot be isolated in considerable amounts from
natural sources. They can be synthesized either by isomerization of the corresponding aldoses in
low yields or by multi-step syntheses involving different protection and deprotection steps or by
enzymatic methods [2–8] resulting in a high price for these ketoses. As part of an ongoing research
project about the synthesis of carbohydrate derived catalysts for asymmetric syntheses [9–12] we
required considerable amounts of d- and l-psicofuranose derivatives 3. Due to the high price of both
enantiomers of psicose [13] we developed a specific synthetic route for the preparation of d- and
l-psicose derivatives 3, starting from d- and l-ribose (2). We chose ribose as the starting material because
both enantiomers of this sugar are commercially available at decent costs [13] and the stereocenters
possess the same configuration as psicose.
 
Figure 1. Fischer projection of d- and l-psicose (1), d- and l-ribose (2) and d- and l-psicose derivatives
3. PG—protective group.
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2. Results and Discussion
We first established a synthetic route starting with the cheap d-enantiomer of ribose and applied
our findings later to the more expensive l-enantiomer. Since ribose is a pentose and psicose a hexose,
the carbohydrate chain of the ribose had to be elongated by one carbon atom. Our strategy for
accomplishing this was to first convert ribose to the corresponding lactone 6 and then elongate its
carbon chain at C-1 via addition of the organometallic reagent 5 (Scheme 1). The latter could be
obtained from tributylstannyl methanol 4 by transmetallation with butyl lithium and had already been
used for the elongation of other carbohydrate derivatives [14–17].
 
Scheme 1. Planned elongation of the carbohydrate chain in order to derive hexose from a pentose.
At first we attempted to react known tri-O-benzyl ribono lactone (8) [18] with unprotected 4
(4a, R = H) [19] since this approach would have led directly to the target molecules without the
need of any additional protecting group manipulations. Unfortunately, treatment of d-8 with 4a only
resulted in decomposition of the starting materials. Next, we decided to use a suitably protected
stannyl reagent 4 since such reagents had previously been used successfully for the elongation of other
aldose derivatives. As a protecting group we chose the methoxyethoxmethyl group (MEM) due to its
orthogonality to benzyl protecting groups and its facile removal [20]. In fact, treatment of lactone d-8
with MEM-protected 4b afforded the corresponding elongated sugar d-9, however in rather poor yield
(Scheme 2).
 
Scheme 2. Hydroxy methylation of d-8 with methoxyethoxmethyl group (MEM)-protected organotin
compound 4b.
It is known that stannyl reagents of the type 4 may rearrange upon transmetallation, with butyl
lithium. Most likely this was the reason for the observed low yield. Such rearrangements may depend
on the nature of the protecting group in 4. [19] Therefore, we decided to use a supposedly more stable
benzyl group instead of the MEM protective group for reagent 4. In order to keep orthogonality
between the protective groups at the ribono lactone and the stannyl reagent we also changed the
substituents at the lactone accordingly. Here, we chose methyl groups as they can be introduced easily
and are stable to broad range of reaction conditions. Thus known ribose derivative d-10 [21] was
first oxidized to d-11 in excellent yield using iodine as the oxidant (Scheme 3). Addition of d-11 to a
solution of the benzylated organotin reagent 4c and n-BuLi finally provided d-12 in good yield as an
inseparable mixture of anomers.
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Scheme 3. Synthesis of methylated d-psicose derivatives.
Next, the benzyl group at position 1 of psicose derivative d-12 was reductively removed in very
high yield using palladium on charcoal as the catalyst. Deprotected compound d-13 again emerges
as a mixture of inseparable anomers. In order to obtain an anomerically pure substance we further
modified d-13 by converting it into the corresponding isopropylidene derivatives d-14 and d-15 both
of which could be isolated in pure form. The configuration at the anomeric center of d-14 and d-15
was verified by NMR spectroscopy. The NOESY spectrum of d-14 shows a NOE between H-1 and the
methyl groups at position 3 and 4 whereas the d-15 has a NOE between H-1 and H-3.
With a working synthetic sequence for the d-enantiomers in hand, we applied it to the l-enantiomer
l-10 as well (Scheme 4). l-10 was prepared as described in the literature for the preparation of d-10. [21]
As was expected, the synthetic route worked smoothly with yields nearly identical yields to those
obtained for the d-enantiomers in all steps of the reaction sequence.
Scheme 4. Synthesis of methylated l-psicose derivatives.
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3. Materials and Methods
3.1. General Remarks
Reactions in dry solvents were carried out under an atmosphere of nitrogen. Dry THF was
distilled from sodium/benzophenone, dry CH2Cl2 was distilled from P4O10, dry acetone was prepared
from HPLC grade acetone by the addition of molecular sieves (4 Å). Tert-butanol and ethanol were
HPLC grade and used without further purification. Solvents used for column chromatography were
techniqual grade and distilled prior to their use. Petroleum ether (PE) refers to the fraction boiling at
60–90 ◦C. Silica gel “60 M” from Machery-Nagel was used for column chromatography. For reaction
monitoring, TLC plates “Polygram Sil G/U254” from Machery-Nagel were used. Optical rotations were
measured with a Perkin Elmer “Polarimeter 341”. NMR spectra were measured at a Bruker “Avance
III HD 400” or a Bruker “Avance HD 300 NanoBay” and are calibrated to the solvent signal. For peak
assignment additional spectra (DEPT, COSY, HMBC, HSQC) were recorded. The atoms are numbered
in accordance with the carbohydrate nomenclature. High resolution mass spectra were measured at a
Bruker “maXis 4G”. Elemental analysis was performed using a HEKAtech “Euro 3000 CHN”.
3.2. Synthesis of Compounds
[(Methoxy-ethoxy-methoxy)-methyl]tributylstannane (4b): To a solution of
tributylstannyl-methanol (4a) (911 mg, 2.83 mmol) [22] in dry CH2Cl2 (10 mL) DIPEA (0.72 mL,
4.25 mmol) and MEM-Cl (0.49 mL, 4.25 mmol) were added and the reaction mixture was stirred at room
temperature for 16 h. Then, again MEM-Cl (0.16 mL, 1.41 mmol) was added and the reaction mixture
was stirred for additional 5 h. The reaction was quenched by the addition of MeOH and afterwards
water was added. The aqueous phase was extracted with CH2Cl2 (3 × 10 mL). The combined organic
layers were dried (Na2SO4) and the solvent was evaporated in vacuo. Column chromatography
(PE + 2% Et3N→ PE/EtOAc, 20/1 + 2% Et3N) provided 4b (985 mg, 85%) as colorless oil. Rf = 0.50
(PE/EtOAc, 10/1 + 2% Et3N); 1H-NMR (400 MHz, CDCl3) δ = 4.61 (s, 2H, SnCH2O), 3.76 (s, 2H,
OCH2O), 3.62–3.68 (m, 2H, OCH2CH2O), 3.53–3.61 (m, 2H, OCH2CH2O), 3.33–3.45 (m, 3H, OCH3),
1.46–1.56 (m, 6H, C4H9), 1.26–1.35 (m, 6H, C4H9), 0.78–0.99 (m, 15H, C4H9); 13C-NMR (101 MHz,
CDCl3) δ = 98.6 (SnCH2O), 71.8 (OCH2CH2O), 66.5 (OCH2CH2O), 59.0 (OCH3), 57.7 (OCH2O),
29.1 (CH2C3H7), 27.3 (CH2C3H7), 13.7 (CH3C3H6), 8.8 (CH2C3H7); HRMS (ESI-TOF) m/z [M +Na]+:
calcd for C17H38O3SnNa: 433.17351, found: 433.17360; Anal calcd for C17H38O3Sn: C 49.9, H 9.36,
found: C 49.76, H 9.38.
3,4,6-Tri-O-benzyl-1-O-(methoxyethoxymethyl)-d-psicose (d-9): To a solution of 4b (239 mg,
0.58 mmol) in dry THF (2 mL) n-BuLi (348 μl, 0.56 mmol; 1.6 m in hexanes) and lactone d-8 (116 mg,
0.28 mmol; dissolved in 2 mL dry THF) were subsequently added at −80 ◦C. The reaction mixture
was stirred at −80 ◦C for 40 min and afterwards the reaction was quenched by the addition of water
(5 mL). The mixture was extracted with EtOAc (3 × 20 mL) and the combined organic layers were
dried (Na2SO4). After evaporation of the solvent, the residue was purified by column chromatography
(PE/EtOAc, 2/1 → 1/1), which provided d-9 (47 mg, 31%) as a colorless oil. [α]20D = −15.6◦ (c = 1.0,
CHCl3); Rf = 0.25 (PE/EtOAc, 2/1); 1H-NMR (400 MHz, CDCl3) δ = 7.11–7.36 (m, 15H, H-Ar), 5.60–5.77
(m, 1H, OH), 4.82–4.86 (m, 1H, CH2Ph), 4.66–4.69 (m, 1H, CH2Ph), 4.58–4.62 (m, 1H, H-1a), 4.54–4.58
(m, 1H, H-1b), 4.43–4.52 (m, 3H, CH2Ph), 4.35–4.42 (m, 1H, CH2Ph), 4.21–4.24 (m, 1H, H-5), 3.95–4.04
(m, 1H, H-6a), 3.64–3.75 (m, 2H, H-3, MEM), 3.44–3.63 (m, 4H, H-6b, MEM), 3.35–3.42 (m, 3H, H-4,
MEM), 3.26 (s, 3H, CH3); 13C-NMR (101 MHz, CDCl3) δ = 137.8, 137.6, 137.5, 128.5, 128.4, 128.4, 128.1,
127.9, 127.9, 127.8, 127.4 (C-Ar), 97.5 (C-2), 95.9 (C-1), 75.4 (C-5), 75.1 (CH2Ph), 74.7 (C-3 or C-4), 73.3
(C-3 or C-4), 71.6 (MEM), 71.4, 71.2 (CH2Ph), 69.1, 66.9 (MEM), 58.9 (CH3), 57.5 (C-6); HRMS (ESI-TOF)
m/z [M + Na]+: calcd for C31H38O8Na: 561.24589, found: 561.24618; Anal calcd for C31H38O8: C 69.13,
H 7.11, found: C 68.82, H 7.19.
2,3,5-Tri-O-methyl-d-ribono-1,4-lactone (d-11): A mixture of d-10 (3.83 g, 19.9 mmol), I2 (10.1 g,
39.8 mmol) and K2CO3 (5.51 g, 39.8 mmol) in tert-butanol (100 mL) was heated to 80 ◦C for 90 min.
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The reaction mixture was cooled to room temperature and water (10 mL) and solid Na2S2O4 were
added to quench the excess of iodine. The mixture was filtered and the solvent was evaporated in
vacuo. Column chromatography (PE/EtOAc, 2/1→ 1/1) provided d-11 (3.50 g, 92%) as light yellow oil.
[α]20D = +52.3
◦ (c = 1.0, CHCl3); Rf = 0.59 (EtOAc); 1H-NMR (300 MHz, CDCl3) δ = 4.47–4.56 (m, 1H,
H-4), 4.25 (d, J = 5.6 Hz, 1H, H-2), 4.05 (dd, J = 5.6, 1.7 Hz, 1H, H-3), 3.64 (s, 3H, CH3), 3.62 (t, J = 2.7 Hz,
2H, H-5), 3.48 (s, 3H, CH3), 3.31–3.39 (m, 3H, CH3); 13C-NMR (75 MHz, CDCl3) δ = 173.3 (C-1), 80.8
(C-4), 77.5 (C-3), 76.4 (C-2), 71.6 (C-5), 59.5, 59.2, 58.0 (CH3); HRMS (ESI-TOF) m/z [M + Na]+: calcd for
C8H14O5Na: 213.07334, found: 213.07374; Anal calcd for C8H14O5: C 50.52, H 7.42, found: C 50.12,
H 7.32.
2,3,5-Tri-O-methyl-l-ribono-1,4-lactone (l-11): Prepared with the same protocol described for
d-11, from l-10 (3.50 g, 18.2 mmol), I2 (9.24 g, 36.4 mmol) and K2CO3 (5.03 g, 36.4 mmol). Colorless
oil, (3.12 g, 90%) yield after column chromatography. [α]20D = −51.1◦ (c = 1.0, CHCl3); Rf and NMR
data was identical to d-11; HRMS (ESI-TOF) m/z [M + Na]+: calcd for C8H14O5Na: 213.07334, found:
213.07350; Anal calcd for C8H14O5: C 50.52, H 7.42, found: C 50.88, H 7.71.
3,4,6-Tri-O-methyl-1-O-benzyl-d-psicose (d-12): To a solution of 4c (6.36 g, 15.5 mmol) [23] in dry
THF (25 mL) n-BuLi (11.6 mL, 18.5 mmol; 1.6m in hexanes) and lactone d-11 (1.96, 10.3 mmol; dissolved
in 25 mL dry THF) was subsequently added at −80 ◦C. The reaction mixture was stirred at −80 ◦C for
90 min and afterwards allowed to reach room temperature and quenched by the addition of AcOH
(1 mL), filtered and the solvent was evaporated in vacuo. Column chromatography (PE/EtOAc, 1/1)
provided d-12 (2.32 g, 72%) as colorless oil. The product was isolated as mixture of anomers in ratio 4:1.
[α]20D = −6.7◦ (c = 1.0, CHCl3); Rf = 0.30 (PE/EtOAc, 1/1); 1H-NMR (300 MHz, CDCl3) δ = 7.23–7.41
(m 5H, H-Ar, both anomers), 4.48–4.73 (m, 2H, CH2Ph, both anomers), 4.20–4.29 (m, 0.8H, H-5, major
anomer), 4.07–4.17 (m, 0.2H, H-4, minor anomer), 4.01–4.05 (m, 0.2H, H-5, minor anomer), 3.89 (d,
J = 5.1 Hz, 0.8H, H-3, major anomer), 3.78–3.85 (m, 0.8H, H-4, major anomer), 3.76 (d, J = 3.2 Hz, 0.2H,
H-3, minor anomer), 3.29–3.68 (m, 13H, H-1a, H-1b, H-6a, H-6b, 3 × CH3); 13C-NMR (75 MHz, CDCl3)
δ = 138.2, 128.3, 128.2, 127.9, 127.7, 127.6, 127.5 (C-Ar), 104.8 (C-2, minor anomer), 102.8 (C-2, major
anomer), 82.9 (C-3, minor anomer), 80.7 (C-5, minor anomer), 79.9 (C-4, minor anomer), 79.8 (C-4,
major anomer), 79.1 (C-3, major anomer), 79.0 (C-5, major anomer), 73.7 (CH2Ph, minor anomer),
73.5 (CH2Ph, major anomer), 73.0 (C-6, minor anomer), 72.5 (C-6, major anomer), 71.1 (C-1, major
anomer), 70.8 (C-1, minor anomer), 60.0 (CH3, minor anomer), 59.3 (CH3, major anomer), 59.2 (CH3,
minor anomer), 59.1 (CH3, major anomer), 58.4 (CH3, minor anomer), 58.4 (CH3, major anomer);
HRMS (ESI-TOF) m/z [M +Na]+: calcd for C16H24O6Na: 335.14651, found: 335.14699; Anal calcd for
C16H24O6: C 61.52, H 7.74, found: C 61.05, H 7.84.
3,4,6-Tri-O-methyl-1-O-benzyl-l-psicose (l-12): Prepared with the same protocol as described for
d-12, from 4c (8.76 g, 21.3 mmol), l-11 (2.70, 14.2 mmol) and n-BuLi (16.0 mL, 25.6 mmol; 1.6 m in
hexanes). Colorless oil, (3.06 g, 69%) yield after column chromatography. [α]20D = +7.3
◦ (c = 1.0, CHCl3);
Rf and NMR data was identical to d-11; HRMS (ESI-TOF) m/z [M + Na]+: calcd for C16H24O6Na:
335.14651, found: 335.14642; Anal calcd for C16H24O6: C 61.52, H 7.74, found: C 61.53, H 7.87.
3,4,6-Tri-O-methyl-d-psicose (d-13): A mixture of d-12 (2.64 g, 8.45 mmol) and Pd (200 mg,
0.19 mmol; 10% on activated carbon) in degassed EtOH (100 mL) was stirred under an atmosphere of
hydrogen for 3 h. The reaction mixture was filtered through a pad of celite. After evaporation of the
solvent in vacuo the residue was purified by column chromatography (EtOAc→ EtOAc/i-PrOH 1/1)
which provided d-13 (1.72 g, 92%) as a colorless oil. The product was isolated as mixture of anomers in
ratio 4:1. [α]20D = +1.6
◦ (c = 1.0, CHCl3); Rf = 0.60 (EtOAc/i-PrOH, 1/1); 1H-NMR (400 MHz, CDCl3)
δ = 4.32 (s, 0.8H, OH, major anomer), 4.19–4.22 (m, 0.8H, H-5, major anomer), 4.12–4.18 (m, 0.2H,
H-5, minor anomer), 4.02–4.06 (m, 0.2H, H-4, minor anomer), 3.91–3.96 (m, 0.8H, H-4, major anomer),
3.87–3.90 (m, 0.8H, H-3, major anomer), 3.78–3.81 (m, 0.2H, H-3, minor anomer), 3.74 (s, 0.2H, OH,
minor anomer), 3.32–3.68 (m, 13H, H-1a, H-1b, H-6a, H-6b, 3 × CH3), 2.50 (bs, 1H, OH); 13C-NMR
(101 MHz, CDCl3) δ = 105.2 (C-2, minor anomer), 103.4 (C-2, major anomer), 83.9 (C-3, minor anomer),
80.7 (C-4, minor anomer), 80.2 (C-5, minor anomer), 80.2 (C-4, major anomer), 79.3 (C-3, major anomer),
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79.2 (C-5, major anomer), 72.7 (C-6, minor anomer), 72.1 (C-6, major anomer), 64.8 (C-1, major anomer),
64.2 (C-1, minor anomer), 60.0 (CH3, minor anomer), 59.6 (CH3, major anomer), 59.3 (CH3, minor
anomer), 59.3 (CH3, major anomer), 58.6 (CH3, major anomer), 58.5 (CH3, minor anomer); HRMS
(ESI-TOF) m/z [M + Na]+: calcd for C9H18O6Na: 245.09956, found: 245.09987; Anal calcd for C9H18O6:
C 48.64, H 8.16, found: C 48.39, H 7.84.
3,4,6-Tri-O-methyl-l-psicose (l-13): Prepared with the same protocol as described for d-13, from
l-12 (1.47 g, 4.70 mmol) and Pd (150 mg, 0.14 mmol; 10% on activated carbon). Colorless oil, (971 mg,
93%) yield after column chromatography. [α]20D = −0.7◦ (c = 1.0, CHCl3); Rf and NMR data was identical
to d-11; HRMS (ESI-TOF) m/z [M + Na]+: calcd for C9H18O6Na: 245.09956, found: 245.09987; Anal
calcd for C9H18O6: C 48.64, H 8.16, found: C 48.83, H 8.24.
1,2-O-Isopropylidene-3,4,6-tri-O-methyl-α-d-psicofuranosid (d-14) and 1,2-O-isopropylidene-
3,4,6-tri-O-methyl-β-d-psicofuranosid (d-15): To a solution of d-13 (26 mg, 0.117 mmol) in dry acetone
(1 mL) para-toluene sulfonic acid (2.3 mg, 0.012 mmol; monohydrate) was added and the resulting
mixture was stirred at room temperature for 20 h. The reaction mixture was alkalized by the addition
of NH3 (0.1 mL; 25% in H2O) and the solvent was evaporated in vacuo. Column chromatography
(PE/EtOAc, 1/1→ 1/3) afforded both anomers in two different fractions. Eluted first: d-14 (22 mg, 70%)
as a colorless oil. [α]20D = −35.3◦ (c = 1.0, CHCl3); Rf = 0.56 (PE/EtOAc, 1/1); 1H-NMR (400 MHz, CDCl3)
δ = 4.26 (d, J = 9.7 Hz, 1H, H-1a), 4.05–4.09 (m, 1H, H-5), 3.97 (d, J = 9.7 Hz, 1H, H-1b), 3.78–3.83
(m, 1H, H-4), 3.76 (d, J = 4.5 Hz, 1H, H-3), 3.56 (s, 3H, CH3O), 3.50 (d, J = 5.1 Hz, 2H, H-6a, H-6b),
3.44 (s, 3H, CH3O), 3.40 (s, 3H, CH3O), 1.48 (s, 3H, CH3C), 1.40 (s, 3H CH3C); 13C-NMR (101 MHz,
CDCl3) δ = 111.8 (C(CH3)2), 110.5 (C-2), 82.3 (C-3), 81.1 (C-4), 79.3 (C-5), 74.0 (C-6), 69.7 (C-1), 59.8, 59.4,
58.4 (CH3O), 26.3, 26.1 (C(CH3)2); HRMS (ESI-TOF) m/z [M + Na]+: calcd for C12H22O6Na: 285.13086,
found: 285.13089. Eluted second: d-15 (4.8 mg, 16%) as a colorless oil. [α]20D = +10.5
◦ (c = 1.0, CHCl3);
Rf = 0.20 (PE/EtOAc, 1/1); 1H-NMR (400 MHz, CDCl3) δ = 4.23–4.26 (m, 1H, H-5), 4.08 (d, J = 9.1 Hz,
1H, H-1a), 4.03 (d, J = 9.1 Hz, 1H, H-1b), 3.77 (dd, J = 6.4, 2.9 Hz, 1H, H-4), 3.59 (d, J = 6.4 Hz, 1H,
H-3), 3.52 (s, 3H, CH3O), 3.48 (d, J = 3.9 Hz, 2H, H-6a, H-6b), 3.44 (s, 3H, CH3O), 3.38 (s, 3H, CH3O),
1.53 (s, 3H, CH3C), 1.47 (s, 3H, CH3C); 13C-NMR (101 MHz, CDCl3) δ = 111.8 (C(CH3)2), 109.2 (C-2),
81.0 (C-5), 80.2 (C-3), 78.2 (C-4), 73.2 (C-6), 71.8 (C-1), 59.5, 58.7, 58.5 (CH3O), 26.6, 26.3 (C(CH3)2);
HRMS (ESI-TOF) m/z [M +Na]+: calcd for C12H22O6Na: 285.13086, found: 285.13106; Anal calcd for
C12H22O6: C 54.95, H 8.45, found: C 54.47, H 8.28.
1,2-O-Isopropylidene-3,4,6-tri-O-methyl-α-l-psicofuranosid (l-14) and 1,2-O-isopropylidene-3,4,6-
tri-O-methyl-β-l-psicofuranosid (l-15): Prepared with the same protocol as described ford-14 andd-15,
from l-13 (148 mg, 0.666 mmol) and para-toluene sulfonic acid (12.6 mg, 0.066 mmol; monohydrate).
Eluted first: l-14 (124 mg, 71%) as a colorless oil. [α]20D = +37.6
◦ (c = 1.0, CHCl3); Rf and NMR data was
identical to d-14; HRMS (ESI-TOF) m/z [M +Na]+: calcd for C12H22O6Na: 285.13086, found: 285.13097;
Anal calcd for C12H22O6: C 54.95, H 8.45, found: C 55.62, H 8:72. Eluted second: l-15 (30 mg, 17%) as
a colorless oil. [α]20D = −9.2◦ (c = 1.0, CHCl3); Rf and NMR data was identical to d-15; HRMS (ESI-TOF)
m/z [M +Na]+: calcd for C12H22O6Na: 285.13086, found: 285.13110; Anal calcd for C12H22O6: 54.95,
H 8.45, found: C 55.18, H 8.45.
4. Conclusions
In summary, we describe a method to prepare derivatives of both enantiomers of rare ketoses
(i.e., psicose) from inexpensively ribose. The ketoses have the protecting groups necessary for the
synthesis of ligands for asymmetric catalysis. With other inexpensive commercially available pentoses
like for instance l-arabinose (100 g, 144 €) or d-xylose (1 kg, 57 €) derivatives of other rare ketoses like
l-fructose (50 mg, 126 €), or d-sorbose (100 mg, 224 €) are accessible [24]. By using the benzylated
lactone 8 in the sequence shown in Schemes 3 and 4, the completely deprotected psicose should be
obtained after the reduction under an atmosphere of hydrogen. Since the methyl groups are hard
to remove, other protective groups like MEM or TIPS at the carbohydrate may be used if an easily
removable to benzyl orthogonal protective group is needed.
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Abstract: In this paper, we report on the synthesis and spectroscopic characterization of the novel
nucleoside 5′-chloro-5′-deoxy-2′,3′-O-isopropylidene-6-fluoro nebularine, obtained as a side product
during the second step of the synthesis of 5′-fluoro-5′-deoxy-5-aminoimidazole-4-carboxamide-β-d-
riboside (5′-F-AICAR), a non-phosphorylable analogue of 5-aminoimidazole-4-carboxamide-β-d-
riboside (AICAR).
Keywords: AICAR; acadesine; phosphorylation; fluorination; fluorinated nucleosides; nucleoside
analogues; modified nucleosides; chlorinated nucleosides; AMPK
1. Introduction
Nucleoside and nucleotide analogues are synthetic modified compounds that have been developed
to mimic their physiological counterparts [1]. Considering that several nucleoside and nucleotide
analogues have been approved by the Food and Drug Administration (FDA) for the treatment of viral
and cancer diseases and others have entered clinical trials [2,3], many research groups have focused
their attention on the preparation of novel compounds to expand the pool of molecules with potential
biological activities, with the aim of discovering “leads” that are safer and more effective. For example,
the replacement of OH groups of sugar moieties with the isosteric F atom has generated life-saving
drugs for the treatment of infectious diseases, such as HIV [4], HBV [5], and HCV [6].
The nucleoside AICAR (1, Figure 1), besides being an intermediate involved in purine biosynthesis,
is an activator of the enzyme adenosine monophosphate-activated protein kinase (AMPK) in the
5′-phosphorylated form [7,8]. This activation leads to a cascade of metabolic events, such as the
inhibition of basal and insulin-stimulated glucose uptake, lipogenesis, and glucose oxidation [9].
The AMPK pathway is also implicated in the regulation of cell proliferation, and activation by AICAR
could result in pro-apoptotic effects [10]. Given the importance of such a molecule, the synthesis of
novel AICAR analogues is an appealing goal to better understand its mechanism of action [11–15].
Considering AICAR’s low intestinal absorption and poor penetration of the blood–brain barrier,
we synthesized a more lipophilic analogue, where the 5′-OH group was replaced by a fluorine atom
(2, 5′-F-AICAR) [16].
For the preparation of nucleoside 2, a key step was the 5′-fluorination of compound 4
(Scheme 1) [16]. In this paper, we report on the synthesis and structural characterization of the
novel nucleoside 8 (Scheme 2), obtained by a side reaction during the fluorination step. This nucleoside
could represent a valuable intermediate for a modular derivatization of the purine base moiety and the
sugar residue.
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Figure 1. Structures of AICAR (1) and 5′-F-AICAR (2).
2. Results and Discussion
For the synthesis of 5′-F-AICAR (2), we used as the starting material the commercially available
6-chloronebularine (3, Scheme 1), which was readily transformed into its 2′,3′-O-isopropylidene
derivative 4 [17]. After 5′-fluorination, the 6-chloropurine was converted into hypoxanthine and
the obtained nucleoside 6 transformed into the derivative 7. The strong electron-withdrawing
2,4-dinitrophenyl group, introduced at the N1 hypoxanthine position, allowed us to obtain the
5′-F-AICAR 2 through a 1,2-diaminoethane-mediated purine ring degradation [18].
In the second step of the synthesis, the 5′-OH group of nucleoside 4 was replaced by
a 5′-F in a one-pot tosylation/fluorination sequence, through the treatment with the tosyl
fluoride/tetrabutylammonium fluoride (TsF/TBAF) reagent system with tetrahydrofuran (THF) as
solvent, according to Shimizu’s procedure [19]. As previously observed by Ashton and Scammells [19],
we noted (TLC monitoring in n-hexane/AcOEt; 1:1) that the process led not only to the formation
of the expected fluorinated product 5a with Rf = 0.48 (Scheme 1), but also to the formation of the
bis-fluorinated product 5b with Rf = 0.42, as a consequence of the substitution in species 4 of the C6
chlorine atom by a fluoride ion.
Scheme 1. Reagents and conditions: (i) acetone, 2,2-dimethoxypropane (DMP), p-toluensulfonic
acid (p-TsOH), 2 h, r.t.; (ii) TsF, TBAF, THF, reflux, 18 h; (iii) 0.1 M NaOH, 4 h, r.t.; (iv), K2CO3,
1-chloro-2,4-dinitrobenzene, N,N-dimethylformamide (DMF), 3 h, 80 ◦C; (v) 1,2-diaminoethane, DMF,
16 h, 50 ◦C; (vi) 50% trifluoracetic acid (TFA) in H2O, 4 h.
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Scheme 2. Proposed mechanisms for the formation of nucleosides 8 and 9.
The TLC also showed a third spot with Rf = 0.52, whose corresponding product was isolated
(10% yield) and analyzed by 1H-NMR. The spectrum evidenced the presence of two compounds
in a ratio of 1:8, which were resolved only by means of high-performance liquid chromatography
(HPLC). The nucleoside in lower amounts and with Rt = 21.2 min was assigned as the novel
5′-chloro-5′-deoxy-2′,3′-O-isopropylidene-6-fluoro nebularine (8, Scheme 2). Its structure was
established through 1D-, 2D-NMR, and HRESI-MS experiments (see Supplementary Materials).
In detail, in the 1H-NMR spectrum the 5′-Ha,b protons resonated as two doublets of doublets at 3.81
and 3.70 ppm, whereas in the 13C-NMR spectrum the 5′C carbon resonated at 43.4 ppm. These data
were consistent with the presence of a 5′C–Cl bond [20]. In the HMBC spectrum, the 2-H proton
at 8.69 ppm correlated with the C6 purine carbon at 159.9 ppm, which appeared as a doublet with
J = 261.8 Hz, as a consequence of the coupling with the F atom.
A similar compound, with the 2′- and 3′-ribose hydroxyls protected as acetates, was synthesized
by Robins et al. [21] and used to obtain fluorescent probes for detecting the cellular uptake of the
drug gemcitabine.
The main component with Rt = 24.2 min was instead identified as the known 5′-chloro-5′-deoxy-
2′,3′-O-isopropylidene-6-chloro nebularine 9 [20].
A plausible mechanism for the formation of compounds 8 and 9 is described in Scheme 2. The Cl−
ions, derived from the partial Cl−/F− exchange at the C6 purine position during the 5′-fluorination
step, yielded the nucleosides 8 and 9 by SN2 displacement of the tosylate groups in the intermediates
10b and 10a, respectively.
3. Materials and Methods
All the reagents and solvents for the chemical syntheses were obtained from commercial sources
and used without further purification. The 1H-, 19F- and 13C-NMR spectra were acquired on
400/700 MHz instruments (Bruker, Billerica, MA, USA) using CDCl3 as the solvent. The chemical
shifts were reported in parts per million (δ) relative to the residual solvent signal (1H: CHCl3 7.27;
13C: CDCl3 77.0) and assigned by 2D-NMR experiments. All the NMR spectra were processed using
the iNMR software package (Nucleomatica, Molfetta, Italy). The HRESI-MS spectra were recorded
in positive mode on a Thermo Orbitrap XL mass spectrometer (ThermoFisher, Waltham, MA, USA).
The column chromatography was performed by using silica gel 60, 70–230 mesh (Merck, Darmstadt,
Germany). The TLC analyses were performed using 0.2 mm thick F254 silica gel plates (Merck,
Darmstadt, Germany). The TLC spots were detected under UV light (254 nm). The high-performance
liquid chromatography (HPLC) was performed on a UP-2075 Plus pump equipped with a UV-2075
Plus UV detector (Jasco, Cremella, Italy) using a 5 μm, 250-10 Si column (Purosphere® STAR, Merck,
Darmstadt, Germany) eluted with n-hexane/AcOEt, 6:4 with a flow rate of 2.0 mL/min.
5′-Chloro-5′-deoxy-2′,3′-O-isopropylidene-6-fluoro nebularine (8). To a stirred solution of 4 (0.28 g,
0.86 mmol) in dry THF (7.5 mL), TsF (0.30 g, 1.7 mmol) and TBAF (2.6 mL of a 1.0 M solution in dry
THF, 2.6 mmol) were added and the mixture refluxed for 16 h (TLC monitoring: n-hexane/AcOEt; 1:1).
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The solvent was removed under reduced pressure and the crude residue purified by silica gel flash
chromatography (n-hexane/AcOEt, 6:4) to afford, in addition to the two expected compounds 5a and
5b [19], the inseparable mixture of the two nucleosides 8 and 9 with Rf = 0.52 (10% yield). The mixture
was purified by HPLC (see above), thus obtaining the pure compound 8. Colorless foam (3.5 mg, 1.2%
yield). 1H-NMR (400 MHz; CDCl3): δ 8.69 (s, 1H, 2-H), 8.29 (s, 1H, 8-H), 6.24 (d, J = 2.6 Hz, 1H, 1′-H),
5.40 (dd, J = 6.4, 2.7 Hz, 1H, 2′-H), 5.13 (dd, J = 6.4, 3.1 Hz, 1H, 3′-H), 4.58-4.55 (m, 1H, 4′-H), 3.82
(dd, J = 11.6, 6.1 Hz, 1H, 5′-Ha), 3.70 (dd, J = 11.6, 4.9 Hz, 1H, 5′-Hb), 1.66 (s, 3H, CH3), 1.42 (s, 3H,
CH3); 19F-NMR (377 MHz; CDCl3): δ −68.4 (s); 13C-NMR (176 MHz; CDCl3): δ 159.9 (d, J = 261.8, 6-C),
154.5 (d, J = 11.1, 4-C), 152.2 (d, J = 14.3, 2-C), 144.0 (8-C), 121.15 (d, J = 29.2, 5-C), 115.1 (Cq acetonide),
91.3 (1′-C), 86.2 (4′-C), 84.2 (2′-C), 82.3 (3′-C), 43.9 (CH2Cl), 27.1 (CH3), 25.3 (CH3); HRESI-MS m/z
329.0809, ([M + H]+ calcd. for C13H15ClFN4O3 329.0817).
Supplementary Materials: The following are available online, Figure S1: copies of 1H- and 19F-NMR spectra
of compound 8; Figure S2: copy of 13C-NMR spectrum of compound 8; Figure S3: copy of HMBC spectrum of
compound 8; Figure S4: copy of HRESI-MS spectrum of compound 8.
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Abstract: The title compound, N-(2-hydroxy-1,1-dimethylethyl)-3-methylbenzamide was synthesized
by reacting 3-methylbenzoyl chloride or 3-methylbenzoic acid with 2-amino-2-methyl-1-propanol.
In the present report, the synthesized target compound was fully characterized by various
spectroscopic methods (1H NMR, 13C NMR, IR, GC-MS), its composition confirmed by elemental
analysis, and its structure determined and confirmed by X-ray analysis. The importance of this
compound lies in its possession of an N,O-bidentate directing group. Such a structural motif is
potentially suitable for metal-catalyzed C–H bond functionalization reactions.
Keywords: organic synthesis; bidentate directing groups; benzamides; chelation assistance;
bis-chelates; C–H bond functionalization; X-ray structure determination
1. Introduction
Functionalization of C–H bonds [1,2] has risen to be a powerful method for the transformation
of inert C–H bonds into reactive ones. Accordingly, the bond activation science enables rapid
access of functionalized molecules from simple non-reactive starting materials. In turn, C–H
bond functionalization enables construction of complex molecules in an atom-economical and
step-economical fashion. Site-selectivity remains a challenge in the environmentally benign
strategy [3,4]. The problem has been tackled by development of monondentate [5,6] and bidentate
directing groups [7]. The Lewis-base-contained directing groups promote formation of cyclometallated
complexes via chelation-assistance thus the setting stage for C–H bond functionalization. Specifically,
relative thermodynamic stability favors the formation of five-membered chelates, allowing the formation
of mono five-membered chelates (1, Figure 1) and double-five-membered chelates (2, Figure 1) by
monodentate and bidentate directing groups, respectively (Figure 1) [8].
Figure 1. Five-membered chelates.
Formation of the thermodynamically stable five-membered chelates necessitates a two-carbon
distance between the Lewis basic atom and the position to be functionalized and the same carbon
distance among the two Lewis basic atoms in bidentate directing groups. Such structural requirements
have triggered the design of bidentate directing groups (3, Figure 2) that led to modular triazole
directing groups (4, Figure 2). Thus, Ackermann et al. have recently disclosed a novel design of a
triazole-based N,N-bidentate (TAM) directing group (5, Figure 2) that enables different C–H bond
functionalization reactions catalyzed by various transition metals [9,10].
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Figure 2. Development of triazole-based directing groups.
In order to mimic the modular triazole design 4 (Figure 2) and, in turn, mimic TAM group 5
(Figure 2), we developed a design of the N,O-bidentate directing groups based on 2-aminoethanol.
The basis was the presence of the two-carbon distance between the N and O Lewis basic atoms thus
enabling the design-based formation of the five-membered and double five-membered cyclometallated
complexes. Thus, amides containing hydroxymethyl(dimethylmethyl) were envisaged (6, Scheme 1)
which would have as a retrosynthetic precursor 2-amino-2-methyl-1-propanol 7 (Scheme 1).
 
Scheme 1. Design-based 2-amino-2-methyl-1-propanol directing group.
Based on the strategic design considerations above and as part of our research program on
the development of design-based bidentate directing groups, [11] we initiated synthesis of amides
containing 2-amino-2-methyl-1-propanol as a potential N,O-bidentate directing group. The aim would
ultimately be to test such amides in metal-catalyzed C–H bond functionalization reactions. Based on
the possession of N and O Lewis basic atoms strategically separated by two carbons in the amides,
it was projected that amides containing 2-amino-2-methyl-1-propanol (6, Scheme 2) could potentially
allow formation of the corresponding double-five-membered chelate (8, Scheme 2) which sets the stage
for the ultimate C–H bond cleavage leading to functionalized amide 9 (Scheme 2). Therefore, amides
containing 2-amino-2-methyl-1-propanol could potentially function as a bidentate directing group in
C–H bond functionalization reactions.
 
Scheme 2. Potential use of amides containing 2-amino-2-methyl-1-propanol in C–H bond functionalization.
In the present communication, a synthesis of the title compound, N-(2-hydroxy-1,1-dimethylethyl)-
3-methylbenzamide is reported. The importance of the compound lies in its potential reactivity as a
N,O-bidentate directing group in metal-catalyzed C–H bond functionalization reactions. The literature
reports studies involving a similar synthesis which suggests the possible formation of the title
compound as a possible reaction intermediate or byproduct [12,13]. However, the compound was
not isolated, its formation was not confirmed, and neither its characterization by spectroscopic
methods nor structure determination have been reported. Li et al. [12] reported Pd-catalyzed C–H
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fluorination of arenes using oxazolines as removable directing groups. The reported synthesis could
have involved the title compound as a possible reaction intermediate or a byproduct. However,
no spectroscopic characterization was reported. In addition, a similar oxazoline synthesis was reported
by Swenton et al. [13]. The reported synthesis could have involved the title compound as a possible
reaction intermediate or byproduct. However, yet again, the title compound was not isolated and,
thus, spectroscopic information or characterization have not been reported.
We wish to report herein a standard synthesis of the title compound, N-(2-hydroxy-1,1-
dimethylethyl)-3-methylbenzamide (11), from the corresponding benzoyl chloride or benzoic acid.
The compound was full characterized by various spectroscopic methods, elemental analysis, and its
structure was determined and confirmed by X-ray analysis (Please see the Supporting Information for
spectra and other Supporting Materials).
2. Results and Discussion
Toward investigating 2-amino-2-methyl-1-propanol as a potential directing group in
metal-catalyzed C–H functionalization, 3-methylbenzamide containing the requisite amino alcohol
indicated above, the title compound, N-(2-hydroxy-1,1-dimethylethyl)-3-methylbenzamide (11),
was synthesized. Thus, 3-methylbenzolyl chloride (10, Scheme 3) was reacted with 2-amino-2-methyl-1-
propanol (7, Scheme 3) under standard amide formation reaction conditions to give the corresponding
amide in isolated 62% yield.
 
Scheme 3. Synthesis of N-(2-hydroxy-1,1-dimethylethyl)-3-methylbenzamide from 3-methylbenzoyl chloride.
For comparison purposes, the target compound (11) was also obtained using a carboxylic
acid-amine coupling method. Thus the 3-methylbenzoic acid (12, Scheme 4) was treated with
the coupling agent; DCC (dicyclohexylcarbodiimide) and 2-amino-2-methyl-1-propanol (7) in
the presence of DMAP (4-N,N-dimethylaminopyridine) to give the desired title compound,
N-(2-hydroxy-1,1-dimethylethyl)-3-methylbenzamide (11), in 11% yield.
 
Scheme 4. Synthesis of N-(2-hydroxy-1,1-dimethylethyl)-3-methylbenzamide from 3-methylbenzoic acid.
The product was characterized by various spectroscopic methods; 1H NMR, 13C NMR, IR, GC-MS,
and its elemental composition was confirmed by elemental analysis. In addition, the crystal structure
of the compound was determined and confirmed by X-ray analysis (Figure 3). CCDC 1965367 contains
the supplementary crystallographic data for this paper. These data can be obtained free of charge from
The Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/conts/retrieving.html
(or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44 1223 336033; E-mail:
deposit@ccdc.cam.ac.uk).
31
Molbank 2020, 2020, M1099
Figure 3. Molecular structure of the title compound. Thermal ellipsoids correspond to 50% probability.
Formation of amides was recently reported by Machetti et al. [14] to proceed from methyl esters and
amines. For comparison purposes, the title amide compound (11) was attempted to be prepared using
the reported ester amidation reaction. Thus, methyl 3-methylbenzoate was treated with an equimolar
amount of 2-amino-2-methyl-1-propanol (7) at 60 ◦C for 24 h. The reaction resulted in formation of
only a very small amount of the desired amide product as detected by thin-layer chromatography
(TLC) and 1H NMR.
3. Materials and Methods
3.1. General Methods
All chemicals, reagents, and solvents were purchased from chemical companies (Sigma–Aldrich
Chemie GmbH, Taufkirchen, Germany) and were used as received without prior purification. Reactions
that required dry conditions were performed in an inert atmosphere with Ar gas. Syringes and needles
for the transfer of reagents were oven dried and cooled in a desiccator over silica gel before use.
The reaction’s progress was monitored by thin-layer chromatography (TLC) on glass plates pre-coated
with Merck silica gel. Thhe TLC plates were examined under a UV lamplight (UVGL-58 Handheld
254/365 nm). Büchi-USA rotary evaporators were used to evaporate solvents using appropriate
temperatures. Flash column chromatography was performed using silica gel (Kieselgel) (70–230) mesh
as an adsorbent. The purified products were characterized using analyses NMR (1H NMR, 13C NMR),
IR, mass spectra, and melting points. Melting points were recorded on a GallenKamp-MPd350.bm2.5
melting point apparatus (Gallenkamp, Kent, UK). Attenuated total-reflectance IR spectra were recorded
on pure samples on Agilent Technologies Cary 630 FTIR (Agilent, Santa Clara, CA, USA). 1H NMR
spectra were recorded in CDCl3 on JEOL ECX-400 spectrometers (JEOL Ltd., Tokyo, Japan). 1H NMR
chemical shifts (δ) were assigned in parts per million (ppm) downfield using an internal standard
trimethyl silane (TMS) and were referenced to CDCl3, δ = 7.24. Abbreviations s, d, t, q, quin, sept, and
m refer to singlet, doublet, triplet, quartet, quintet, septet, and multiplet, respectively. Chemical shifts
in 13C spectra (175 MHz) were quoted in ppm and referenced to the central line of the CDCl3 triplet, δ C
77.0. Coupling constants (J) were recorded in hertz (Hz). The GC-MS spectra were obtained using an
Agilent mass spectrometer (Agilent, Santa Clara, CA, USA). Elemental analysis was performed using
an EuroEA Elemental Analyzer (configuration CHN (EuroVector Instruments & Software, Milano,
Italy) with a calibration type of K-factor. Single-crystal X-ray structure determinations were performed
at room temperature on a Stoe IPS II diffractometer using monochromatic Mo−Kα radiation (λ =
0.71073 Å). A multi-scan absorption correction was applied. The data reduction, including an empirical
absorption correction using spherical harmonics, was implemented in LANA. The crystal structures
were solved by direct methods using the online version of WinGX and then refined by full-matrix
least-squares (SHELXL2014) on F2. The non-hydrogen atoms were refined anisotropically. All of the
hydrogen atoms were positioned geometrically in idealized positions and refined with the riding
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model approximation with Uiso(H) = 1.2 or 1.5 Ueq(C). The molecular graphics program MERCURY
from the Cambridge Structural Database (CSD) package was used.
3.2. Synthesis of N-(2-Hydroxy-1,1-dimethylethyl)-3-methylbenzamide (11)
3-Methylbenzoyl chloride (10) (1.30 mL, 9.86 mmol) was added dropwise under an atmosphere of
N2 into a cold (0 ◦C ice-water bath) solution of 2-amino-2-methylpropan-1-ol (7) (0.50 mL, 5.2 mmol),
in CH2Cl2 (20 mL). Triethylamine (Et3N (1.40 mL, 10.0 mmol) was then added to the 0 ◦C mixture
under N2. The mixture was stirred for 1 h at 0 ◦C, allowed to warm up to room temperature, and then
stirred for an additional 23 h. To the reaction mixture, an aqueous saturated NaHCO3 solution (20 mL)
was added. The mixture was extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were
dried over anhydrous MgSO4 and filtered. The solvents were evaporated under reduced pressure, and
the crude residue was purified by flash chromatography (SiO2) using hexane:Et2O (5:1), giving the title
compound 11 (0.66 g, 62%) as white crystals after recrystallization from CH2Cl2:hexane; Rf = 0.12 (Pet.
Ether/EtOAc, 1:1) and mp = 81–83 ◦C. 1H NMR (400 MHz, CDCl3): δ 7.52 (s, 1H), 7.49 (d, J = 2.3 Hz,
1 H), 7.48 (d, J = 1.9 Hz, 1 H), 7.28 Hz (dd, J = 3.8, 3.3 Hz, 1 H), 7.25 (s, 1 H), 6.24 (s, 1 H), 3.66 (s, 2 H),
2.37 (s, 3 H), 1.39 (s, 6 H). 13C NMR (176 MHz, CDCl3): δ 168.8, 138.6, 134.8, 132.5, 128.6, 127.7, 123.9,
70.8, 56.5, 24.8, 24.4. IR (film): ν max/cm−1: 3340, 3198, 2924, 1627, 1535, 1548, 1481. Elemental analysis
calculated: C (69.54), H (8.27), N (6.76), found (average of two runs): C (69.33), H (8.17), N (6.53).
3.3. Refinement Details of the X-ray Structure
Single-crystal X-ray structure determinations were performed at room temperature on a Stoe IPS
II diffractometer using monochromatic Mo−Kα radiation (λ = 0.71073 Å). A multiscan absorption
correction was applied. The data reduction, including an empirical absorption correction using
spherical harmonics, implemented in LANA. The crystal structures were solved by direct methods
using the online version of WinGX [15] and then refined by full-matrix least-squares (SHELXL2014)
on F2 [16,17]. The nonhydrogen atoms were refined anisotropically. All of the hydrogen atoms were
positioned geometrically in idealized positions and refined with the riding model approximation, with
Uiso(H) = 1.2 or 1.5 Ueq(C). The molecular graphics the program MERCURY from the CSD package
was used [18]. The structure was solved by direct methods. The data used for the refinement are up
to a resolution of 2-theta = 37.7 degrees as the intensity of the data dropped rapidly after this point.
The flack parameter (x = −0.901) was refined by full-matrix least squares (i.e., using the TWIN/BASF
commands in the SHELXL.ins file) [19]. Hydrogen atoms were included in calculated positions.
4. Conclusions
The title compound, N-(2-hydroxy-1,1-dimethylethyl)-3-methylbenzamide, was synthesized from
either the acid chloride (62%, Scheme 3) or the carboxylic acid (11%, Scheme 4) with the former
being the more efficient method. The compound was characterized by various spectroscopic methods
(1H NMR, 13C NMR, IR, GC-MS), its elemental composition was determined by elemental analysis
measurements, and its crystal structure was determined and confirmed by X-ray analysis. With amides
containing the requisite 2-amino-2-methyl-1-propanol now in hand, work is currently underway to
investigate their potential in functioning as N,O-bidentate directing groups in metal-catalyzed C–H
bond functionalization reactions.
Supplementary Materials: The following are available online, Figure S1: GC-MS of the tile compound, Figure S2:
IR of the title compound, Figure S3: 1H NMR of the title compound, Figure S4: 13C NMR of the title compound,
Figure S5: Elemental analysis of the title compound.
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Abstract: Synthesis of N′-acetyl-3-methyl-1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine-4-carbohydrazide
from the phenyl acetates of 3-acetyl-5-(3-methyl-1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine-4-yl)-2,3-
dihydro-1,3,4-oxadiazol-2-yl in alkaline medium and its characterization by spectroscopic methods.
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1. Introduction
N′-acetyl and N′-benzoyl hydrazide derivatives containing a heterocycle nucleus have shown
antimicrobial and anti-TB activities [1,2]. These compounds are usually synthesized from carbohydrazide
derivatives by an addition–elimination reaction with acyl chlorides [3,4]. N′-acetyl and N′-benzoyl
hydrazides are also used for the synthesis of 1,3,4-oxadiazole compounds, which can be found in
the structure of molecules with reported bioactivity to several targets and related to a wide range of
diseases [5–7].
On the other hand, N′-acetyl derivatives are often found as the metabolites of the hydrazide
group from drugs, such as isoniazid [8,9]. However, the administration of acetylisoniazid leads to
diacetylhydrazine (CH3CONHNHCOCH3) as the primary metabolite excreted in which the acyl C–N
bond from the pyridine–carboxamide is more susceptible to lysis than is the acyl C–N bond from the
alkylamide group [8].
Herein, we describe an unexpected approach to obtain N′-acetylhydrazides from hydrolysis of the
3-acetyl-2,3-dihydro-1,3,4-oxadiazole derivatives of 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine nucleus
and their characterization by spectroscopic methods.
2. Results and Discussion
Hydrolysis methods using sodium acetate are widely used in aromatic acetate deprotection
reactions, whereas the ordinarily, stable, aliphatic amides require stronger hydrolysis conditions
than the ester motif [10]. In this sense, it could be expected that the mild alkaline and/or no heating
conditions could provide the selective hydrolysis of the O-acetyl group from the phenyl acetates of
3-acetyl-5-(3-methyl-1,6-diphenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl.
In fact, if the treatment of compounds 1a–1c with a 4.2 M aqueous NaOAc solution in n-butanol at
room temperature did not give any reaction, the exposure to a methanolic/aqueous NaHCO3 solution
at room temperature resulted as being effective in the O-acetyl group cleavage [11]. Conversely,
both the treatment with a 4.2 M aqueous NaOAc solution in n-butanol under conventional heating
or microwave irradiation (Methods A and B, respectively) and with a methanolic KOH (3 equiv.)
solution (Method C) yielded the N′-acetylhydrazide derivative 2 (Scheme 1), as a consequence of the
2,3-dihydro-1,3,4-oxadiazole rings’ degradation [12]. The opening of the 2,3-dihydro-1,3,4-oxadiazoles
was previously reported under acidic conditions only [13,14].
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Scheme 1. N′-acetyl-3-methyl-1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine-4-carbohydrazide (2) from
2,3-dihydro-1,3,4-oxadiazoles derivatives: 1a (4-OAc), 1b (3-OAc-4-OCH3), 1c (3,4-di-OAc). Methods:
(A) NaOAc, n-BuOH, reflux; (B) NaOAc, n-BuOH, M.W.; (C) KOH, MeOH, r.t.
The structure of compound 2 was confirmed by spectroscopic methods (Infrared (IR), nuclear
magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS), Figures S1–S4). In the
protonic nuclear magnetic resonance (1H-NMR) spectrum of compound 2, the signals of the protons
from 1,6-dipheny-1H-pyrazolo[3,4-b]pyridine nucleus were observed at δ 2.64 ppm (s, 3H) for the
methyl group at the C-3 position; δ 7.36 (dd, 1H), δ 7.55–7.62 ppm (m, 5H), δ 8.25 (d, 2H) and δ
8.33 ppm (d, 2H) for phenyl groups in the N-1 and C-6 positions; and δ 7.90 ppm (s, 1H) for the
aromatic proton at the C-5 position [11]. Additionally, one signal at δ 2.00 ppm (s, 3H) corresponding
to the methyl group from acetyl-hydrazine moiety and two signals at δ 10.03 ppm (s, 1H) and δ 10.56
ppm (s, 1H) corresponding to hydrazide protons (RCONHNHCOR’), were observed. The protons
of the 2,3-dihydro-1,3,4-oxadiazole ring (singlet at δ 7.1 ppm) and of the substituted phenyl groups
present in the compounds 1a–1c were not observed [11]. In the same way, the signals corresponding
to the carbons of these moieties in the APT spectrum were also not detected. The splitting of signals
observed in the NMR spectra of compound 2 could be related to the presence of conformers around
the N–CO bond, as reported for similar compounds [15,16]. However, it needs further analysis. In the
HRMS spectrum of compound 2, the presence of the molecular ion peak at m/z = 386.1611 ([M + H]+)
supported the proposed structure.
In conclusion, we have described the unusual synthesis of N’-acetylhydrazide 2 from derivatives
1a–1c. These results show the lability of the 2,3-dihydro-1,3,4-oxadiazole ring in alkaline medium. This
fact could be exploited for stability studies related to drugs containing this moiety.
3. Materials and Methods
All commercial products (Sigma-Aldrich Brasil Ltda., São Paulo, Brazil) and solvents (Vetec
Química Fina Ltda., Duque de Caxias, Brazil) were used without further purification. Compounds
1a–1c were synthesized according to methods previously described in the literature [11,17]. The reactions
under microwave irradiation were conducted in a domestic microwave device (Brastemp®, São Paulo,
Brazil, model BMX35, 900W, 30 L) using a flat bottom balloon connected to an L-shaped adapter
joint glassware. All reactions were monitored by thin-layer chromatography (TLC) analysis from
reaction aliquots and were performed on Merck 60 F254 aluminum in combination with ultraviolet
(UV) detection (254 and 365 nm). Melting points were determined in a capillary Thomas Hoover
PC03296 apparatus, and the values are uncorrected. IR spectra were measured on a Varian 660-IR,
FT-IR spectrophotometer (Agilent Technologies, Santa Clara, CA, USA), by using the KBr pellet method.
NMR spectra were recorded on a Varian VNMRS spectrophotometer (Agilent Technologies, 1H-NMR
at 500 MHz and 13C-NMR at 125 MHz).
Proton chemical shifts (δ) are reported in parts per million (ppm) relative to tetramethylsilane
(TMS), with the solvent employed as the internal standard (dimethyl sulfoxide DMSO-d6). The structure
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identification was aided by an Attached Proton Test (APT) spectrum. Mass spectra were recorded on
AmaZon SL-Electrospray (ESI) ion trap Bruker spectrometer, and HRMS (positive ESI-Q-TOF) analyses
were performed on an Impact HD mass spectrometer (Bruker Corporation, Billerica, MA, USA).
N’-Acetyl-3-methyl-1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine-4-carbohydrazide (2)
Method A
A suspension of 2-(acetoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole (1b, 0.12 g, 0.21 mmol) in
n-butanol (1 mL) was stirred at reflux temperature until complete solubilization. Then, NaOAc
(0.5 mL of a 4.2 M aqueous solution, 2.1 mmol) was added, and the mixture was stirred for additional
3 h at reflux temperature. The reaction was monitored by TLC using ethyl acetate in hexane 3:4 v/v as
the eluent. At the end of the reaction, the solution was cooled at room temperature and poured into
water (10 mL). The mixture was extracted with ethyl acetate (3 × 10 mL). The combined organic phases
were washed with brine, dried over anhydrous sodium sulfate, and the solvent was removed under
vacuum. Recrystallization from methanol gave pure 2 (0.052 g, 64% yield).
Method B
A suspension of 2-(acetoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole (1b or 1c, 0.12 g, 0.21 mmol) in
n-butanol (1 mL) was prepared. NaOAc (0.5 mL of a 4.2 M aqueous solution, 2.1 mmol) was added to
the mixture and homogenized manually. The mixture was put under microwave irradiation (900 W) at
regular intervals of 30 s. The monitoring of the reaction, work-up and purification steps were identical
to Method A. The pure compound 2 (0.079 g, 97% yield) was obtained after 3 min or 10 min of reaction
from 1b or 1c, respectively.
Method C
KOH (0.016 g, 0.28 mmol) was added to a suspension of 2-(acetoxyphenyl)-2,3-dihydro-1,3,4-
oxadiazole (1a, 0.050 g, 0.090 mmol) in methanol (10 mL). The mixture reaction was stirred for 1 h at
room temperature, and its progress monitored like previously described. At the end of the reaction, the
pH was adjusted to 7.0 (neutral) with a 1M aqueous solution of HCl (20 mL). The mixture was poured
into water (10 mL) and extracted with ethyl acetate (3 × 10 mL). The combined organic phases were
dried over anhydrous sodium sulfate and the solvent was removed under vacuum. Recrystallization
from methanol gave pure 2 (0.032 g; 87% yield).
Structural Characterization
White solid. m.p. = 268–270 ◦C. Rf = 0.51 (ethyl acetate–hexane, 3:4 v/v). IR (ν-cm−1): 3197
(N–H); 3040 (Csp2–H); 2922 (Csp3–H); 1611 (C=O). 1H-NMR (DMSO-d6/TMS): δ (ppm) = 2.00 (s, 3H,
H3C(CO)N–); 2.64 (s, 3H, H-8); 7.36 (t, 1H, J = 7.5 Hz, H-4′); 7.55–7.62 (m, 5H, H-3′/H-3”/H-4”); 7.90 (s,
1H, H-5); 8.25 (d, 2H, J = 7.5 Hz, H-2”); 8.33 (d, 2H, J = 8.0 Hz, H-2′); 10.03 (s, 1H, N-H); 10.56 (s, 1H,
N-H). 13C NMR-APT (DMSO-d6/TMS): (ppm) = 14.0 (C-8); 20.2 (H3CC=O); 111.4 (C-3a); 112.7 (C-5);
120.3 (C-2′); 125.4 (C-4′); 127.0 (C-1”); 127.1 (C-2”); 128.7 (C-4”); 128.9 (C-3′); 129.7 (C-3”); 137.7 (C-4);
138.8 (C-1′); 142.2 (C-3); 150.9 (C-7a); 156.0 (C-6); 164.2 (-HNHNC=O); 168.1 (H3CC=O). HRESI-MS
m/z 386.1611, ([M + H] + calcd. for C22H19N5O2 386.1611).
Supplementary Materials: The following are available online, Compound 2 spectra: IR (Figure S1); 1H-NMR
(Figure S2); APT (Figure S3); HRMS (Figure S4).
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Abstract: During the synthesis of symmetrical dodeco-6,7-diuloses that are potential candidates
for inhibition of glycosidases, an unanticipated epoxide-oxetane rearrangement was observed.
A bicyclic sugar consisting of a glycal moiety and an anomeric esterified furanose was oxidized under
epoxidation conditions (mCPBA/KF). The isolation of the pure epoxide was not possible since a rapid
reversible conversion accompanied by the migration of the ester group took place and resulted in
the formation of an unusual oxetane-bridged disaccharide scaffold. X-ray diffractometric structure
elucidation and the suggested mechanism of the rearrangement are provided.
Keywords: oxetane; epoxide; rearrangement; carbohydrate; C-glycosylation; spiro-oxetane; ester
group migration
1. Introduction
Oxetane rings attached directly to a carbohydrate unit rarely occur in literature, due to steric
reasons [1]. The most common representatives are 3,5-anhydrofuranose derivatives, which are formed
by nucleophilic [2,3] or additive [4] intramolecular ring closure reactions. In addition to the furanoid
3,5-linked oxetanes, there also exists a limited number of 1,2-fused or anomeric spiro-oxetanes having
a pyranoid constitution. These highly strained scaffolds are prepared photochemically [5–7] or via
template-directing C-glycosylations [8,9]. In synthesis, sugar oxetanes are used as versatile precursors
since the rigid conformation and steric repulsion of the bridge favor high stereoselectivities [10].
Furthermore, the detection of antimicrobial properties has brought these structures closer to the focus
of current research [4]. In this communication, we introduce a new method for the generation of
anomerically bridged oxetanes whose formation was initiated by an unexpected rearrangement of an
epoxide assisted by an adjacent ester group.
2. Results and Discussion
Starting from the known compounds 1 [11] and 2 [12] a base-induced coupling of two anomeric
centers analogous to Shiozaki’s protocol [13] was performed (Scheme 1). Contrary to Shiozaki’s
procedure, which involved the use of toxic stannylated glycals, we could employ 1-phenylsulfinyl
glycals since it is known that they are easily lithiated in a similar fashion with one equivalent of
phenyllithium [14]. Sulfoxide 1 was treated with phenyllithium at –78 ◦C followed by quenching with
manno-lactone 2 after 5 minutes. The observance of this reaction time is mandatory since a longer
reaction time results in the irreversible formation of the protonated glycal species in increasing amounts
leading to by-products. The coupled disaccharide 3 was isolated as an anomeric mixture (α/β ratio
1:5) in 80% yield. Next, the anomeric hydroxyl group was masked in order to avoid its coordinating
effect on the envisaged stereoselective epoxidation. For this purpose, we decided to choose the ester
protecting groups acetyl and benzoyl. Thus, the fully protected disaccharides 4a and 4b were obtained
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after the acylation step in 96% and 68% yield, respectively. In both cases solely the β-anomers were
obtained which was proven by H,H-NOESY NMR spectroscopy (see Supplementary Materials).
Scheme 1. Synthesis of the isopropylidene-protected oxetane-bridged disaccharide 8 and X-ray
structures of 5a and 7a.
Furthermore, the configuration could be confirmed by growing crystals of 5a suitable for X-ray
diffraction by recrystallization of the latter from n-hexane and ethyl acetate. Compound 5a was obtained
through desilylation of 4a with tetra-n-butylammonium fluoride (Scheme 1). The moderate yield of 71%
can be explained by detectable partial cleavage of the acetyl group in alkaline milieu during desilylation.
The benzoyl protecting group was significantly more stable under the same conditions resulting in a
yield of 89% for the conversion of 4b to 5b. In our efforts to synthesize symmetrical dodeco-6,7-diuloses
both sugar moieties need to be manno-configured. Therefore, the next step was to stereoselectively
convert the glycal entity into a mannose derivative. Conventional methods for the implementation of
stereoselective dihydroxylation on similar allyl alcohol systems use substrate-directing reagents such as
molybdenum catalysts [15], vanadyl acetylacetonate (VO(acac)2) [16,17] or meta-chloroperbenzoic acid
(mCPBA) [17,18] for epoxidation. Subsequent epoxide opening leads to the desired diol derivatives.
When these methodologies were applied to disaccharides 5a and 5b the best results were achieved
using the Camps reagent (mCPBA/KF) [18,19]. The addition of potassium fluoride reduces the solubility
of mCPBA and mCBA and thus, inhibiting nucleophilic epoxide opening by the acids. However, we
could not isolate the pure epoxides 6a and 6b for a rapid rearrangement of the latter to oxetane species
7a and 7b occurred. Upon early quenching of the epoxidation reaction, only 8:1 mixtures of epoxide
and oxetane could be isolated in yields of 94% for 6a and 90% for 6b, respectively. In order to enable the
complete conversion of the epoxide to the oxetane derivatives the reaction times were extended and 7a
and 7b could be obtained neatly in 70% and 63% yields, respectively. Crystals of compound 7a suitable
for X-ray crystallography could be obtained by overlaying a saturated solution of 7a in methylene
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chloride with n-heptane and slowly evaporating the methylene chloride. Thus, the oxetane-bridged
disaccharide structure of 7a with two anomeric α-configurations could be unambiguously verified
(Scheme 1). For the formation of oxetanes 7 we propose a mechanism deduced from the X-ray data
in which ester group migration from position 7 to 6 occurs simultaneously with O-heterocyclic ring
extension of the oxirane ring to the less strained oxetane ring (Figure 1). The rearrangement process
can also be visualized by 1H-NMR spectroscopy since the H-5 signal of oxetane 7a (4.96 ppm, 4.6 Hz)
is significantly shifted to lower field compared to the characteristic doublet of H-5 in epoxide 6a
(3.66 ppm, 2.4 Hz) (Figure 1). To some extent, this rearrangement resembles the Ferrier rearrangement
of acetylated glycals. Alternatively, a stepwise mechanism via the intermediate formation of carbenium
ions can also be envisaged.
 
Figure 1. Proposed mechanisms for the rearrangement from epoxide 6a to oxetane 7a and their 1H-NMR
spectra in CDCl3 to illustrating the reaction progress.
It must also be mentioned that the rearrangement appeared to be reversible for in attempts to
recrystallize 7a from boiling n-hexane the precipitation of an amorphous substance which turned out
to be epoxide 6a was observed. Studies are ongoing to evaluate both the effect of the temperature
and of the solvent on the equilibrium ratio between compounds 6a and 7a. After removal of the
ester protecting groups of 7a and 7b with ammonia in methanol, oxetane 8 was obtained from
both compounds in 99% and 80% yield respectively (Scheme 1). Oxetanes 8 did not recede to the
corresponding epoxides according to TLC monitoring. Consequently, it was proven that 7b is also
present as an oxetane-fused disaccharide.
3. Materials and Methods
All reactions were performed under an atmosphere of nitrogen using solvents dried by standard
procedures. Reaction progress was monitored by TLC on Polygram SIL G/UV254 silica gel plates from
Macherey and Nagel, Germany. Detection of spots was affected by carbonizing with sulfuric acid (5%
in EtOH), staining by spraying the plates with an alkaline aqueous solution of potassium permanganate
or by inspection of the TLC plates under UV light (254 nm). Preparative flash chromatography was
performed on silica gel (0.032–0.063 mm) from Macherey-Nagel, using plastic cartridges from Götec.
The flowrate was regulated by a Sykam S1122 solvent delivery system. Nuclear magnetic resonance
(NMR) spectra were recorded with a Bruker Avance 400 spectrometer and calibrated for the solvent
signal (1H: CDCl3: δ = 7.26 ppm; acetone-d6: δ = 2.05 ppm; DMSO-d6: δ = 2.50 ppm; 13C: CDCl3:
δ =77.16 ppm; acetone-d6: δ = 29.92 ppm; DMSO-d6: δ = 39.52 ppm). All NMR-assignments were
proven by 2D-experiments to be correct. ESI-TOF-HRM spectrometry was performed on a Bruker
MAXIS 4G spectrometer. Elemental analyses were obtained from a HEKA tech Euro EA 3000 apparatus.
Optical rotations were determined with a Perkin-Elmer Polarimeter 341 in a 10 cm cuvette at 20 ◦C
with a wavelength of 589 nm (Na-lamp). Melting points were measured with a Büchi Melting Point
M-560 apparatus.
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2,6-Anhydro-5-deoxy-4-O-(tert-butyldimethylsilyl)-1,3:8,9:11,12-tri-O-isopropylidene-d-arabino-l-gulo-
dodeco-7-ulo-6-enitol (3)
To a suspension of 1 (2.62 g, 6.18 mmol) and grounded molecular sieve (3 Å, 30 mg) in THF
(40 mL) was added phenyllithium (1.9 M in Bu2O, 3.57 mL, 6.79 mmol) at −78 ◦C over a period of
15 min. After 5 min a further solution containing 2 (1.75 g, 6.79 mmol) in THF (20 mL) was added
dropwise over a period of 30 min. Subsequently, the reaction mixture was stirred for 2 h at the same
temperature before the cooling bath was removed. The reaction was quenched by addition of sat. aq.
NH4Cl-solution (60 mL) at ambient temperature and the molecular sieve was filtered off. The organic
layer was separated, the aqueous layer was extracted with CH2Cl2 (3 × 20 mL) and the combined
organic layers were dried with Na2SO4. Removing of the solvent followed by column chromatography
(methylene chloride/ethyl acetate 5:1) furnished 3 (2.77 mg, 4.97 mmol, 80%, anomeric mixture α:β, 1:5)
as a colorless crystalline solid. Rf = 0.22–0.46 (methylene chloride/ethyl acetate 5:1).
3β*(major anomer): 1H-NMR (400 MHz, CDCl3): δ(ppm) = 5.04 (d, J5,4 = 2.2 Hz, 1H, H-5), 4.82 (dd,
J9,8 = 5.7 Hz, J9,10 = 3.5 Hz, 1H, H-9), 4.53 (d, J8,9 = 5.9 Hz, 1H, H-8), 4.38–4.44 (m, 1H, H-11), 4.33–4.35
(m, 1H, H-4), 4.15 (dd, J10,11 = 7.2 Hz, J10,9 = 3.5 Hz, 1H, H-10), 4.07–4.11 (m, 1H, H-12a), 4.03 (dd,
J = 8.7 Hz, J = 4.9 Hz, 1H, H-12b), 3.86–3.95 (m, 2H, H-1a, H-1b), 3.71–3.76 (m, 2H, H-2, H-3), 2.77
(s, 1H, OH), 1.50, 1.44, 1.42, 1.40, 1.38, 1.31 (6s, 18H, C(CH3)2), 0.87 (s, 9H, SiC(CH3)3), 0.07, 0.06 (2s,
6H,SiCH3). 13C-NMR (101 MHz, CDCl3): δ(ppm) = 150.4 (C-6), 113.3, 109.1 (C(CH3)2), 104.3 (C-5),
103.4 (C-7), 99.4 (C(CH3)2), 86.7 (C-8), 80.0 (C-9), 79.4 (C-10), 73.2 (C-11), 72.9 (C-3), 70.2 (C-2), 68.2
(C-4), 66.7 (C-12), 61.7 (C-1), 28.9, 26.8, 25.8 (C(CH3)2), 25.7 (SiC(CH3)3), 25.4, 25.0, 19.1 (C(CH3)2), 18.1
(SiC(CH3)3), –4.4, –4.8 (SiCH3).
3α*(minor anomer): 1H-NMR (400 MHz, CDCl3): δ(ppm) = 5.07 (d, J5,4 = 2.1 Hz, 1H, H-5), 4.79 (dd,
J9,8 = 6.0 Hz, J9,10 = 3.7 Hz, 1H, H-9), 4.62 (d, J8,9 = 6.0 Hz, 1H, H-8), 4.34–4.35 (m, 2H, H-4, H-11),
4.10–4.11 (m, 1H, H-12a), 4.01–4.02 (m, 1H, H-12b), 3.85–3.88 (m, 2H, H-1a, H-1b, 3.76–3.80 (m, 3H,
H-2, H-3, H-10), 2.77 (s, 1H, OH), 1.57, 1.49, 1.42, 1.40, 1.36 (5s, 18H, C(CH3)2), 0.88 (s, 9H, SiC(CH3)3),
0.08, 0.07 (2s, 6H, SiCH3). 13C-NMR (101 MHz, CDCl3): δ(ppm) = 150.8 (C-6), 113.6, 109.3 (C(CH3)2),
103.1 (C-5), 100.6 (C-7), 99.6 (C(CH3)2), 80.7 (C-8), 80.0 (C-9), 78.6 (C-10), 73.2 (C-11), 72.8 (C-3), 70.3
(C-2), 67.8 (C-4), 67.2 (C-12), 61.7 (C-1), 28.9, 26.9, 25.9 (C(CH3)2), 25.8 (SiC(CH3)3), 25.2, 24.6, 19.0
(C(CH3)2), 18.2 (SiC(CH3)3), –4.4, –4.8 (SiCH3). HRESIMS m/z 581.27570 (calcd for C27H46O10SiNa,




A solution of 3 (300 mg, 0.537 mmol) and 4-dimethylaminopyridine (13 mg, 0.107 mmol) in
triethylamine (7 mL) was treated with acetic anhydride (508 μL, 5.37 mmol) at 0 ◦C. After stirring for
12 h at ambient temperature until TLC indicated complete transformation of the starting material,
the reaction mixture was diluted with ethyl acetate (20 mL). The organic phase was washed with
1 N hydrochloric acid (3 × 10 mL), sat. aq. NH4Cl-solution (1 × 10 mL) and brine (1 × 10 mL). The
solution was dried with Na2SO4, the solvent was removed and the crude product was purified by
column chromatography (petroleum ether/ethyl acetate 5:1) to afford 4a (309 mg, 0.515 mmol, 96%)
as a colorless crystalline solid. Rf = 0.82 (methylene chloride/ethyl acetate 5:1). [α]
20
D = +64.3 (c = 1.0,
CHCl3). M.p. 52 ◦C (n-hexane). 1H-NMR (400 MHz, CDCl3): δ (ppm) = 4.99 (d, J5,4 = 2.2 Hz, 1H, H-5),
4.86 (dd, J9,8 = 5.6 Hz, J9,10 = 3.4 Hz, 1H, H-9), 4.69 (d, J8,9 = 5.6 Hz, 1H, H-8), 4.42 (ddd, J = 8.3 Hz,
J = 5.9 Hz, J = 3.9 Hz, 1H, H-11), 4.35 (dd, J4,3 = 6.7 Hz, J4,5 = 2.1 Hz, 1H, H-4), 4.09–4.15 (m, 1H,
H-12a), 3.99–4.07 (m, 2H, H-10, H-12b), 3.80–3.89 (m, 2H, H-1aH-1b), 3.61–3.73 (m, 2H, H-2, H-3), 2.01
(s, 3H, COCH3), 1.48, 1.47, 1.45, 1.37, 1.37, 1.33 (6s, 18H, C(CH3)2), 0.83 (s, 9H, SiC(CH3)3), 0.03, 0.03
(2s, 6H, SiCH3).13C-NMR (101 MHz, CDCl3): δ(ppm) = 168.3 (CO), 146.9 (C-6), 113.9, 109.4 (C(CH3)2),
107.4 (C-7), 104.8 (C-5), 99.3 (C(CH3)2), 86.4 (C-8), 81.2 (C-10), 79.6 (C-9), 73.0 (C-3), 72.8 (C-11), 70.2
44
Molbank 2020, 2020, M1108
(C-2), 68.2 (C-4), 67.1 (C-12), 61.7 (C-1), 28.9, 27.0, 25.8 (C(CH3)2), 25.6 (SiC(CH3)3), 25.1, 25.1 (C(CH3)2),
21.5 (COCH3), 19.1 (C(CH3)2), 18.0 (SiC(CH3)3), –4.4, –4.9 (SiCH3). HRESIMS m/z 623.28604 (calcd for
C29H48O11SiNa, 623.28581); anal. C 58.10, H 8.21, calcd for C29H48O11Si, C 57.98, H 8.05.
2,6-Anhydro-5-deoxy-7-O-benzoyl-4-O-(tert-butyldimethylsilyl)-1,3:8,9:11,12-tri-O-isopropylidene-β-d-
manno-d-lyxo-dodeco-6-enitol (4b)
A solution of 3 (930 mg, 1.67 mmol) and DMAP (41 mg, 0.333 mmol) in pyridine (15 mL) was
treated with benzoyl chloride (1.92 mL, 16.7 mmol) at 0 ◦C. After stirring for 48 h at ambient temperature
TLC indicated complete transformation of the starting material and the reaction mixture was diluted
with ethyl acetate (60 mL). The organic layer was washed with 1 N hydrochloric acid (3 × 30 mL), sat.
aq. NaHCO3-solution (3 × 20 mL) and brine (1 × 20 mL). The solution was dried with Na2SO4, the
solvent was removed and the crude product was purified by column chromatography (toluene/ethyl
acetate, gradient: 100:1 – 20:1) to afford 4b (749 mg, 1.13 mmol, 68%) as a colorless crystalline
solid. Rf = 0.66 (toluene/ethyl acetate 4:1). [α]
20
D = +57.1(c = 1.0, CHCl3). M.p. 58
◦C. 1H-NMR
(400 MHz, CDCl3): δ(ppm) = 7.90–8.02 (m, 2H, Ph), 7.52–7.62 (m, 1H, Ph), 7.39–7.48 (m, 2H, Ph), 5.11 (d,
J5,4 = 2.3 Hz, 1H, H-5), 4.90–5.01 (m, 2H, H-8, H-9), 4.47 (ddd, J = 8.2 Hz, J = 6.0 Hz, J11,12b = 4.0 Hz,
1H, H-11), 4.41 (dd, J4,3 = 6.7 Hz, J4,5 = 2.2 Hz, 1H, H-4), 4.08–4.17 (m, 2H, H-10, H-12a), 4.05 (dd,
J12b,12a = 9.1 Hz, J12b,11 = 4.0 Hz, 1H, H-12b), 3.66–3.84 (m, 4H, H-1a, H-1b, H-2, H-3), 1.52, 1.48, 1.42,
1.38, 1.37 (5s, 18H, C(CH3)2), 0.86 (s, 9H, SiC(CH3)3), 0.06, 0.06 (2s, 6H, SiCH3).13C-NMR (101 MHz,
CDCl3): δ(ppm) = 164.0 (CO), 147.3 (C-6), 133.4, 130.2, 129.9, 128.5 (Ph), 114.2, 109.6 (C(CH3)2), 108.2
(C-7), 105.1 (C-5), 99.5 (C(CH3)2), 86.7 (C-8), 81.8 (C-10), 80.0 (C-9), 73.3 (C-3), 73.0 (C-11), 70.4 (C-2),
68.5 (C-4), 67.3 (C-12), 61.8 (C-1), 29.1, 27.1, 26.0 (C(CH3)2), 25.8 (SiC(CH3)3), 25.4, 25.3, 19.3 (C(CH3)2),
18.2 (SiC(CH3)3), –4.2, –4.7 (SiCH3). HRESIMS m/z 685.30154 (calcd for C34H50O11SiNa, 685.30146);
anal. C 61.26, H 8.02, calcd for C34H50O11Si, C 61.61, H 7.60.
General Procedure A for Desilylation of 4a and 4b
Tetra-n-butylammonium fluoride (1.0 M in THF, 1.5 eq.) was added to a solution of 4a or 4b
(1.0 mmol) in THF (10 mL) at 0 ◦C. The reaction mixture was warmed to room temperature and stirring
was continued until complete conversion of the starting material was detected by TLC. Subsequently,
the solution was diluted with CH2Cl2 (20 mL) and washed with brine (3 × 10 mL). The aqueous phase
was extracted with CH2Cl2 (2 × 20 mL) and the combined organic phases were dried with Na2SO4.
The solvent was evaporated and the residue was purified by column chromatography (petroleum
ether/ethyl acetate 2:1 containing 0.5% Et3N).
2,6-Anhydro-5-deoxy-7-O-acetyl-1,3:8,9:11,12-tri-O-isopropylidene-β-d-manno-d-lyxo-dodeco-6-enitol (5a)
Following general procedure A 5a was obtained as a white amorphous solid and was prepared
from 4a in 71% yield stirring the reaction mixture for 20 h. Rf = 0.28 (petroleum ether/ethyl acetate
1:1). [α]20D = +98.0 (c = 1.0, CHCl3). M.p. 179
◦C (n-hexane/ethyl acetate). 1H-NMR (400 MHz, CDCl3):
δ(ppm) = 5.14 (d, J5,6 = 2.2 Hz, 1H, H-5), 4.88 (dd, J9,8 = 5.7 Hz, J9,10 = 3.5 Hz, 1H, H-9), 4.71 (d,
J8,9 = 5.7 Hz, 1H, H-8), 4.37–4.45 (m, 2H, H-4, H-11), 4.01–4.12 (m, 3H, H-10, H-12a, H-12b), 3.85–3.94
(m, 2H, H-1a, H-1b), 3.68–3.80 (m, 2H, H-2, H-3), 2.02 (s, 3H, COCH3), 1.53, 1.47, 1.45, 1.42, 1.37, 1.33
(6s, 18H, C(CH3)2). 13C-NMR (101 MHz, CDCl3): δ (ppm) = 168.2 (CO), 148.0 (C-6), 113.7, 109.4
(C(CH3)2), 107.1 (C-7), 102.9 (C-5), 99.7 (C(CH3)2), 86.3 (C-8), 81.5 (C-10), 79.6 (C-9), 73.2 (C-3), 72.8
(C-11), 69.9 (C-2), 67.8 (C-4), 67.0 (C-12), 61.5 (C-1), 28.9, 27.0, 25.8, 25.1, 24.9 (C(CH3)2), 21.6 (COCH3),
19.2 (C(CH3)2). HRESIMS m/z 509.19928 (calcd for C23H34O11Na, 509.19933); anal. C 56.57, H 7.17,
calcd for C23H34O11, C 56.78, H 7.04.
2,6-Anhydro-5-deoxy-7-O-benzoyl-1,3:8,9:11,12-tri-O-isopropylidene-β-d-manno-d-lyxo-dodeco-6-enitol (5b)
Following general procedure A 5b was obtained as a colorless amorphous solid and was prepared
from 4b in 89% yield stirring the reaction mixture for 24 h. Rf = 0.37 (petroleum ether/ethyl acetate 1:1).
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[α]20D = +89.4 (c = 1.0, CHCl3).
1H-NMR (400 MHz, CDCl3): δ(ppm) = 7.92–7.99 (m, 2H, Ph), 7.54–7.60
(m, 1H, Ph), 7.41–7.47 (m, 2H, Ph), 5.26 (d, J5,4 = 2.2 Hz, 1H, H-5), 4.99 (dd, J9,8 = 5.9 Hz, J9,10 = 3.6 Hz,
1H, H-9), 4.95 (d, J8,9 = 5.9 Hz, 1H, H-8), 4.41–4.50 (m, 2H, H-4, H-11), 4.09–4.14 (m, 2H, H-10, H-12a),
4.04 (dd, J = 9.1 Hz, J = 4.2 Hz, 1H, H-12b), 3.72–3.88 (m, 4H, H-1a, H-1b, H-2, H-3), 2.11 (br. s., 1H,
OH), 1.53, 1.52, 1.42, 1.41, 1.38, 1.36 (6 s, 18H, C(CH3)2).13C-NMR (101 MHz, CDCl3): δ(ppm) = 163.9
(CO), 148.4 (C-6), 133.5, 130.1, 129.9, 128.6 (Ph), 114.0, 109.6 (C(CH3)2), 107.9 (C-7), 103.2 (C-5), 99.9
(C(CH3)2), 86.6 (C-8), 82.0 (C-10), 79.9 (C-9), 73.4 (C-3), 73.0 (C-11), 70.2 (C-2), 68.1 (C-4), 67.2 (C-12),
61.6 (C-1), 29.1, 27.1, 26.0, 25.2, 25.1, 19.4 (C(CH3)2). HRESIMS m/z 571.21543 (calcd for C28H36O11Na,
571.21498); anal. C 61.18, H 6.77, calcd for C28H36O11, C 61.30, H 6.61.
General Procedure B for Epoxidation of 5a and 5b and Further Rearrangement to the Oxetanes
To a solution of mCPBA (2.5 eq.) in CH2Cl2 (10 mL) was added potassium fluoride (5 eq.) and
the resulting suspension was stirred for 30 min at ambient temperature. A solution containing 5a
or 5b (0.5 mmol) in CH2Cl2 (10 mL) was added in one portion and stirring was continued for 2 h
(epoxidation). To enforce the rearrangement to the oxetanes the reaction mixture was stirred for
20 h, the white precipitate was filtered off and the solution was stirred for further 20 h. The reaction
was quenched by addition of sat. aq. NaHCO3-solution (10 mL) and sat. aq. Na2S2O3-solution
(10 mL). Subsequently, the aqueous layer was extracted by CH2Cl2 (3 × 10 mL), the combined organic




Following general procedure B a mixture of 6a and 7a (8:1) was obtained after quenching
the reaction after 2 h as a white amorphous solid and was prepared from 5a in 94% yield. A
mixture of petroleum ether/ethyl acetate 3:1 containing 0.5% Et3N was used as the eluent for
column chromatography. Rf = 0.58 (petroleum ether/ethyl acetate 1:2). 1H-NMR (400 MHz, CDCl3):
δ(ppm) = 4.96 (d, J8,9 = 6.0 Hz, 1H, H-8), 4.91 (dd, J9,8 = 6.0 Hz, J9,10 = 3.9 Hz, 1H, H-9), 4.31–4.38
(m, 1H, H-11), 4.20 (dd, J10,11 = 6.6 Hz, J10,9 = 3.9 Hz, 1H, H-10), 3.85–4.06 (m, 5H, H-1a, H-3, H-4,
H-12a, H-12b), 3.77 (dd, J = 10.7 Hz, J = 10.7 Hz, 1H, H-1b), 3.66 (d, J5,4 = 2.4 Hz, 1H, H-5), 3.49 (ddd,
J = 10.2 Hz, J = 10.2 Hz, J = 5.7 Hz, 1H, H-2), 2.38 (br. s., 1H, OH), 2.06 (s, 3H, COCH3), 1.57, 1.48,
1.42, 1.39, 1.35, 1.33 (6s, 18H, C(CH3)2). 13C-NMR (101 MHz, CDCl3): δ(ppm) = 169.2 (CO), 114.2,
109.2 (C(CH3)2), 107.9 (C-7), 99.7 (C(CH3)2), 86.2 (C-8), 85.0 (C-6), 82.9 (C-10), 79.9 (C-9), 73.2 (C-11),
73.0 (C-3), 70.6 (C-2), 69.9 (C-4), 66.4, 61.7 (C-1), 57.3 (C-5), 29.1, 27.0, 25.6, 25.3, 24.6 (C(CH3)2), 21.9
(COCH3), 19.3 (C(CH3)2). HRESIMS m/z 525.19448 (calcd for C23H34O12Na, 525.19425).
5,6-Anhydro-7-O-benzoyl-1,3:8,9:11,12-tri-O-isopropylidene-β-d-manno-β-d-manno-dodeco-6,7-diulo-2,6-
pyranose-7,10-furanose (6b)
Following general procedure B, a mixture of 6b and 7b (8:1) was obtained after quenching
the reaction after 2 h as a white amorphous solid and was prepared from 5b in 90% yield. A
mixture of petroleum ether/ethyl acetate 3:1 containing 0.5% Et3N was used as the eluent for
column chromatography. Rf = 0.64 (petroleum ether/ethyl acetate 1:2). 1H-NMR (400 MHz, CDCl3):
δ(ppm) = 7.92–7.99 (m, 2H, Ph), 7.59–7.63 (m, 1H, Ph), 7.45–7.50 (m, 2H, Ph), 5.18 (d, J8,9 = 6.0 Hz,
1H, H-8), 5.03 (dd, J9,8 = 6.1 Hz, J9,10 = 4.0 Hz, 1H, H-9), 4.34–4.41 (m, 1H, H-11), 4.31 (dd,
J10,11 = 6.6 Hz, J10,9 = 3.9 Hz, 1H, H-10), 4.13–4.18 (m, 1H, H-4), 4.03 (dd, J = 8.9 Hz, J = 6.2 Hz,
1H, H-12a), 3.91–3.99 (m, 2H, H-3, 12b), 3.73–3.83 (m, 3H, H-1a, H-1b, H-5), 3.54 (ddd, J = 10.0 Hz,
J = 10.0 Hz, J = 6.0 Hz, 1H, H-2), 2.42 (br. s., 1H, OH), 1.62, 1.48, 1.39, 1.37, 1.34 (5s, 18H, C(CH3)2).
13C-NMR (101 MHz, CDCl3): δ(ppm) = 164.7 (CO), 133.8, 129.9, 129.8, 128.8 (Ph), 114.3, 109.2 (C(CH3)2),
108.5 (C-7), 99.7 (C(CH3)2), 86.4 (C-8), 85.3 (C-6), 83.2 (C-10), 80.0 (C-9), 73.2 (C-11), 73.0 (C-3), 70.7
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(C-2), 69.9 (C-4), 66.4 (C-12), 61.6 (C-1), 57.4 (C-5), 29.0, 26.9, 25.6, 25.3, 24.6, 19.3 (C(CH3)2). HRESIMS
m/z 587.21029 (calcd for C28H36O12Na, 587.20990).
5,7-Anhydro-6-O-acetyl-1,3:8,9:11,12-tri-O-isopropylidene-β-d-manno-β-d-manno-dodeco-6,7-diulo-2,6-
pyranose-7,10-furanose (7a)
Following general procedure B 7a was obtained after quenching the reaction after 40 h as a white
crystalline solid and was prepared from 5a in 70% yield. A mixture of petroleum ether/ethyl acetate 2:1
was used as the eluent for column chromatography. Crystals from 7a were grown by overlaying a
saturated solution of 7a in methylene chloride with n-heptane and slowly evaporating the methylene
chloride. Rf = 0.51 (petroleum ether/ethyl acetate 1:2). [α]
20
D = +18.5 (c = 1.0, CHCl3). M.p. 151
◦C
(n-hexane/ethyl acetate). 1H-NMR (400 MHz, CDCl3): δ(ppm) = 5.04 (d, J8,9 = 5.6 Hz, 1H, H-8), 4.96
(d, J4,5 = 4.9 Hz, 1H, H-5), 4.70 (dd, J9,8 = 5.6 Hz, J9,10 = 4.0 Hz, 1H, H-9), 4.37–4.46 (m, 1H, H-11),
4.00–4.13 (m, 3H, H-3, H-12a, H12b), 3.86–3.97 (m, 3H, H-1a, H-4, H-10), 3.80 (dd, J = 10.5 Hz, 1H, H-1b),
3.65–3.74 (m, 1H, H-2), 2.14 (d, JOH,4 = 9.0 Hz, 1H, OH), 2.10 (s, 3H, COCH3), 1.56, 1.55, 1.43, 1.43, 1.39,
1.36 (6s, 18H, C(CH3)2). 13C-NMR (101 MHz, CDCl3): δ(ppm) = 169.4 (CO), 114.2 (C(CH3)2), 112.9
(C-7), 109.5, 99.9 (C(CH3)2), 98.3 (C-6), 80.9 (C-5), 80.0 (C-10), 79.1 (C-8), 78.6 (C-9), 73.5 (C-11), 71.6
(C-3), 69.1 (C-2), 68.9 (C-4), 67.1 (C-12), 61.8 (C-1), 29.1, 27.1, 25.9, 25.8, 25.4 (C(CH3)2), 21.2 (COCH3),
19.2 (C(CH3)2). HRESIMS m/z 525.19318 (calcd for C23H34O12Na, 525.19425); anal. C 55.08, H 7.11,
calcd for C23H34O12, C 54.97, H 6.82.
5,7-Anhydro-6-O-benzoyl-1,3:8,9:11,12-tri-O-isopropylidene-β-d-manno-β-d-manno-dodeco-6,7-diulo-2,6-
pyranose-7,10-furanose (7b)
Following general procedure B 7b was obtained after quenching the reaction after 40 h as a white
amorphous solid and was prepared from 5b in 63% yield. A mixture of petroleum ether/ethyl acetate
2:1 was used as the eluent for column chromatography. Rf = 0.60 (petroleum ether/ethyl acetate 1:2).
[α]20D = +15.7 (c = 1.0, CHCl3).
1H-NMR (400 MHz, acetone-d6): δ(ppm) = 8.04–8.10 (m, 2H, Ph),
7.68–7.74 (m, 1H, Ph), 7.53–7.59 (m, 2H, Ph), 5.16 (d, J8,9 = 5.6 Hz, 1H, H-8), 5.10 (d, J5,4 = 4.5 Hz,
1H, H-5), 4.82 (dd, J9,8 = 5.6 Hz, J9,10 = 3.7 Hz, 1H, H-9), 4.36 (ddd, J = 6.5 Hz, J = 6.5 Hz, J = 5.1 Hz,
1H, H-11), 4.15–4.26 (m, 2H, H-3, OH), 3.99–4.06 (m, 3H, H-4, H-10, H-12a), 3.80–3.97 (m, 4H, H-1a,
H-1b, H-2, H-12b), 1.52, 1.51, 1.37, 1.35, 1.34, 1.28 (6s, 18H, C(CH3)2). 13C-NMR (101 MHz, acetone-d6):
δ(ppm) = 165.7 (CO), 135.0, 130.8, 130.2, 129.7 (Ph), 114.2 (C(CH3)2), 113.5 (C-7), 109.5, 100.2 (C(CH3)2),
99.5 (C-6), 83.3 (C-5), 80.1 (C-10), 79.6 (C-9), 79.6 (C-8), 74.5 (C-11), 72.1 (C-3), 70.7 (C-2), 69.4 (C-4),
67.1 (C-12), 62.4 (C-1), 29.5, 27.2, 26.3, 26.2, 25.7, 19.3 (C(CH3)2). HRESIMS m/z 587.20977 (calcd for
C28H36O12Na, 587.20990); anal. C 59.64, H 6.86, calcd for C28H36O12, C 59.57, H 6.43.
5,7-Anhydro-1,3:8,9:11,12-tri-O-isopropylidene-β-d-manno-β-d-manno-dodeco-6,7-diulo-2,6-pyranose-7,10-
furanose (8)
From 7a: 7a (50 mg, 0.10 mmol) was dissolved in methanol (2 mL) and ammonia (7 N in methanol,
280 μL, 1.99 mmol) was added at ambient temperature. TLC indicated complete transformation of the
starting material after 5 h and the volatile components were removed. Neat 8 (46 mg, 0.099 mmol,
99%) remained as a white crystalline solid.
From 7b: 7b (20 mg, 0.0354 mmol) was dissolved in methanol (1 mL) and ammonia (7 N in methanol,
101 μL, 0.708 mmol) was added at ambient temperature. TLC indicated complete transformation of
the starting material after 5 h and the volatile components were removed. Subsequently, the crude
product was purified by column chromatography (petroleum ether/ethyl acetate 1:2) and 8 (13 mg,
0.282 mmol, 80%) was isolated as a white crystalline solid.
Rf = 0.32 (petroleum ether/ethyl acetate 1:3). [α]
20
D = +17.5 (c = 1.0, CHCl3). M.p. 122
◦C (n-hexane).
1H-NMR (600 MHz, DMSO-d6): δ(ppm) = 7.09 (s, 1H, OH-6), 5.16 (d, JOH,4 = 5.7 Hz, 1H, OH-4), 4.75
(d, J8,9 = 5.9 Hz, 1H, H-8), 4.57–4.63 (m, 2H, H-5, H-9), 4.22 (ddd, J11,10 = 7.3 Hz, J11,12a = 6.4 Hz,
J11,12b = 5.1, 1H, H-11), 4.01 (dd, J12a,12b = 8.4 Hz, J12a,11 = 6.4 Hz, 1H, H-12a), 3.92 (dd, J12b,12a = 8.4 Hz,
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J12b,11 = 5.1 Hz, 1H, H-12b), 3.78–3.85 (m, 2H, H-1a, H-3), 3.76 (dd, J10,11 = 7.3 Hz, J10,9 = 3.7 Hz,
1H, H-10), 3.68 (dd, J1b,1a = 10.5 Hz, J1b,2 = 10.5 Hz, 1H, H-1b), 3.52 (ddd, J = 9.7 Hz, J4,OH = 5.1 Hz,
J = 4.4 Hz, 1H, H-4), 3.40 (ddd, J2,1b = 9.9 Hz, J = 9.9 Hz, J = 5.8 Hz, 1H, H-2), 1.45, 1.39, 1.32, 1.31,
1.28, 1.26 (6s, 18H, C(CH3)2).13C-NMR (101 MHz, DMSO-d6): δ(ppm) = 112.5 (C-7), 112.3, 108.2, 98.8
(C(CH3)2), 97.4 (C-6), 83.9 (C-5), 78.2 (C-9), 77.0 (C-8), 76.9 (C-10), 72.7 (C-11), 71.1 (C-3), 67.8 (C-4), 66.8
(C-2), 66.1 (C-12), 61.1 (C-1), 28.9,26.6, 25.8, 25.5, 25.2, 19.0 (C(CH3)2). HRESIMS m/z 483.18377 (calcd
for C21H32O11Na, 483.18368); anal. C 54.58, H 7.41, calcd for C21H32O11, C 54.78, H 7.00.
4. Conclusions
In summary, we have demonstrated that the stability of 2,5-anhydro sugars depends on their
chemical environment. In the case of epoxide 6a and 6b, where an ester group is adjacent to the
epoxide group, reversible rearrangements to highly annulated oxetane-bridged disaccharides 7a and
7b occur. In further studies, these compounds serve as precursors for the synthesis of symmetrical
dodeco-6,7-diuloses.
Supplementary Materials: The following are available online, 1H-NMR and 13C-NMR spectra of all compounds,
H,H-NOESY-NMR spectra of compounds 4a and 4b and X-ray data of compounds 5a and 7a.
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Abstract: Methyl [S-phenyl 4-O-acetyl-2,3-di-O-benzyl-1-thio-α-d-mannopyranoside (R/S)S-oxide]
uronate was synthesised from a thioglycoside mannosyl uronate donor in a 98% yield. By using one
equivalent of meta-chloroperbenzoic acid (m-CPBA) as the sulphur oxidant, a smooth conversion
to the diastereomeric sulfoxide products was achieved. The product was fully characterized by 1H,
13C and 2D NMR alongside MS analysis.
Keywords: glycosyl sulfoxide; uronate; thioglycoside oxidation; mannose
1. Introduction
Glycosyl sulfoxides have been successfully used as glycosyl donors within carbohydrate
synthesis ever since a report by Kahne and co-workers in which they activated an anomeric
sulfoxide with triflic anhydride to glycosylate a deoxycholic ester derivative [1]. Since then, glycosyl
sulfoxides’ use has continued, along with developments in mechanistically understanding their role in
glycosylation reactions [2]. Glycosyl sulfoxides are traditionally formed by the careful oxidation of
a parent thioglycoside component to form an S-oxide, typically by using meta-chloroperbenzoic
acid (m-CPBA) as the oxidant, although other methods, including OXONE®, have recently
been developed [3,4]. Whilst the oxidation generally proceeds to yield diastereomeric mixtures,
stereoselective sulfoxidations have been reported for particular classes of parent thioglycosides, e.g.,
α-mannopyranose thioglycosides [5–7].
Uronic acids, where the C6 pyranosyl carbon is at the carboxylic acid oxidation level, have
also been prepared as glycosyl sulfoxide donors for the synthesis of oligosaccharide targets that
contain d-glucuronic acid [8]. As part of a wider project concerning the chemical synthesis of alginate
oligosaccharides [9], we required access to a d-mannuronic acid glycosyl sulfoxide building block (3)
and provide here our record of its synthesis and full characterization from S-phenyl thioglycoside (2).
2. Results
Starting from d-mannose 1, we prepared thioglycoside uronate donor 2 by using established
procedures (Scheme 1) [10–14]. Briefly, peracetylation of 1 followed by anomeric thioglycosidation using
PhSH/BF3·Et2O enabled global deacetylation and 4,6-benzylidenation. The benzyl protection of the
remaining hydroxy groups was then followed by 4,6-benzylidene hydrolysis to allow for regioselective
C6 oxidation of the corresponding mannuronic acid. Finally, methylation of the carboxylic acid and
4-OH protection with acetate delivered thioglycoside donor 2.
We next pursued the preparation of glycosyl sulfoxide 3 by using one equivalent of m-CPBA as the
oxidant at −78 ◦C (Scheme 1). Following the addition of the oxidant, the reaction was slowly allowed
to warm to −30 ◦C over four hours. Thin layer chromatography (TLC) analysis at this point showed
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the appearance of two new, lower Rf spots, which were indicative of an oxidised material. Following
workup, 1H NMR analysis of the crude residue indicated that a mixture of sulfoxide diastereomers
had formed (3major:3minor, 2:1). The diastereoisomers were separated by column chromatography
and analytical data collected for both.
m-
Scheme 1. Synthesis of methyl [S-phenyl 4-O-acetyl-2,3-di-O-benzyl-1-thio-α-d-mannopyranoside
(R/S)S-oxide] uronate 3 from thioglycoside 2.
For the major diastereoisomer, an analysis of the 1H NMR data [5.11 ppm (d (doublet), J = 10.1
Hz, H1)] suggested that the product adopted a 1C4 conformation in solution and the H1–H2 coupling
supported a trans-diaxial relationship. This observation was further supported by the multiplicity for
H4 (dd (doublet of doublets), J = 3.9, 1.4 Hz), which was distinct from the usual trans-diaxial coupling
observed for 4C1 mannose derivatives (Figure 1). The coupling observed for the minor diastereoisomer
was different [5.26 ppm (br d, J = 7.4 Hz, H1)] and more closely matched the J value that was observed
for 2 [5.80 ppm (d, J = 7.1 Hz, H1)], thus suggesting that the barrier to interconvert between 1C4 and
4C1 was lower for this diastereoisomer, as evidenced by signal broadening and J value averaging in the
1H NMR spectrum. Diastereomeric sulfoxide 3 is currently being evaluated as a glycosyl donor for the
synthesis of mannonate-containing oligosaccharides. Copies of NMR data for the major and minor





Figure 1. Indication of 1C4 conformation for (3) using 1H NMR coupling constant data.
3. Materials and Methods
3.1. General
All reagents and solvents that were available commercially were purchased from Acros Organics™
Belgium, Alfa Aesar™Ward Hill, MA, Fisher Scientific™Waltham MA, or Sigma Aldrich™ St. Louis
MO. All reactions in non-aqueous solvents were conducted in flame-dried glassware under a nitrogen
atmosphere with a magnetic stirring device. Solvents were purified by passing through activated
alumina columns, used directly from a PureSolv-MD solvent purification system, and transferred
under nitrogen. Reactions requiring low temperatures used the following cooling baths: −78 ◦C
(dry ice). Infrared spectra were neatly recorded on a Perkin Elmer Spectrum 100 FT-IR spectrometer;
selected absorbencies (νmax) are reported in cm−1. 1H NMR spectra were recorded at 400 MHz, and
13C spectra were recorded at 100 MHz with the use of a Bruker AVIII400 spectrometer. 1H NMR signals
were assigned with the aid of gDQCOSY. 13C NMR signals were assigned with the aid of gHSQCAD.
Coupling constants are reported in Hertz. Chemical shifts (δ, in ppm) were standardized against the
deuterated solvent peak. NMR data were analysed with the Nucleomatica iNMR software. 1H NMR
splitting patterns were assigned as follows: s (singlet), br d (broad doublet), d (doublet), t (triplet), dd
(doublet of doublets), ddd (doublet of doublet of doublets), or m (multiplet and/or multiple resonances).
Reactions were followed by TLC by using Merck silica gel 60F254 analytical plates (aluminium support)
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and were developed with the use of standard visualising agents: short wave UV radiation (245 nm)
and 5% sulfuric acid in methanol/Δ. Purification via flash column chromatography was conducted by
using silica gel 60 (0.043–0.063 mm). Optical activities were recorded on a Rudolph autopol I automatic
polarimeter (concentration in g/100mL). MS and HRMS (ESI) were obtained on Waters (Xevo, G2-XS
TOF) or Waters Micromass LCT spectrometers by using a methanol mobile phase. High resolution
(ESI) spectra were obtained on a Xevo, G2-XS TOF mass spectrometer.
3.2. Methyl [S-phenyl 4-O-acetyl-2,3-di-O-benzyl-1-thio-α-d-mannopyranoside (R/S)S-oxide] uronate 3
m-CPBA (66 mg, 0.38 mmol, 1.0 equiv.) was added to a stirred solution of 2 (200 mg, 0.38 mmol,
1.0 equiv.) in CH2Cl2 (20 mL) at −78 ◦C, followed by warming to -30 ◦C over 4 h, whereupon TLC
analysis (EtOAc/hexane, 1/2) indicated that no starting material remained. The reaction was quenched
by the addition of a saturated aqueous NaHCO3 solution (25 mL) and the organic layer separated and
washed with brine (2 × 25 mL). The organic layer was dried (MgSO4), filtered, and concentrated under
reduced pressure, furnishing crude 3 as a yellow oil. Purification was conducted with the use of silica
gel flash column chromatography eluting with EtOAc/hexane (0/100, 20/80, 40/60, 90/10) to afford (3)
(201 mg, 0.34 mmol, 98%) as two separable diastereoisomers (3major:3minor, 2:1, 132 mg:69 mg).
Analytical data for 3minor. Rf 0.18 (EtOAc/hexane, 1/2); [α]
26
D +100 (c. 1.0, CHCl3);
1H NMR (400 MHz;
CDCl3) δ 7.63–6.91 (15 H, m, ArH), 5.51 (1 H, dd, J = 5.3, 3.4 Hz, H4), 5.24 (1 H, d, J = 7.4 Hz, H1), 4.57
(1 H, d, J = 3.2, Hz, H5), 4.50 (1 H, d, J = 12.9 Hz, CH2Ph-attached to C3), 4.47 (1 H, d, J = 12.6 Hz,
CH2Ph-attached to C3), 4.40 (1 H, d, J = 11.8 Hz, CH2Ph-attached to C2), 4.33 (1 H, d, J = 11.8 Hz,
CH2Ph-attached to C2), 4.05 (1 H, dd, J = 7.5, 2.9 Hz, H2), 3.92 (1 H, dd, J = 5.0, 2.8 Hz, H3), 3.58 (3 H,
s, CO2CH3), 2.05 (3 H, s, C(O)CH3); 13C NMR (101 MHz; CDCl3) δ 169.7 (C=O of C(O)CH3), 168.1
(C=O of CO2CH3), 140.7, 137.3, 137.3, 130.7, 128.9, 128.3, 128.2, 127.9, 127.7, 127.7, 124.5, 92.2 (C1), 74.5
(C5), 73.2 (C3), 72.7 (CH2Ph-attached to C3), 71.2 (CH2Ph-attached to C2), 70.0 (C2), 69.4 (C4), 52.4
(CO2CH3), 20.9 (C(O)CH3); LRMS (ESI+) m/z 539 [(M + H)+, 100%]; HRMS (ESI+) m/z Found: (M +
H)+ 539.1739 C29H30O8S requires (M +H)+, 539.1734; IR νmax/cm−1 1735 (s, C=O), 1183 (s, C–O), 1143
(s, C–O), 1074 (s, S=O).
Analytical data for 3major. Rf 0.10 (EtOAc/hexane, 1/2); [α]
26
D −2.3 (c. 1.0, CHCl3); 1H NMR (400 MHz;
CDCl3) δ 7.79–7.31 (15 H, m, ArH), 5.52 (1 H, dd, J = 3.9, 1.4 Hz, H4), 5.10 (1 H, d, J = 10.1 Hz, H1), 4.73
(1 H, d, J = 11.1 Hz, CH2Ph-attached to C2 or C3), 4.62 (1 H, d, J = 12.0 Hz, CH2Ph-attached to C2 or
C3), 4.58 (2 H, d, J = 12.0 Hz, CH2Ph-attached to C2 or C3), 4.57 (1 H, d, J = 11.1 Hz, CH2Ph-attached
to C2 or C3), 4.39 (1 H, d, J = 1.0 Hz, H5), 4.21 (1 H, dd, J = 10.1, 2.7 Hz, H2), 3.92–3.90 (1 H, m, H3),
3.42 (3 H, s, CO2CH3), 2.09 (3 H, s, C(O)CH3); 13C NMR (101 MHz; CDCl3) δ 170.0 (C=O of C(O)CH3),
167.9 (C=O of CO2CH3), 137.0, 137.0, 130.6, 128.6, 128.5, 128.4, 128.4, 128.2, 128.1, 128.0, 125.1, 86.8 (C1),
74.5 (C5), 72.6 (CH2Ph-attached to C2 or C3), 72.4 (CH2Ph-attached to C2 or C3), 72.4 (C3), 70.6 (C2),
69.4 (C4), 52.1 (CO2CH3), 21.1 (C(O)CH3); LRMS (ESI+) m/z 539 [(M +H)+, 100%]; HRMS (ESI+) m/z
Found: (M + H)+ 539.1719 C29H30O8S requires (M + H)+, 539.1734; IR νmax/cm−1 1735 (s, C=O), 1183
(s, C–O), 1143 (s, C–O), 1074 (s, S=O).
Supplementary Materials: The following are available online, Figure S1: 1H NMR spectrum of compound 3major,
Figure S2: 13C NMR spectrum of compound 3major, Figure S3: 1H NMR spectrum of compound 3minor, Figure
S4: 13C NMR spectrum of compound 3minor.
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Abstract: 3′,5′-O-Bis(tert-butyldimethylsilyl)-8-fluoro-N-2-isobutyryl-2′-deoxyguanosine was synthesized
from 3′,5′-O-bis(tert-butyldimethylsilyl)-N-2-isobutyryl-2′-deoxyguanosine by the treatment with
N-fluorobenzenesulfonimide. A similar fluorination reaction with 3′,5′-O-bis(tert-butyldimethylsilyl)-
N-2-(N,N-dimethylformamidine)-2′-deoxyguanosine, however, failed to give the corresponding
fluorinated product. It was found that 8-fluoro-N-2-isobutyryl-2′-deoxyguanosine is labile under
acidic conditions, but sufficiently stable in dichloroacetic acid used in solid phase synthesis.
Incorporation of 8-fluoro-N-2-isobutyryl-2′-deoxyguanosine into oligonucleotides through the
phosphoramidite chemistry-based solid phase synthesis failed to give the desired products.
Furthermore, treatment of 8-fluoro-N-2-isobutyryl-2′-deoxyguanosine with aqueous ammonium
hydroxide did not give 8-fluoro-2′-deoxyguanosine, but led to the formation of a mixture consisting
of 8-amino-N-2-isobutyryl-2′-deoxyguanosine and C8:5′-O-cyclo-2′-deoxyguanosine. Taken together,
an alternative N-protecting group and possibly modified solid phase synthetic cycle conditions will
be required for the incorporation of 8-fluoro-2′-deoxyguanosine into oligonucleotides through the
phosphoramidite chemistry-based solid phase synthesis.
Keywords: 8-Fluoro-2′-deoxyguanosine; 19F NMR spectroscopy; fluorination; solid phase
synthesis; phosphoramidite
1. Introduction
Among the numerous modifications to nucleic acids, introduction of fluorine has attracted
significant interest due to its small size and the ability for stereochemical control [1]. In this respect,
presence of fluorine in the sugar residues allows for the control over sugar puckers, while introduction
of fluorine to the nucleobases enables unique hydrogen bonding properties. Furthermore, presence
of fluorine in nucleic acids presents an opportunity to study the structures of nucleic acids and the
interaction involving these molecules by 19F NMR spectroscopy due to the abundance of 19F among its
isotopes, large gyromagnetic ratio, and the sensitivity of 19F chemical shifts to structural changes [2].
We recently demonstrated that 5-fluoro-2′-deoxycytidine 1 (Figure 1) is a useful probe for the study of
the B/Z-DNA handedness switch by 19F NMR [3].
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Figure 1. Nucleosides with fluorine modification in the nucleobase.
We are interested in expanding the scope of fluorine modification of nucleobases,
especially to the guanine base in this respect, as d(CG) repeats are the most widely studied
sequences for the DNA handedness switch. We wish to describe the chemical synthesis of
8-fluoro-N-isobutyryl-2′-deoxyguanosine 4 and its reactivity under the conditions for the assembly of
oligonucleotides through the phosphoramidite chemistry-based solid phase.
2. Results and Discussion
Syntheses of adenine nucleosides, such as 2-fluoro-2′-deoxyadenosine 2a [4–7] and
2-fluoroadenosine 2b [6,8] have been demonstrated through different approaches. Introduction
of fluorine to the C-8 position of purine nucleosides is more challenging, likely due to the
instability of the resulting nucleosides. The F-C bond in 8-F-rA 3b is labile under basic
conditions. In this respect, basic conditions that are required for the removal of N-acyl protecting
groups can lead to defluorination. Thus, an early attempt to synthesize 8-fluoroadenosine
3b by the treatment of 2′,3′,5′-O-triacetyl-8-fluoroadenosine with methanolic ammonia [9] was
later found not to give the desired 8-F-rA [10]. Enzymatic [11] or deprotection conditions
under mild acidic conditions [12] allowed for the access of 8-F-rA. Fluorination of guanosine
at the C-8 position was demonstrated by treatment with elemental fluorine [13]. This method,
however, is inconvenient due to the difficulty in handling elemental fluorine. More recently,
syntheses of protected 8-fluoro deoxyinosine, deoxyadenosine (which led to the formation of
8-fluoro-2′-deoxyadenosine 3a after deprotection), and deoxyguanosine derivatives were demonstrated
through metalation-electrophilic fluorination by the treatment of suitably protected purine nucleosides
with lithium diisopropylamide (LDA) followed by N-fluorobenzenesulfonimide (NFSI) [14], all
in low or moderate yields. In this chemistry, guanosine derivatives had to be protected at
O-6 position. We found that N-2-isobutyryl protected, but not N-2-formamidine protected,
2′-deoxyguanosine, compounds 6 and 8, respectively, can be fluorinated using this chemistry.
Thus, 3′,5′-O-bis(tert-butyldimethylsilyl)-N-2-isobutyryl-2′-deoxyguanosine 6 was subjected to
metalation−electrophilic fluorination with LDA and NSFI to generate the corresponding 8-fluoro
analog 7 in 30% yield (Scheme 1), with recovery of 50% the starting material 6. A similar reaction with
3′,5′-O-bis(tert-butyldimethylsilyl)-N-2- dimethylformamidine-2′-deoxyguanosine 8 failed to give the
corresponding fluorinated product 9.
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Scheme 1. Synthesis of 8-fluoro-deoxyguanosine derivatives. Reagents and conditions: (i). a.
(CH3)3SiCl, ((CH3)2CHCO)O, C5H5N, r.t. 2.5 h; b. aq. NH3, 0 ◦C, 30 min; (ii). TBDMSCl, DMF, r.t.,
24 h; (iii). a. LDA, toluene, −78 ◦C, 2 h; b. NFSI; (iv). TBAF, THF, r.t., 1 h; (v). (CH3)2NCH(OCH3)2,
MeOH, r.t., 2 d.
In order to introduce 8-fluoro-2′-deoxyguanosine into oligonucleotides through the
phosphoramidite chemistry-based solid phase synthesis, the stability of 8-fluoro-N-2-isobutyryl
-2′-deoxyguanosine 12 in acidic conditions was investigated. This property is of importance as di- or
trichloroacetic acid (DCA and TCA, respectively) is typically used for the removal of dimethoxytrityl
(DMTr) group during the detritylation reaction. As such, 8-fluoro-2′-deoxyguanosine derivatives will
need to be sufficiently stable under the acidic detritylation condition. Thus, experiments were conducted
by 19F NMR spectroscopy to determine the stability of 8-fluoro-N-isobutyryl-2′-deoxyguanosine 4 in
acids of different pKa.
As seen in Table 1, 8-fluoro-N-isobutyryl-2′-deoxyguanosine 4 is stable in 3% benzoic acid and
80% acetic acid in methanol, and relatively stable in monochloroacetic acid (MCA), however, removal
of the DMTr group with these acids is reversible. While 8-fluoro-N-isobutyryl-2′-deoxyguanosine 4
is relatively unstable in DCA and TCA, It was previously shown that DMTr removal can be effected
by DCA and TCA in as little as 20 s [15], thus, DCA appears to be the most suited for the removal
of DMTr groups in solid phase synthesis involving 8-fluoro-N-isobutyryl-2′-deoxyguanosine 4. This
nucleoside was subsequently protected with DMTr at 5′-OH (as in 10) and then transformed into the
corresponding 3′-phosphoramidite 11 (Scheme 2).
Table 1. Half-lives of 8-fluoro-N-isobutyryl-2′-deoxyguanosine 4 under acidic conditions. (TCA:
trichloroacetic acid; DCA: dichloroacetic acid; MCA: monochloroacetic acid).
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Scheme 2. Synthesis of phosphoramidite 11. Reagents and conditions: (i). DMTr-Cl, C5H5N, r.t.,
30 min; (ii). NCCH2CH2P(Cl)N(i-Pr)2, EtN(i-Pr)2, r.t., 30 min.
Solid phase syntheses were carried out using the ABI standard 1 μmol cycle conditions for the
assembly of d(CG)6 sequences where a single dG was replaced with 8-fluoro-dG at each of the dG
positions. The products were cleaved from the solid support and deprotected by incubation with
concentrated aqueous ammonium hydroxide at 55 ◦C overnight. All modified sequences were found by
mass spectrometry to contain a major species with a mass of 3753 Da, which is 87 mass unit higher than
the expected sequences (3665 Da). The exact nature of the modification during solid phase synthesis
that led to the formation of this higher mass species remains to be identified. It was found that the
treatment of 8-fluoro-N-2-isobutyryl-2′-deoxyguanosine 12 with the activator (5-ethylthio-1H-tetrazole)
for coupling reactions or the oxidation solution containing aqueous iodine in pyridine, did not lead
to the formation of displacement products 13 and 14, respectively, which, if reacted with 2,6-lutidine
during the capping step, could generate the corresponding modified dG species 15 with the 87 extra
mass units found in the oligonucleotides (Figure 2).
 
Figure 2. Hypothesized formation of a 2,6-lutidine–guanine adduct 15 during solid phase synthesis.
Finally, it was found that treatment of 8-fluoro-N-isobutyryl-2′-deoxyguanosine 4 (Scheme 3)
with concentrated aqueous ammonium hydroxide at 55 ◦C overnight, the typical conditions for the
deprotection of N-acyl groups, did not give the desired 8-fluoro-2′-deoxyguanosine 18; instead, a
mixture of 8-amino-2′-deoxyguanosine 16 and C8:5′-O-cyclo-2′-deoxyguanosine 17 was obtained in
approximately a 2:1 ratio, as indicated by the reverse phase HPLC profile in Figure S28.
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Scheme 3. Attempted deprotection of 8-fluoro-N-isobutyryl-2′-deoxyguanosine 4. (i). conc. aq.
NH4OH, 55 ◦C, overnight.
Taken together, these results suggest that 8-fluoro-N-isobutyryl-2′-deoxyguanosine 4 is unsuitable
for the introduction of 8-fluoro-2′-deoxyguanosine into oligonucleotides via the phosphoramidite
chemistry-based solid phase synthesis. Alternative N2-protecting groups, as well as modified solid
phase synthesis conditions, will be required for successful incorporation of 8-fluoro-2′-deoxyguanosine
into oligonucleotides.
3. Materials and Methods
1H NMR spectra were measured at 400 MHz with a Bruker Avance 400 Digital NMR spectrometer
(Billerica, MA, USA). 13C, 31P and 19F NMR spectra were recorded at 100.6, 162.0 and 376.6 MHz
respectively, with the same spectrometer. Chemical shifts and coupling constants (J values) are given
in ppm and Hz, respectively. Deuterated solvents were purchased from C/D/N Isotopes (Montreal,
QC, Canada). EI (electron impact) and FAB (fast atom bombardment) mass spectra were obtained
with a Thermo Scientific DFS mass spectrometer (Waltham, MA, USA); ESI (electrospray) spectra were
measured with a Bruker HCT Plus ion-trap mass spectrometer. Desican silica gel (230–400 mesh) was
used for column chromatography. Thin layer chromatography was performed on Silicycle F-254 silica
TLC plates using the following solvent mixtures:
Solvent A: methanol-dichloromethane (5:95, v/v)
Solvent B: methanol-dichloromethane (20:80, v/v)
3.1.Solvents and Chemicals
Toluene was dried by heating under reflux over sodium in the presence of benzophenone for 4 h
and then distilled under nitrogen. N,N-Diisopropylethylamine and pyridine were dried by heating
under reflux over calcium hydride for 4 h and then distilled under nitrogen. N,N-Dimethylformamide
was dried by heating at 60 ◦C over calcium hydride for 4 h and then distilled under vacuum.
Dichloromethane was dried by heating under reflux over phosphorus pentoxide for 4 h and then
distilled under nitrogen. All other reagents were purchased from Sigma-Aldrich or TCI America
without further purification prior to use unless stated otherwise.
3.1. 3′,5′-Bis(tert-butyldimethylsilyl)-N-isobutyryl-2′-deoxyguanosine (6)
N-Isobutyryl-2′-deoxyguanosine 5 (3.50 g, 10.4 mmol), imidazole (4.66 g, 68.6 mmol) and
tert-butyldimethylsilyl chloride (6.90 g, 45.7 mmol) were stirred in dry dimethylformamide (30 mL) for
5 h. The resulting slurry was diluted with ethanol (25 mL) and stored at −20 ◦C for 24 h. White crystals
were collected by vacuum filtration to give the title compound (4.93 g, 84%). M.p. 102–104 ◦C (ethanol).
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Rf (system A): 0.38. HR-MS (EI) found 565.3099, C26H47N5O5Si2 required 565.3116. δH (CDCl3): 0.09,
0.10, 0.117 and 0.119 (total 12 H, Si(CH3)2), 0.920 and 0.925 (total 18 H, Si(C(CH3)3), 1.27 (3 H, d, J = 6.5,
iBu), 1.29 (3 H, d, J = 6.5), 2.37 (1 H, ddd, J = 3.8, 6.0 and 10.0, H-2′), 2.47 (1 H, m, H-2′’), 2.65 (1 H,
CH(CH3)2, septet, J = 6.9), 3.78 (2 H, m, H-5′/5′’), 3.99 (1 H, q, J = 3.4, H-4′), 4.58 (1 H, m, H-3′), 6.23 (1
H, dd, J = 6.5 and 6.5, H-1′), 7.98 (1 H, s, H-8), 8.40 (1 H, s, NH), 12.00 (1 H, s, NH). δC (CDCl3): −5.51,
−5.38, −4.77, −4.68, 18.0, 18.4, 18.95, 19.01, 25.7, 26.0, 36.6, 41.4, 62.8, 71.8, 83.5, 88.0, 121.5, 136.8, 147.3,
147.8, 155.5, 178.1.
3.2. 3′,5′-Bis(tert-butyldimethylsilyl)-8-fluoro-N-isobutyryl-2′-deoxyguanosine (7)
3′,5′-Bis(tert-butyldimethylsilyl)-N-isobutyryl-2′-deoxyguanosine 6 (4.00 g, 7.08 mmol) was
co-evaporated with dry toluene (3 × 15 mL) and dissolved in dry toluene (80 mL). After
the mixture was cooled to −78 ◦C (acetone–dry ice bath), 2.0 M lithium diisopropylamide
solution in THF/heptane/ethylbenzene (17.7 mL, 35.4 mmol) was added slowly. After 2 h,
N-fluorobenzenesulphonamide (6.68 g, 21.2 mmol) was added and the mixture was stirred for
1.5 h at −78 ◦C and then allowed to warm up to room temperature over 30 min. Saturated aqueous
ammonium chloride solution (80 mL) was added and the layers were separated. The aqueous layer
was extracted with dichloromethane (2 × 40 mL), and the combined organic layers were washed with
saturated sodium bicarbonate solution (100 mL), dried over magnesium sulfate and concentrated
under reduced pressure. The residue was purified by column chromatography on silica gel. The
appropriate fractions, which were eluted with dichloromethane–methanol (99.3:0.7 v/v), were pooled
and concentrated under reduced pressure to give the title compound as a pale yellow solid (825 mg,
20%). Rf (system A): 0.41. HR-MS (EI) found 583.3015, C26H46N5O5Si2F required 583.3022. δH (CDCl3):
0.04 (3 H, s, Si(CH3)2), 0.06 (3 H, s, Si(CH3)2), 0.13 (6 H, s, Si(CH3)2), 0.89 (9 H, s, Si(C(CH3)3)2), 0.93 (9 H,
s, Si(C(CH3)3)2), 1.24 (3 H, d, J = 7.0, CH(CH3)2), 1.27 (3 H, d, J = 7.0, CH(CH3)2), 2.26 (1 H, ddd, J = 3.9,
6.6 and 10.7, H-2′), 2.66 (1 H, CH(CH3)2, septet, J = 6.9), 2.78 (1 H, m, H-2′’), 3.71 (2 H, m, H-5′/5′’), 3.89
(1 H, m, H-4′), 4.59 (1 H, m, H-3′), 6.16 (1 H, dd, J = 6.8 and 6.8, H-1′), 8.69 (1 H, s, NH), 12.12 (1 H, s,
NH). δF (CDCl3): −101.3. δC (CDCl3): −5.5, −5.4, −4.8, −4.7, 18.0, 18.4, 18.8, 19.1, 25.8, 25.9, 36.5, 37.9,
62.7, 71.7, 82.3, 87.7, 114.8 (d, JC,F = 13.9), 146.7 (d, JC,F = 3.3), 147.7 (d, JC,F = 2.7), 149.6 (d, JC,F = 251.1),
154.8, 178.5.
3.3. 8-Fluoro-N-isobutyryl-2′-deoxyguanosine (4)
3′,5′-Bis(tert-butyldimethylsilyl)-8-fluoro-N-isobutyryl-2′-deoxyguanosine 7 (350 mg, 0.60 mmol)
and tetra-n-butylammonium fluoride (391 mg, 1.5 mmol) were stirred in tetrahydrofuran (12 mL)
for 1 h at r.t., followed by addition of warm water (50 ◦C) until all salts dissolved. The product
crystalized from water to give 127 mg (60%) of the title compound as white crystals. M.p.: decomposed
at 183–185 ◦C (water). Rf (system B): 0.72. HR-MS (EI) found 335.1220, C14H18N5O5F requires 355.1292.
δH (DMSO-d6): 1.13 (6 H, d, J = 6.6, CH(CH3)2), 2.24 (1 H, ddd, J = 3.8, 6.5 and 10.2, H-2′), 2.76 (2 H, m,
H-2′’ and CH(CH3)2), 3.79 (1 H, m, H-4′), 4.37 (1 H, m, H-3′), 4.84 (1 H, t, J = 5.6, 5′-OH, ex), 5.35 (1
H, d, J = 4.0, 3′-OH, ex), 6.17 (1 H, t, J = 6.9, H-1′), 11.68 (1 H, s, NH, ex), 12.17 (1 H, s, NH, ex). δC
(DMSO-d6): 14.0, 19.3, 35.3, 37.5, 62.0, 70.7, 82.8, 88.2, 113.9 (d, JC,F = 13.1), 147.5 (d, JC,F = 3.2), 148.9 (d,
JC,F = 2.6), 149.5 (d, JC,F = 247.6), 154.4 (d, JC,F = 2.1), 180.6. δF (DMSO-d6): −102.9.
3.4. 5′-(4,4′-Dimethoxytrityl)-8-fluoro-N-isobutyryl-2′-deoxyguanosine (10)
8-Fluoro-N-isobutyryl-2′-deoxyguanosine 4 (0.50 g, 1.4 mmol) was co-evaporated with dry
pyridine (3 × 10 mL) and dissolved in dry pyridine (5 mL), followed by addition of 4,4′-dimethoxytrityl
chloride (0.72 g, 2.1 mmol). After 30 min, the reaction was quenched with a triethylamine/ethanol
(1:1 v/v) mixture (1 mL). The products were diluted with dichloromethane (50 mL) and extracted
with saturated aqueous sodium hydrogen carbonate (50 mL). The aqueous layer was back-extracted
with dichloromethane (30 mL) and the combined organic layers were dried (MgSO4) and evaporated
under reduced pressure. The oily residue was purified by column chromatography on silica gel. The
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appropriate fractions, which were eluted with dichloromethane–ethanol–triethylamine (98.2:1.5:0.3
v/v/v), were pooled and concentrated under reduced pressure to give the title compound as a colorless
glass (850 mg, 92%). Rf (system A): 0.27. MS (ESI) found 658.2 (M-H+), C35H37FN5O7+ required
658.2677. δH (CDCl3): 0.98 (3 H, d, J = 6.7), 1.07 (3 H, d, J = 7.0), 2.27 (1 H, CH(CH3)2, m), 2.34 (1 H,
ddd, J = 4.2, 6.2 and 10.6, H-2′), 3.00 (1 H, m, H-2′’), 3.24 (1 H, dd, J = 5.2 and 10.3, H-5′), 3.36 (1 H, dd,
J = 3.7 and 10.3, H-5′’), 3.74 and 3.75 (6 H, (OCH3)2), 4.09 (1 H, ddd, J = 4.1, 4.1 and 8.5, H-4′), 4.82 (1
H, m, H-3′), 6.14 (1 H, dd, J = 6.2 and 6.2, H-1′), 6.74 (3 H, d, J = 3.1), 6.77 (3 H, d, J = 3.1), 7.14–7.23
(3 H, m), 7.30 and 7.32 (4 H), 7.44 (2 H, dd, J = 1.5 and 8.3). δF(CDCl3): −103.7. δC (CDCl3): 18.75, 18.77,
36.0, 36.2, 55.2, 63.9, 71.4, 82.8, 86.1, 86.3, 113.1, 115.0, 126.9, 127.8, 128.1, 129.96, 130.0, 135.9, 136.1,
144.9, 146.9, 147.8, 148.6, 158.5, 179.4.
3.5. 5′-(4,4′-Dimethoxytrityl)-8-fluoro-N-isobutyryl-2′-deoxyguanosine-3′-(2-cyanoethyl)-N,N
-diisopropylphosphoramidite (11)
5′-(4,4′-Dimethoxytrityl)-8-fluoro-N-isobutyryl-2′-deoxyguanosine 10 (1.00 g, 1.52 mmol) was
co-evaporated with dry toluene (3× 10 mL) and then dissolved in dry dichloromethane (20 mL), followed
by addition of dry N,N-diisopropylethylamine (1.0 mL, 5.7 mmol) and (2-cyanoethyl)-N,N-diisopropyl
phosphochloridite (0.72 g, 3.0 mmol). After the reaction mixture was stirred for 30 min, triethylamine
(1 mL) was added and products were concentrated under reduced pressure. The residue was
purified by column chromatography on silica gel. The appropriate fractions, which were eluted with
hexane–acetone–triethylamine (70:28:2 v/v/v), were pooled and concentrated under reduced pressure.
The resulting oil was dissolved in dichloromethane (2 mL) and added dropwise to pentane (20 mL) at
−40 ◦C under stirring. The cloudy suspension was centrifuged for 20 min and the supernatant was
decanted. The white solid was collected and dried to give the title phosphoramidite (0.57 g, 44%).
HR-MS (FAB) found 858.3787 ([M + H]+), C44H54FN7O8P+ required 858.3755. δH(CDCl3) include the
following signals: 2.45–2.56 (1 H, m, H-2′), 3.12–3.51 (3 H, m, H-2”, H-5′, and H-5”), 3.774, 3.777, 3.782
and 3.787 (6 H, -OMe), 4.21–4.29 (1 H, m, H-4′), 4.77–4.89 (1 H, m, H-3′), 6.19 (1 H, m, H-1′), 6.75–6.79
(4 H, m). δF (CDCl3): −106.27 and −104.28. δP(CDCl3): 147.78 and 147.96.
3.6. Treatment of 8-Fluoro-N-isobutyryl-2′-deoxyguanosine under Ammonolysis Conditions
8-Fluoro-N-isobutyryl-2′-deoxyguanosine (4 mg) was incubated with concentrated aqueous
ammonium hydroxide (1.0 mL) at 55 ◦C for 16 h. Upon cooling the products were lyophilized. The
residue was purified by column chromatography using C18-reverse phase matrix (1 × 15 cm) on a
BioRad DuoFlow FPLC system. The column was eluted with acetonitrile–water (0:100 to 30:70 v/v) in a
linear gradient over 60 min. Eluants were collected in 1.0 mL fractions and lyophilized.
3.7. Oligonucleotide Synthesis
Oligonucleotides were synthesized using an ABI 3400 DNA synthesizer (Waltham, MA, USA)
under the standard 1 μmol cycle conditions. Phosphoramidites were prepared as 100 mM solutions
in dry acetonitrile. A solution of 5-(ethylthio)-1H-tetrazole (250 mM in dry acetonitrile) was used
as the activator, and coupling reaction time was set at 60 s. Detritylation was effected by delivering
dichloroacetic acid (3% in dichloromethane) to reaction columns for 110 s. After solid phase synthesis
was complete, the products were cleaved from solid support and deprotected by incubation with
ammonium hydroxide at 55 ◦C for 24 h and then lyophilized.
4. Conclusions
3′,5′-O-Bis(tert-butyldimethylsilyl)-8-fluoro-N-2-isobutyryl-2′-deoxyguanosine was synthesized
by treating 3′,5′-O-bis(tert-butyldimethylsilyl)-N-2-isobutyryl-2′-deoxyguanosine with LDA and
N-fluorobenzenesulfonimide. Subsequent deprotection afforded 8-fluoro-N-2-isobutyryl-2′-deoxyguanosine.
The latter compound was found to be sufficiently stable in 3% dichloroacetic acid, however,
incorporation of the corresponding phosphoramidite into d(CG)6 sequences did not lead to the
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formation of the desired 8-fluoro-2′-deoxyguanosine modified oligonucleotides. Treatment of
8-fluoro-N-2-isobutyryl-2′-deoxyguanosine under ammonolysis conditions led to the formation of
a mixture of 8-amino-2′-deoxyguanosine and C8:5′-O-cyclo-2′-deoxyguanosine. Future work will
explore protecting groups for the exocyclic amine that are readily removable under conditions that do
not lead to modification of this nucleoside. Furthermore, cycle conditions for solid phase synthesis
need to be modified in order to successfully incorporate 8-fluoro-2′-deoxyguanosine.
Supplementary Materials: The supplementary materials are available online.
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Abstract: Naturally occurring nucleoside-peptide antibiotics such as muraymycins or caprazamycins
are of major interest for the development of novel antibacterial agents. However, the synthesis of new
analogues of these natural products for structure–activity relationship (SAR) studies is challenging.
In our synthetic efforts towards a muraymycin-derived nucleoside building block suitable for
attachment to a solid support, we came across an interesting side product. This compound resulted
from an undesired Fmoc deprotection with subsequent cyclization, thus furnishing a remarkable
caprazamycin-like seven-membered diazepanone ring.
Keywords: muraymycins; caprazamycins; nucleosides; uridine; cyclization; seven-membered rings
1. Introduction
Emerging bacterial strains that are resistant to antibiotics are a severe threat in healthcare [1–3].
To address this problem, novel antibacterial agents with previously unexploited modes of action are
urgently needed [4]. A promising class that meets this requirement are uridine-derived nucleoside-
peptide antibiotics that interfere with bacterial cell wall biosynthesis [5–7]. They inhibit MraY,
an enzyme that catalyzes a membrane-associated step in the intracellular part of peptidoglycan
formation [8–13]. Among this structurally diverse class, our research focusses mainly on the subclasses
of muraymycins [14,15] and caprazamycins [16–22] (Figure 1). For muraymycins, a co-crystal
structure in complex with MraY has been reported, enabling deeper insights into the inhibitor-target
interaction [23–25]. However, experimental structure–activity relationship (SAR) studies are still
crucial due to the pronounced conformational plasticity of MraY, and have therefore been carried out
extensively as exemplified by the according work on muraymycins [26–35].
 
Figure 1. Structures of the nucleoside-peptide antibiotics muraymycins and caprazamycins.
In contrast to previously reported solution-phase syntheses of muraymycin derivatives [28,30,31],
we have recently described a solid phase-supported approach for the preparation of structurally
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simplified muraymycin analogues [36]. This novel strategy was based on the stepwise construction of
the muraymycin peptide unit on the solid support. As part of our initial studies on this approach, we
had also investigated a potential attachment of the muraymycin nucleoside unit (or an analogue thereof)
to the solid phase. Hence, we had envisioned to prepare uridine-derived building block 5 (see Scheme 2)
that could then be connected to the solid phase. The design of 5 was based on our previously reported
strategy to simplify the muraymycin core structure by omission of the 5′-substituent (“5′-deoxy”
analogues) [30,33,35–38]. Carboxylic acid 5 was intended to be attached to a trityl resin by formation
of a trityl ester. In order to then apply standard solid-phase protocols for the assembly of the peptide
unit, we chose Fmoc as protecting group for the terminal amino group of the linker moiety. For the
preparation of 5, we intended to selectively cleave the tert-butyl ester in the 7′-position of precursor
4 (Schemes 1 and 2). Studies on this particular transformation have furnished the unexpected side
reaction reported in this work.
2. Results
The synthesis of the fully protected uridine-derived precursor building block 4 involved protocols
that were previously reported by our group. Thus, uridine 1 was transformed into the protected
nucleosyl amino acid 2 using an established five-step route (Scheme 1) [30,37,38]. This was followed
by reductive amination of 2 with Fmoc-protected aldehyde 3 [36]. The reductive amination step
was carried out in a similar way as with other Cbz-protected aldehydes as previously reported [30]
(i.e., using amberlyst as acidic activator and sodium triacetoxyborohydride as reducing agent). The
resultant product 4 was obtained in 71% yield (Scheme 1).
 
Scheme 1. Synthesis of protected uridine-derived precursor building block 4.
For the envisioned selective deprotection of the 7′-carboxylate of 4, we needed a method that
would cleave the tert-butyl ester but leave the tert-butyldimethylsilyl (TBDMS) groups intact. We
therefore studied the mild acidic cleavage of the tert-butyl ester of 4—as previously reported by us for
similar transformations [39]—in order to potentially obtain 5 (Scheme 2). In first attempts, the reaction
was carried out by stirring a solution of 4 in toluene in the presence of silica at reflux temperature
(i.e., 111 ◦C (Table 1, entries 1–3)). The conversion of 4 was monitored by thin layer chromatography
(TLC). Surprisingly, a seven-membered diazepanone ring was formed to give main product 6 (without
the Fmoc protecting group) in a yield of 41% (Table 1, entry 1). This was unexpected, as the Fmoc
group usually requires basic conditions for its cleavage. We speculated that, under the applied
reaction conditions (high temperature, extended reaction period of 5 days), the secondary amine at the
6′-position of 4 might have been sufficiently basic to mediate Fmoc deprotection. The resultant primary
amine then probably attacked the 7′-tert-butyl ester of 4, thus leading to ring formation (proposed
mechanism not shown). By significantly decreasing the reaction period, the yield of side product 6
even increased to 68% (after 1.5 days, Table 1, entry 2) and 76% (after 5 h, entry 3), respectively. This
demonstrated that 6 was indeed the main product of this transformation at elevated temperatures.
Variation of the temperature then revealed that the desired product 5 might have been formed at
lower temperatures, but only in small amounts. Target compound 5 was obtained when the reaction
mixture was stirred at 80 ◦C for 1 day and then at room temperature (rt) for further 2 days, furnishing
a moderate yield of 48% of 5 (Table 1, entry 4). Further attempts to repeat this reaction towards 5
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and possibly improve its yield only gave worse results (i.e., lower yields with significant amounts of
unidentified impurities). We also explored other conditions to selectively cleave the tert-butyl ester,
mainly the treatment of 4 with TFA (Table 1, entries 5–7) or with pig liver esterase (PLE, entry 8), but
none of these experiments afforded satisfying conversions to the desired carboxylic acid 5.
 
Scheme 2. Attempted deprotection of 4 towards 5, yielding diazepanone 6 as major product instead.
Table 1. Investigated conditions for the attempted reaction of 4 to 5 (see Scheme 2).
# Reagents Temperature Reaction Period Product
1 SiO2, toluene 111 ◦C (reflux) 5 days 41% 6
2 SiO2, toluene 111 ◦C (reflux) 1.5 days 68% 6
3 SiO2, toluene 111 ◦C (reflux) 5 h 76% 6
4 SiO2, toluene 80 ◦C, then rt 3 days 48% 5
5 80% TFA/CH2Cl2 rt 2 h
partial TBDMS
deprotection
6 80% TFA/CH2Cl2 rt 1 h
16% 5
(24% brsm 1)
7 50% TFA/CH2Cl2 rt 2.5 h full TBDMS deprotection
8 PLE, phosphate buffer (pH 7.5,0.1 M), DMF rt 2 days no reaction
1 brsm = based on recovered starting material.
Since no reaction conditions were identified that gave the desired uridine-derived building block
5 in robust, reproducible and satisfying yields, this strategy for the solid phase-supported synthesis of
muraymycin analogues was discarded, and our reported route (vide supra) was established instead [36].
The obtained diazepanone side product 6 represented an interesting structure as it strongly resembles
the core structure (“caprazol”) of caprazamycin antibiotics (cf. Figure 1). We therefore intended to
evaluate a deprotected derivative of 6 for its biological activity. Uridine-derived diazepanone 6 was
globally deprotected using 80% aqueous TFA for acidic desilylation (Scheme 2). The resultant fully
deprotected caprazol analogue 7 was purified by semipreparative HPLC. In the 1H NMR spectrum of
the obtained product, two sets of signals for the H-5 and H-6 protons of the nucleobase were observed,
hinting at a uracil-derived impurity that could not be separated from target compound 7 and that
could not be identified. However, the amount of this impurity could be estimated from the 1H NMR to
be ~30% based on the uracil-associated signals. We therefore decided to test this mixture of 7 and the
unidentified impurity for its potential to inhibit the bacterial target protein MraY, using an established
in vitro assay for MraY activity [32,33,40]. It was found that the IC50 value of the mixture containing
caprazol analogue 7 was outside of the relevant range (IC50 > 50 μg/mL), thus demonstrating that 7 did
not inhibit MraY to a relevant extent (also see Supplementary Materials, Figure S1, for measured data).
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3. Discussion
The encountered side reaction from precursor 4 to diazepanone 6 is highly interesting as the
construction of the diazepanone scaffold represents one of the main challenges in the total synthesis of
caprazamycins and their analogues [18,19,21,22]. To the best of our knowledge, a simple thermally
promoted nucleophilic attack of the linker unit to a 7′-carboxylic acid ester moiety has not been
successfully explored for the diazepanone-forming step before. The good yields of 6 obtained from this
reaction strongly suggest that it should be investigated for caprazamycin syntheses in a more systematic
way in the future. Additionally, it has not escaped our notion that this transformation might even be
considered to be “biomimetic” with respect to the proposed biosynthesis of caprazamycins [41,42].
However, it seems possible that a cyclization precursor decorated with more functional groups
(i.e., an analogue of 4 closer resembling a non-simplified caprazamycin precursor) might undergo
decomposition reactions at the elevated temperatures needed for diazepanone formation. Such hurdles
might be overcome by the choice of more reactive (i.e., less bulky) ester units in the 7′-position, thus
potentially allowing lower temperatures for the ring closure reaction after Fmoc deprotection.
The missing inhibitory potential of the deprotected uridine-derived diazepanone 7 towards MraY
shows that a simplified 5′-defunctionalized (“5′-deoxy”) version of the caprazamycin core structure
(“caprazol”) does not inhibit this bacterial target protein, at least not in the relevant concentration
range. This supports the conclusion that at least some of the functionalized side chain structures found
in caprazamycins (cf. Figure 1) are relevant for biological activity.
In summary, we report an interesting and unexpected formation of a caprazamycin-like
seven-membered diazepanone ring in a supposedly facile ester cleavage en route to muraymycin
analogues. It is particularly remarkable that this side product was obtained in yields much higher
than those of the desired product. Additionally, the complete cleavage of the Fmoc group under the
(supposedly slightly acidic) reaction conditions was surprising. The observed side reaction might pave
the way for the development of more efficient strategies for diazepanone formation in the synthesis of
caprazamycin analogues.
4. Materials and Methods
4.1. Synthesis
General methods: All chemicals were purchased from standard suppliers and used without
further purification. Reactions involving oxygen and/or moisture sensitive reagents were carried out
under an atmosphere of nitrogen using anhydrous solvents. Anhydrous solvents were obtained in
the following manner: THF was dried with a solvent purification system (MBRAUN MB SPS 800,
M. Braun, Garching, Germany). All other solvents were of technical quality and distilled prior to
use, and deionized water was used throughout. Analytical TLC was performed on aluminum plates
precoated with silica gel 60 F254 (VWR, Darmstadt, Germany). Visualization of the spots was carried
out using UV light (254 nm) and/or staining under heating (H2SO4 staining solution: 4 g vanillin, 25 mL
conc. H2SO4, 80 mL AcOH and 680 mL MeOH; KMnO4 staining solution: 1 g KMnO4, 6 g K2CO3
and 1.5 mL 1.25 m NaOH solution, all dissolved in 100 mL H2O; ninhydrin staining solution: 0.3 g
ninhydrin, 3 mL AcOH and 100 mL 1-butanol). Preparative TLC was carried out on a ChromatotronTM
7924T by T-Squared Technology (San Bruno/CA, USA), using glass plates coated with silica gel 60
PF254 containing a fluorescent indicator (VWR, Darmstadt, Germany; thickness depending on the
amount of crude material to be separated, for 50–500 mg: 1 mm layer). Column chromatography
was carried out on silica gel 60 (0.040–0.063 mm, 230–400 mesh ASTM, VWR, Darmstadt, Germany)
under flash conditions. Semipreparative HPLC was performed on an Agilent Technologies 1200 Series
system equipped with an MWD detector (254/280) (Agilent Trechnologies, Waldbronn, Germany)
and a LiChroCartTM column (10 × 250 mm) containing reversed phase silica gel PurospherTM RP18e
(5 μm, VWR, Darmstadt, Germany). Method: eluent A water, eluent B MeCN; 0–35 min gradient of B
(10%–100%), 35–39 min 100% B, 39–40 min gradient of B (100%–10%), 40–45 min 10% B; flow 3 mL/min.
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500 MHz-1H, 126 MHz-13C, and 376 MHz-19F NMR spectra were recorded on Bruker AVANCE-500
spectrometers (Bruker, Bremen, Germany). All 13C and 19F NMR spectra were 1H-decoupled. All
spectra were recorded at room temperature and were referenced internally to solvent reference
frequencies wherever possible. Chemical shifts (δ) are given in ppm and coupling constants (J) are
reported in Hz. Assignment of signals was carried out using 1H,1H-COSY, HSQC and HMBC spectra.
High-resolution ESI mass spectra were measured on a Dionex UltiMate 3000 HPLC system and on a
Bruker time-of-flight (TOF) maXis (Bruker, Bremen, Germany). Infrared spectra (IR) were measured
on a Bruker Vertex 70 spectrometer equipped with an integrated ATR unit (PlatinumATRTM, Bruker,
Bremen, Germany). Wavenumbers (υ̃) are quoted in cm–1. UV spectra were measured on an Agilent
Cary 100 spectrophotometer (Agilent Trechnologies, Waldbronn, Germany). Wavelengths of maximum
absorption (λmax) are reported in nm.
N-Fmoc-protected aminoalkylated uridinyl amino acid tert-butyl ester (4): Protected nucleosyl
amino acid 2 [30,37,38] (98.0 mg, 0.167 mmol) was dissolved in THF (6 mL) over molecular sieves (4 Å).
N-Fmoc-protected aldehyde 3 [36] (75.0 mg, 0.254 mmol) was added and the mixture was stirred at rt
for 21 h. Amberlyst™ (7.9 mg, 37 μmol) and sodium triacetoxyborohydride (75.7 mg, 0.357 mmol) were
added and the solution was stirred at rt for further 24 h. The reaction mixture was then filtered, and the
molecular sieves were washed with EtOAc. The combined filtrates were washed with saturated (sat.)
Na2CO3 solution (50 mL) and the aqueous layer was extracted with EtOAc (50 mL). The organic layer
was dried over Na2SO4 and the solvent was evaporated under reduced pressure. The resultant crude
product was purified by column chromatography (100:0→ 99:1→ 98:2, CH2Cl2–MeOH) to give 4 as a
colorless foam (102 mg, 71%). 1H NMR (500 MHz, CDCl3): δ [ppm] = 0.07 (s, 3H, SiCH3), 0.07 (s, 3H,
SiCH3), 0.07 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), 0.88 (s, 9H, SiC(CH3)3), 0.90 (s, 9H, SiC(CH3)3), 1.47 (s,
9H, OC(CH3)3), 1.65–1.71 (m, 2H, 2′′-H), 1.83–1.89 (m, 1H, 5′-Ha), 1.98–2.02 (m, 1H, 5′-Hb), 2.54–2.59
(m, 1H, 1′′-Ha), 2.70–2.75 (m, 1H, 1′′-Hb), 3.24–3.35 (m, 3H, 3′′-H, 6′-H), 3.66–3.68 (m, 1H, 3′-H),
4.10–4.14 (m, 1H, 4′-H), 4.20–4.25 (m, 2H, 2′-H, Fmoc-9-H), 4.33–4.42 (m, 2H, Fmoc-CH2), 5.41–5.44
(m, 1H, 3′′-NH), 5.59 (s, 1H, 1′-H), 5.71 (d, J = 8.2 Hz, 1H, 5-H), 7.29 (t, J = 7.4 Hz, 2H, Fmoc-3-H,
Fmoc-6-H), 7.34 (d, J = 8.2 Hz, 1H, 6-H), 7.38 (t, J = 7.4 Hz, 2H, Fmoc-2-H, Fmoc-7-H), 7.59 (d, J =
7.4 Hz, 2H, Fmoc-4-H, Fmoc-5-H), 7.75 (d, J = 7.4 Hz, 2H, Fmoc-1-H, Fmoc-8-H). 13C NMR (126 MHz,
CDCl3): δ [ppm] = −4.74 (SiCH3), −4.67 (SiCH3), −4.44 (SiCH3), −4.02 (SiCH3), 18.08 (SiC(CH3)3), 18.18
(SiC(CH3)3), 25.88 (SiC(CH3)3), 25.95 (SiC(CH3)3), 28.21 (OC(CH3)3), 29.90 (C-2′′), 37.36 (C-5′), 39.30
(C-3′′), 45.67 (C-1′′), 47.38 (Fmoc-C-9), 60.03 (C-6′), 66.72 (Fmoc-CH2), 74.87 (C-2′), 75.39 (C-3′), 81.08
(C-4′), 81.93 (OC(CH3)3), 92.41 (C-1′), 102.32 (C-5), 120.07 (Fmoc-C-1, Fmoc-C-8), 125.21 (Fmoc-C-4,
Fmoc-C-5), 127.11 (Fmoc-C-3, Fmoc-C-6), 127.75 (Fmoc-C-2, Fmoc-C-7), 140.53 (C-6), 141.40 (Fmoc-C-1a,
Fmoc-C-8a), 144.12 (Fmoc-C-4a, Fmoc-C-5a), 150.07 (C-2), 156.61 (urea-C=O), 163.22 (C-4), 173.96 (C-7′).
HRMS (ESI): calcd. for C45H69N4O9Si2: 865.4598 [M + H]+, found 865.4608. IR (ATR): υ̃ = 2929, 2856,
1687, 1450, 1251, 1151, 836, 776, 739. UV (CHCl3): λmax = 266, 301. optical rotation: α20D = +90.0 (c = 1.0,
CHCl3). TLC: Rf = 0.20 (19:1, CH2Cl2–MeOH).
N-Fmoc-protected aminoalkylated uridinyl amino acid (5): N-Fmoc-protected aminoalkylated
uridinyl amino acid tert-butyl ester 4 (54.4 mg, 62.9 μmol) was dissolved in toluene (10 mL). Silica
(409 mg) was added, the reaction mixture was heated to 80 ◦C and stirred at this temperature for
1 day. Then, the mixture was allowed to cool to rt and stirred at rt for further 2 days. The mixture
was filtered, the silica was washed with a mixture of CH2Cl2 and MeOH (1:1), and the solvent of the
combined filtrates was evaporated under reduced pressure. The resultant crude product was purified
by preparative TLC (chromatotron, 9:1→ 4:1, CH2Cl2–MeOH) to give 5 as a yellowish solid (24.6 mg,
48%). 1H NMR (500 MHz, CDCl3): δ [ppm] = −0.13 (s, 3H, SiCH3), −0.01 (s, 3H, SiCH3), 0.07 (s, 6H,
SiCH3), 0.81 (s, 9H, SiC(CH3)3), 0.89 (s, 9H, SiC(CH3)3), 1.78–1.94 (m, 2H, 2′′-H), 2.03–2.33 (m, 2H,
5′-H), 3.02–4.53 (m, 11H, 1′′-H, 3′′-H, 6′-H, 2′-H, 3′-H, 4′-H, Fmoc-9-H, Fmoc-CH2), 5.02–5.19 (m, 2H,
1′-H, 3′′-NH), 5.55–5.71 (m, 1H, 5-H), 7.26–7.29 (m, 2H, Fmoc-3-H, Fmoc-6-H), 7.33–7.37 (m, 3H, 6-H,
Fmoc-2-H, Fmoc-7-H), 7.51–7.62 (m, 2H, Fmoc-4-H, Fmoc-5-H), 7.72 (d, J = 7.7 Hz, 2H, Fmoc-1-H,
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Fmoc-8-H). MS (ESI): m/z = 809.51 [M +H]+. HRMS (ESI): calcd. for C41H61N4O9Si2: 809.3972 [M +
H]+, found 809.3949. TLC: Rf = 0.18 (9:1, CH2Cl2–MeOH).
Protected uridine-derived diazepanone (6): N-Fmoc-protected aminoalkylated uridinyl amino
acid tert-butyl ester 4 (63.1 mg, 49.8 μmol) was dissolved in toluene (8 mL). Silica (208 mg) was added
and the reaction mixture was stirred under reflux for 1.5 days. Then, the mixture was allowed to cool to
rt and the solvent was evaporated under reduced pressure. The resultant crude product was purified
by column chromatography (95:5→ 9:1→ 4:1, CH2Cl2–MeOH) to give 6 as a colorless oil (19.3 mg,
68%). 1H NMR (500 MHz, CD3OD): δ [ppm] = 0.04 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), 0.13 (s, 3H,
SiCH3), 0.16 (s, 3H, SiCH3), 0.89 (s, 9H, SiC(CH3)3), 0.94 (s, 9H, SiC(CH3)3), 1.57–1.66 (m, 1H, 2′′-Ha),
1.71–1.77 (m, 2H, 2′′-Hb, 5′-Ha), 2.32–2.37 (m, 1H, 5′-Hb), 2.90–2.95 (m, 1H, 1′′-Ha), 3.23–3.27 (m, 2H,
1′′-Hb, 3′′-Ha), 3.35–3.42 (m, 1H, 3′′-Hb), 3.55 (dd, J = 8.2, 5.3 Hz, 1H, 6′-H), 3.99 (dd, J = 4.4, 3.3 Hz, 1H,
3′-H), 4.13 (ddd, J = 10.6, 3.3, 3.3 Hz, 1H, 4′-H), 4.40 (dd, J = 5.9, 4.4 Hz, 1H, 2′-H), 5.77 (d, J = 8.1 Hz, 1H,
5-H), 5.84 (d, J = 5.9 Hz, 1H, 1′-H), 7.67 (d, J = 8.1 Hz, 1 H, 6-H). 13C NMR (126 MHz, CD3OD): δ [ppm]
= −4.64 (SiCH3), −4.38 (SiCH3), −4.35 (SiCH3), −4.17 (SiCH3), 18.87 (SiC(CH3)3), 18.97 (SiC(CH3)3),
26.34 (SiC(CH3)3), 26.42 (SiC(CH3)3), 31.43 (C-2′′), 36.99 (C-5′), 41.99 (C-3′′), 51.58 (C-1′′), 58.68 (C-6′),
75.35 (C-2′), 77.09 (C-3′), 84.67 (C-4′), 91.31 (C-1′), 103.23 (C-5), 143.12 (C-6), 152.28 (C-2), 165.97 (C-4),
178.69 (C-7′). MS (ESI): m/z = 569.33 [M + H]+. HRMS (ESI): calcd. for C26H49N4O6Si2: 569.3185 [M +
H]+, found 569.3177. IR (ATR): υ̃ = 2920, 2851, 1738, 1457, 1374, 1229, 1070, 797. UV (CHCl3): λmax =
224. TLC: Rf = 0.24 (9:1, CH2Cl2–MeOH).
Uridine-derived diazepanone (7): Protected uridine-derived diazepanone 6 (6.1 mg, 10.7 μmol)
was dissolved in TFA (80% in water, 3 mL). The reaction mixture was stirred at rt for 24 h and the solvent
was evaporated under reduced pressure. The resultant crude product was purified by semipreparative
HPLC to give 7 (TFA salt) as a colorless solid (2.0 mg containing ~30% of an unknown uracil-derived
impurity; 100% yield: 4.9 mg). 1H NMR (500 MHz, D2O): δ [ppm] = 1.77–1.85 (m, 1H, 2′′-Ha), 1.94–2.05
(m, 2H, 5′-Ha, 2′′-Hb), 2.50–2.55 (m, 1H, 5′-Hb), 3.22–3.27 (m, 1H, 3′′-Ha), 3.35–3.37 (m, 1H, 1′′-Ha),
3.47–3.52 (m, 2H, 1′′-Hb, 3′′-Hb), 4.07–4.11 (m, 2H, 3′-H, 4′-H), 4.14–4.17 (m, 1H, 6′-H), 4.43 (dd, J =
5.0, 3.9 Hz, 1H, 2′-H), 5.71 (d, J = 3.9 Hz, 1H, 1′-H), 5.76 (d, J = 7.7 Hz, 1H, unknown, probably 5-H),
5.86 (d, J = 8.1 Hz, 1 H, 5-H), 7.50 (d, J = 7.6 Hz, 1 H, unknown, probably 6-H), 7.63 (d, J = 8.1 Hz, 1H,
6-H). 13C NMR (126 MHz, D2O): δ [ppm] = 26.70 (C-2′′), 32.73 (C-5′), 39.77 (C-3′′), 48.83 (C-1′′), 56.78
(C-6′), 72.66 (C-2′), 73.15 (C-3′), 80.67 (C-4′), 91.97 (C-1′), 101.10 (unknown, probably C-5), 102.34 (C-5),
142.95 (C-6), 143.47 (unknown, probably C-6), 151.52 (C-2), 166.31 (C-4), 173.19 (C-7′). 19F NMR (376
MHz, D2O): −75.69 (TFA-CF3). MS (ESI): m/z = 341.11 [M + H]+. HRMS (ESI): calcd. for C14H21N4O6:
341.1456 [M + H]+, found 341.1448. UV (H2O): λmax = 202, 260. HPLC: tR = 8.4 min.
4.2. Overexpression of MraY from S. aureus
The overexpression of MraY was performed as described before [32,33,40].
4.3. Fluorescence-Based MraY Assay
The MraY assay was performed as described before [32,33,40]. Measured data are shown in the
Supplementary Materials, Figure S1.
Supplementary Materials: The following are available online, data from the MraY assays, copies of NMR and
IR spectra.
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Abstract: Attempts to convert 1,1,2,2,7,7,8,8-octaethoxyocta-3,5-diyne to a symmetric allene by
reduction with lithium aluminum hydride failed. Instead reduction accompanied by isomerization
occurred and afforded 1,1,2,7,8,8-hexaethoxyocta-2,6-dien-4-yne as a mixture of three isomers in 63%
total isolated yield.
Keywords: conjugated diyne; LAH reduction; diacetal; pent-1,2,3,4-tetraene intermediate
1. Introduction
Since the synthesis of 3,3,4,4-tetraethoxybutyne (TEB) was reported some 15 years ago [1–3], many
of its chemical properties have been uncovered and used to prepare a range of chemical compounds
with rich structural diversity [4–15]. Among the most densely functionalized molecules made is
1,1,2,2,7,7,8,8-octaethoxyocta-3,5-diyne (1), which has one ketal moiety in propargylic position to each
of the triple bonds [16]. The compound therefore belongs to a group of compounds that can undergo
SN2′ reactions by nucleophilic attack of the triple bond, which is accompanied by C–C bond migration
that leads to the release of a leaving group from the propargylic carbon and formation of an allene
moiety. The most common leaving groups are alkanoates [17–19], bromide [20,21], and chloride [22,23],
but examples involving alkoxides have also been published [24–27]. As for the nucleophiles, both
carbanions and hydride have been applied [17–27].
On this basis, we envisaged that 1 might be used as a substrate to make a functionalized diallene by
two SN2′ reactions, one at each of the propargylic moieties, using hydride as a nucleophile (Scheme 1).
Lithium aluminum hydride (LAH) was deemed to be a suitable reagent [23] but, as reported here,
when the reaction was performed, the expected product was not obtained; instead, an isomeric mixture

























Scheme 1. Expected and obtained products from lithium aluminum hydride (LAH) reduction of 1.
2. Results and Discussion
The reaction was carried out under anhydrous conditions in refluxing diethyl ether using six
equivalents of hydride with respect to diallene formation. The reaction was monitored by TLC and
when quenched and worked up after 1 h, three products were detected and subsequently isolated by
flash chromatography. All the products had the same molecular weight as the expected product, but
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their IR spectra did not show any absorption in the allene region (1955–1925 cm−1) [28], which rules out
that diallene formation had occurred. However, absorptions in the 1680–1620 cm−1 and 840–790 cm−1
regions indicate the presence of trisubstituted alkenes [28], and this requires the presence of a C–C triple
bond to be compatible with the determined molecular weight. Considering the symmetry of the starting
material, the triple bond would be expected to be symmetrically substituted, and this would explain the
absence of an absorption in the 2270–2120 cm−1 region [28]. In order to determine whether this was a
reasonable assumption, the Raman spectrum of 2 was recorded. To our satisfaction, a strong absorption
appeared at 2186 cm−1. This observation made the structure elucidation fairly straightforward when
1H- and 13C-NMR data were considered, and the three compounds, isolated in 26%, 34% and 3% yield,
were proved to be the (Z,Z), (E,Z) and (E,E) isomers of 1,1,2,7,8,8-hexaethoxyocta-2,6-dien-4-yne, 2a,
2b and 2c, respectively.
The stereoisomers could be differentiated by a detailed study of the 3.4–5.5 ppm region of their
proton NMR spectra, shown in Figure 1. The (Z,Z) and (E,E) isomers both exhibit C2 symmetry, and
the methine protons at C-1 and C-8 consequently have the same chemical shift, as do the olefinic
protons at C-3 and C-6, and the methylene groups in the ethoxy groups attached to C-2 and C-7. These
isomers will therefore show the same number of signals in the 3.4–5.5 ppm region. The asymmetry of
the corresponding (E,Z) isomer results in twice the number of signals in this region, giving rise to the
middle spectrum in Figure 1, which interestingly is almost identical to that obtained when the top and
the bottom spectra are combined.
 
Figure 1. The 5.5–3.4 ppm region of the 1H-NMR spectra of the three isomers of 2. The signals in
the 4.6–3.4 ppm region are due to the methylene moieties in the ethoxy groups attached to C-1, C-2,
C-7, and C-8. To denote the two hydrogen atoms in the methylene group in EtO attached to C-n, the
following notation is used: 2H-(OEt-n).
The assignments of the proton spectra of 2a, 2b and 2c shown in Figure 1 were arrived at by using
information harvested from the DEPT-90, DEPT-135, HSQC, and HMBC spectra of each of the isomers.
The DEPT and HSQC spectra confirmed the presence of the methyl, methylene, and methine protons,
the olefinic CH groups, and the quaternary carbon atoms, whereas the HMBC spectrum showed the
correlation between hydrogen and carbon atoms two and three bonds apart. The HMBC spectra can
therefore be used to assign the H-1, H-8 and H-3, H-6 singlets, which is clearly illustrated by the
spectrum for 2c (Figure S13). In this spectrum, the proton singlet at 5.47 ppm correlates through three
bonds with the methylene carbon atoms at 63.1 ppm due to the ethoxy groups at C-1 and C-8 and
through two bonds with the quaternary carbon atoms at 161.9 ppm (C-2 and C-7); thus, this proton
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singlet is due to H-1 and H-8. This assignment is further supported by correlations between the proton
singlet at 4.95 ppm and the olefinic quaternary carbons at 161.9 ppm (C-2 and C-7) and the acetal
carbon atoms at 98.4 ppm (C-1 and C-8).
In order to differentiate between the (Z,Z) and (E,E) isomers, the chemical shifts of the methine
hydrogen at C-1 (and C-8) and the methylene protons in the ethoxy group attached to C-2 (and C-7)
in the two isomers were compared. Due to the anisotropy of the triple bond attached to C-3 (and
C-6), protons cis to the acetylenic moiety will be deshielded, whereas those in trans position will be
shielded [29]. Thus, since the methylene quartet in the bottom spectrum appears at a lower field
than in the top spectrum, 4.44 ppm compared to 3.84 ppm, and the methine singlet in the bottom
spectrum appears at a higher field than in the top spectrum, 4.72 ppm compared to 5.47 ppm, the
bottom spectrum belongs to (Z,Z)-2 (2a) and the top spectrum to (E,E)-2 (2c).
The complete absence in the reaction mixture of the expected diallene and any of the by-products
this cumulene conceivably could have given under the reaction and work-up conditions [30–33]
indicates that 1 is not attacked initially at C-4 (and C-5). A likely explanation for this is that the
1,1,2,2-tetraethoxyethyl groups attached to the ends of the buta-1,3-diyne moiety render its termini
relatively electropositive and make initial attack of C-3 (and C-6) more favorable. It is also conceivable
that coordination of one or several oxygen atoms to species derived from LAH at some stage will
facilitate the same sort of attack (see Scheme 2). This leads to formation of a pent-1,2,3,4-tetraene
derivative (3), which is unstable in the presence of a hydride source and reacts quickly to give dienyne
1,1,2,7,8,8-hexaethoxyocta-2,6-dien-4-yne (2) (Scheme 2). Thus, the two hydrogens replacing the two
ethoxy groups in the conversion of 1 to 2 are attached by hydride attack in a SN2′ fashion, not by
reaction with water during the quenching of the reaction. In accordance with this, quenching using
D2O did not lead to deuterium incorporation in 2. Traces of any intermediate were not detected, neither
spectroscopically nor by TLC.
 
Scheme 2. Possible mechanism for formation of dienyne 2 from diyne 1 by two subsequent SN2′
reactions with hydride as a nucleophile.
3. Materials and Methods
3.1. General
The chemicals were obtained from commercial suppliers and used without further purification.
Thin-layer chromatography (TLC) was performed using pre-coated aluminum TLC plates (Alugram,
0.20 mm Silica Gel 60 F254) and eluting with a 95:5 mixture of hexanes and ethyl acetate. The Rf values
were determined after the liquid front had migrated 4–5 cm. Visualization of the chromatograms was
done with phosphomolybdic acid (NH4)4MoO4·4H2O) in ethanol followed by heating. Flash-column
chromatography (FC) was performed manually using Silica Gel from Fluka Analytical (230–400 mesh)
and eluting with a 80:20 mixture of hexanes and ethyl acetate. NMR spectra were recorded on a
Bruker Biospin AV500 instrument (500 MHz for 1H, 125 MHz for 13C) in CDCl3 as solvent, using the
solvent peaks as references in both 1H- and 13C-NMR spectra (7.26 and 77.16 ppm, respectively). The
chemical shifts are reported in ppm, the coupling constants (J) in Hz, and the multiplicity is given as s
(singlet), d (doublet), t (triplet), and m (multiplet). Infrared (IR) spectra were recorded on a Nicolet
Protege 460 FT-IR spectrophotometer with an attenuated total reflectance (ATR) unit attached. Samples
were analyzed neat on a ZnSe crystal, and absorption peaks are reported in wavenumbers (cm−1) and
characterized as strong (s), medium (m), weak (w) and broad (br). Raman spectra were recorded on a
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Kaiser RamanRxn1TM instrument operated under standard conditions. High-resolution mass spectra
(HRMS) were obtained on a Jeol AccuTOFTM mass spectrometer operated in the ESI mode under
standard conditions.
3.2. Reduction of 1,1,2,2,7,7,8,8-Octaethoxyocta-3,5-diyne (1)
A two-necked, round-bottom flask, equipped with a magnetic stirring bar, a condenser with a
CaCl2 tube, and a septum, was charged with dry diethyl ether (6 mL) and LAH (0.099 g, 2.6 mmol).
The suspension was cooled (ice/water) and a solution of 1 (0.399 g, 0.87 mmol) in dry diethyl ether
(3.0 mL) was added dropwise with a syringe. The bath was removed, and the resulting mixture was
stirred under reflux for 1 h. The mixture was then added to some ice and when the ice had melted,
a saturated solution of Rochelle salt was added. The hydrolysate was extracted with diethyl ether
(4 × 10 mL); the combined organic phases were dried (Na2SO4), filtered, and concentrated under
vacuum on a rotary evaporator. The residue contained three products (TLC), which were isolated by
flash chromatography and proved to be isomers of 1,1,2,7,8,8-hexaethoxyocta-2,6-dien-4-yne (2) based
on the following spectroscopic and spectrometric data.
(Z,Z)-1,1,2,7,8,8-Hexaethoxyocta-2,6-dien-4-yne (2a): Yellowish liquid (0.090 g, 26%); Rf 0.48; FT-IR (film):
νmax 2976 (s), 2930 (m), 2883 (m), 2171 (w), 1649 (m), 1621 (m), 1180 (s), 1110 (s), 1049 (s), 913 (s), 841
(m), 793 (m) cm−1; 1H-NMR (CDCl3, 500 MHz): δ 5.23 (s, 2H, 2 CH(OEt)2), 4.72 (s, 2H, 2 -CH=), 4.44 (q,
4H, J = 7.0 Hz, 2 OCH2CH3), 3.65-3.48 (m, 8H, 4 OCH2CH3), 1.30 (t, 6H, J = 7.0 Hz, 2 OCH2CH3), 1.21
(t, 12H, J = 7.0 Hz, 4 OCH2CH3) ppm; 13C NMR (CDCl3, 125 MHz): δ 158.6 (2C), 100.1 (2C), 88.4 (2C),
85.7 (2C), 66.6 (2C), 62.0 (4C), 15.6 (2C), 15.3 (4C) ppm; HRMS Calcd for C20H34O6Na+ [M + Na]+ m/z
393.22531, found m/z 393.22555.
(E,Z)-1,1,2,7,8,8-Hexaethoxyocta-2,6-dien-4-yne (2b): Yellowish liquid (0.110 g, 34%); Rf 0.36; FT-IR (film):
νmax 2976 (s), 2930 (m), 2882 (m), 2187 (w), 1641 (m), 1612 (m), 1252 (s). 1110 (s), 1049 (s), 839 (m), 793
(m) cm−1; 1H-NMR (CDCl3, 500 MHz): δ 5.43 (s, 1H, CH(OEt)2), 5.26 (d, 1H, J = 2.6 Hz, -CH=), 4.94 (d,
1H, J = 2.6 Hz, -CH=), 4.72 (s, 1H, CH(OEt)2), 4.45 (q, 2H, J = 7.0 Hz, OCH2CH3), 3.83 (q, 2H, J = 7.0 Hz,
OCH2CH3), 3.76-3.49 (m, 8H, 4 OCH2CH3), 1.36 (t, 3H, J = 7.0 Hz, OCH2CH3), 1.31 (t, 3H, J = 7.0 Hz,
OCH2CH3), 1.24 (t, 6H, J = 7.0 Hz, 2 OCH2CH3), 1.22 (t, 6H, J = 7.0 Hz, 2 OCH2CH3) ppm; 13C NMR
(CDCl3, 125 MHz): δ 162.2 (1C), 158.4 (1C), 100.1 (1C), 98.4 (1C), 88.1 (1C), 87.7 (1C), 85.9 (1C), 84.5
(1C), 66.5 (1C), 64.1 (1C), 63.2 (2C), 62.1 (2C), 15.6 (1C), 15.32 (2C), 15.27 (2C), 14.3 (1C) ppm; HRMS
Calcd for C20H34O6Na+ [M + Na]+ m/z 393.22531, found m/z 393.22566.
(E,E)-1,1,2,7,8,8-Hexaethoxyocta-2,6-dien-4-yne (2c): Yellowish liquid (0.009 g, 3%); Rf = 0.20; FT-IR
(film): νmax 2976 (s), 2930 (m), 2881 (m), 2172 (w), 1626 (s), 1254 (s), 1198 (s), 1110 (s), 1048 (s), 956 (s),
794 (s) cm−1; 1H-NMR (CDCl3, 500 MHz): δ 5.47 (s, 2H, 2 CH(OEt)2), 4.95 (s, 2H, 2 -CH=), 3.84 (q, 4H,
J = 7.0 Hz, 2 OCH2CH3), 3.77-3.55 (m, 8H, 4 OCH2CH3), 1.37 (t, 6H, J = 7.0 Hz, 2 OCH2CH3), 1.25
(t, 12H, J = 7.1 Hz, 4 OCH2CH3) ppm; 13C NMR (CDCl3, 125 MHz): δ 161.9 (2C), 98.4 (2C), 87.3 (2C),
84.4 (2C), 64.1 (2C), 63.1 (4C), 15.3 (4C), 14.4 (2C) ppm. HRMS Calcd for C20H34O6Na+ [M + Na]+ m/z
393.22531, found m/z 393.22567.
Supplementary Materials: The following are available online, Figures S1–S9: IR, 1H-NMR, and 13C-NMR spectra
of compounds 2a, 2b, and 2c; Figures S10–S13: DEPT-90, DEPT-135, HSQC, and HMBC spectra of 2c; Figure S14:
Raman spectrum of a mixture of compounds 2a, 2b, and 2c.
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Abstract: A new pyrrole-substituted terpyridine derivative that possesses an allene moiety was
obtained as an “unexpected” sole product during an attempt to alkylate the N-atom of pyrrole with
propargyl bromide in order to obtain an alkyne-functionalized terpyridine.
Keywords: ligand; pyridine derivatives; allenic compounds; N-alkylation
1. Introduction
Terpyridine ligands (terpy) and their complexes have been widely studied [1]. This can be
easily explained by the huge number of terpyridine derivatives that can be obtained by varying the
substitution pattern of the ligand as well as the nature of the complexed metal. In particular, terpyridines
that contain a five membered heterocycle, such as furan [2] or thiophene [3], have attracted a lot of
attention. In fact, they can be used as intermediates in the preparation of materials for solar cells [4]
or nanoparticles [5], as biological probes [6], as ligands in catalysis [7], as antimicrobial agents [8], as
electrochromic materials [9] or as chromophores [10], to name just a few applications. Although a little
less studied, terpyridines that include a pyrrole ring have also been a subject of interest. For example,
such terpyridines have been used for the preparation of cytotoxic molecules [11], for application in
OLED (organic light emitting diodes) [12] or sensor devices [13] or for the preparation of catalytic
materials [14]. Thus, the preparation of terpyridine derivatives that contain a functionalized pyrrole
is of interest in the fields of both organic synthesis and material science. This article describes how
pyrrole-containing terpyridine 1 was obtained as an unexpected product during attempts to prepare
compound 2 (Figure 1), which features an alkyne chain for possible future functionalization [15].
Figure 1. Structures of terpyridine compounds (1) and (2).
2. Results and Discussion
The synthetic approach towards molecule 2 relies on the N-alkylation of the pyrrole moiety of
4′-(pyrrol-2-yl)-2,2′:6′,2”-terpyridine (3) with propargyl bromide (Figure 2), applying a protocol that
has been described for the preparation of N-alkyl terpyridine pyrroles [16]. At the end of the reaction,
Molbank 2020, 2020, M1142; doi:10.3390/M1142 www.mdpi.com/journal/molbank79
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a single product was noticed by TLC. This product was easily separated from the starting material by
flash chromatography, but 1H NMR did not agree with the structure of 2.
Figure 2. Synthetic pathway that afforded compound 1.
Instead, structure 1 was coherent with 1H NMR. In particular, the spectrum exhibits the signals
for the allenic protons. In fact, a triplet is observed at 7.14 ppm (J = 6.4 Hz). This signal accounts for
the allenic proton e (Figure 3). In addition, a doublet is observed at 5.50 ppm (J = 6.4 Hz) for the allenic
protons g. These multiplicities and chemical shifts are in accordance with those reported for other
allene-functionalized pyrroles [17–19].
Figure 3. 1H NMR spectra of compound 1 (inset: structure and atom numbering of 1).
All other signals arising from the terpyridine and the pyrrole parts of the molecule are present.
Additionally, the structure of 1 was further confirmed by Supplementary Materials 13C NMR, as well as by
HR-MS. For instance, the 13C NMR spectrum features 15 signals due to the symmetry of the molecule,
while mass spectra exhibit the molecular ion peak at 337.14466 (calc. for [C22H16N4 +H]+: 337.14477).
As pointed out in the above-mentioned literature, the formation of compound 1 is not so
“unexpected”. Nevertheless, no trace of alkyne 2 was noticed, while N-propargylation of pyrrole and
indole derivatives under similar reaction conditions are described in the literature [20,21]. Therefore,
the obtention of 1 as the sole product is “unexpected”.
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3. Materials and Methods
All reagents were purchased from commercial suppliers and used as received.
The 4′-(Pyrrol-2-yl)-2,2′:6′,2”-terpyridine (3) was prepared according to the literature [16]. A volume of
85% Potassium hydroxide pellets (VWR Chemicals, France) was powdered using a mortar and a pestle.
Anhydrous DMSO and 80% propargyl bromide solution in toluene were purchased from ACROS Organics
(Geel, Belgium) and used as received. Flash chromatography was carried out on a Combiflash Rf+ Lumen
(Teledyne ISCO, Lincoln, NE, USA) using a Redisep Rf neutral alumina column (Teledyne ISCO, Lincoln,
NE, USA) with a hexane/ethyl acetate mixture (100:0 to 80:20 v:v) as eluent. The 1H and 13C NMR spectra
were recorded on a Brucker AC 400 (Bruker, Wissembourg, France) at 400 and 100 MHz, respectively, using
CDCl3 as a solvent. The melting point was recorded with a Stuart SMP 10 melting point apparatus (Bibby
Sterilin, Stone, UK) and was uncorrected. HR-MS was recorded at Sayence SATT, Dijon, France.
4′-(N-(Propan-1,2-dienyl)pyrrol-2-yl)-2,2′:6′,2”-terpyridine (1): Into a round bottomed flask, the
powdered potassium hydroxide (0.44 g; 6.7 mmol) and dimethylsulfoxide (35 mL) were successively
placed. The resulting suspension was stirred at room temperature under argon for 30 minutes. Then,
4′-(pyrrol-2-yl)-2,2′:6′,2”-terpyridine (1.00 g; 3.35 mmol) was added and the red solution was stirred at
room temperature under argon for 30 min. Finally, propargyl bromide (80% solution in toluene, 0.50 g;
3.36 mmol) was added and the reaction mixture was stirred at room temperature under argon for 24 h.
The solution was then poured onto water (100 mL) and a small amount of brine was added to ensure
proper decantation. The aqueous layer was extracted with dichloromethane (4 × 25 mL). The organic
layers were combined, washed with brine (100 mL), dried over sodium sulfate and concentrated under
vacuo. The crude was purified by flash chromatography. The title compound was obtained as a white
solid (0.52–0.66 g) Mp = 128 ◦C. 1H NMR (CDCl3, 400 MHz), δ (ppm): 8.71 (d, 2H H6, 6”, J = 4.0 Hz),
8.65 (d, 2H, H3, 3”, J = 8.0 Hz), 8.56 (s, 2H, H3’, 5’), 7.86 (td, 2H, H4, 4”, J = 7.7 Hz, J = 1.7 Hz), 7.34 (ddd,
2H, H5, 5”, J = 7.4 Hz, J = 4.8 Hz, J = 1.0 Hz), 7.14 (t, 1H, He, J = 6.4 Hz), 7.05 (dd, 1H, Hd, J = 2.7 Hz,
J = 1.8 Hz), 6.65 (dd, 1H, Hc, J = 3.6 Hz, J = 1.6 Hz), 6.35 (t, 1H, Hb, J = 3.2 Hz), 5.50 (d, 1H, Hg, J = 6.4
Hz). 13C NMR (CDCl3, 100 MHz), δ (ppm): 203.5, 156.2, 155.7, 149.2, 141.8, 136.8, 131.6, 123.8, 122.7,
121.3, 119.9, 112.4, 110.4, 98.7, 87.2. HR-MS: calc. for [C22H16N4 + H]+ 337.14477, found 337.14466.
4. Conclusions
A new pyrrole-containing terpyridine has been prepared and characterized. It features an allenic
part that is linked via the N-atom of the pyrrole nucleus. Considering the fact that allenes are valuable
intermediates in the preparation of polymer [22] or molecular materials [23], and the impressive
metal-coordination properties of terpyridine ligands [1], this new compound could be useful for the
fabrication of novel metal-containing functional materials.
Supplementary Materials: The following are available online, 1H, 13C, 1H-1H COSY and 1H-13C HSQC NMR,
HR-MS spectra of terpyridine 1.
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L.G. analyzed data and contributed to manuscript preparation. All authors have read and agreed to the published
version of the manuscript.
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Abstract: The title compound contains a guanidinium cation that was unexpectedly found during
X-ray single crystal analysis of a copper(I) cyanide network expected to contain protonated
N,N’-dimethyl-1,3-diaminopropane. The cation was presumably formed by reaction of the amine
with cyanide ions in the aqueous sodium cyanide/copper cyanide mixtures used in the synthesis.
The structure of the network solid features the guanidinium cation as a guest in an anionic
two-dimensional polymeric framework with stoichiometry Cu2(CN)3−. Confirmation of the structure
was provided by analytical, thermal gravimetric and infrared data.
Keywords: copper; cyanide; network; guanidinium; unexpected iminium cation
1. Introduction
Polymeric copper(I) cyanide networks with guest cations continue to attract interest in light of
their varied topologies and interesting physical properties, including chemiluminescence [1–5].
Our own work on CuCN complexes with amine bases, which initially sought to incorporate CuII into
these CuI networks to provide neutral polymeric networks, has led to the characterization of both
mixed valence CuCN compounds [6] and CuICN networks with protonated amines as guests [7].
We report here the unexpected formation of the cyclic guanidinium complex
poly[1,3-dimethyltetrahydropyrimidin-2(1H)-iminium [tri-μ2-cyanido-κ6C:N-dicuprate(I)]], 1,
during an attempted synthesis of a copper cyanide polymer involving the diamine
N,N′-1,3-dimethyldiaminopropane. We had originally hoped for the formation of a crystalline mixed
valence CuICuII cyanide polymer with the CuII atoms stabilized by coordination of the bidentate
amine ligands. The lack of color in the crystalline product indicated, however, that only CuI was
involved, so we suspected that the amine base would be present as its conjugate acid, to provide charge
neutrality for an anionic CuICN network, as in the structure reported in reference [6]. Single crystal
X-ray diffraction analysis, however, indicated that reaction of the diamine with cyanide had occurred
with formation of a cyclic guanidinium cation. Lin et al. have reported a similar structure featuring the
unexpected formation of the unsubstituted guanidinium cation [8]. We report here the crystal and
molecular structure of 1, together with chemical analyses, thermal decomposition and infrared data.
2. Results
2.1. Synthesis
In a typical synthesis: 0.246 g NaCN (5.0 mmol) was dissolved in 2–3 mL water, 0.279 g (3.1 mmol)
CuCN was added and the mixture was stirred until all solid had dissolved. Separately, 0.431 g
N,N′-dimethyl-1,3-diaminopropane was dissolved in 2–3 mL water, and the solution was added slowly
to the NaCN/CuCN mixture. Colorless crystals were usually obtained within a week after filtration
and water washing.
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2.2. X-ray Structure
The single crystal structure indicates a molecular formula [LH][Cu2(CN)3], where LH+ is the
cyclic guanidinium cation. The asymmetric unit showing thermal ellipsoids and atom numbering is
given in Figure 1. The compound crystallizes as a two-dimensional CuCN network with the cations as
guests; see Figure 2.
Figure 1. Asymmetric unit for compound 1, showing thermal ellipsoids with 50% probability. Only one
orientation of the disordered CN groups is shown. C14 and C15 are also disordered; only the major
component is shown.
(a) (b) 
Figure 2. Packing Diagrams for 1. (a) One CuCN sheet and one cation layer, viewed down the c axis.
(b) Sheet edges, viewed down the a axis. Nitrogen atoms are shown in blue, carbon and hydrogen
atoms in black and copper atoms in red. Cu1 and Cu2 are labeled in their reference positions.
The CuCN sheets are made up of 18-membered CuCN rings in a honeycomb arrangement.
They are deformed from planarity, evidently in order to accommodate the guanidinium cations and in
contrast to the planar sheets found in our earlier work on a similar structure [7]. The sheet deformation
occurs with minimum deviation from ideal geometry for the trigonal planar Cu atoms: Cu1 and Cu2
lie only 0.035(2) and 0.073(2) Å above the plane through the three atoms bonded to them, and the
angles at the Cu atoms differ from 120◦ by at most 2.4(1)◦. Bonding at the bridging CN groups deviates
from linearity by an average of 4.1(1)◦, with a maximum of 8.1(2)◦.
The cation is the cyclic guanidinium cation shown in Figure 1 and not the expected conjugate acid
of the base. The new cation appears to have been formed by an oxidation reaction between the cyanide
ion and the diamine base:
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Perhaps the reaction involves a CuI/CuII cyanide system as catalyst—the faint blue color of the
solutions during slow formation of the product indicated some CuII being present, presumably from
air-oxidation. The central CN3 group of the guanidinium cation is rigidly planar, and the C–N bond
lengths average 1.318(7) Å, which is close to the expected value. For example, the average C–N distance
in a series of some 50 structures containing the guanidinium cation CH6N3+ [9] is 1.321 Å. There does
not appear to be any significant hydrogen-bonding or other intermolecular interaction between the
guanidinium cations and the anionic sheets. The thermal ellipsoids in Figure 1 imply rigid body
vibration is occurring about an axis perpendicular to the plane of the molecule, a vibration that would
be hampered if the iminium group were involved in significant hydrogen bonding.
2.3. Thermal Gravimetric Analysis
On heating a sample of 1 under nitrogen at 50 ◦C/min to 600 ◦C, the sample suffered a 38% mass
loss by 300 ◦C, and then further losses in a complex fashion as the mass tended towards the 38%
expected for residual CuCN(s); see Figure 3a. Similarly, a sharp drop in mass of 38% was observed
when separate samples were heated rapidly to 225 ◦C or to 275 ◦C (Figure 3b) and held at those
temperatures for an hour and a half, during which there was only 1–2% further loss.
 
(a) (b) 
Figure 3. Thermal gravimetric analysis for 1: (a) 0–600 ◦C at 50 ◦C/min, (b) 0–275 ◦C at 20 ◦C/min and
hold 90 min.
Since the molar mass of [LH][Cu2(CN)3 where L is the guanidine base is 333.3 u, the 38% mass loss
corresponds to a loss of 127 u, suggesting that the guanidinium cation in 1 loses a proton to form the
cyclic guanidine L, with mass 127 u, which is then released. If the cation were the expected protonated
dimethylpropanediamine, the mass loss would have been very different. The nature of the remaining
solid at 225 or 275 ◦C is not clear. In similar experiments with an N-methylethanolamine complex [10],
the sample lost methylethanolamine and HCN gas separately at 200 ◦C to leave behind CuCN, but the
CuCN in the present case is not formed until much higher temperatures.
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2.4. Spectroscopy and Analyses
The infrared spectrum of 1 shows strong absorptions at 2110 cm−1 (C≡N stretch) and 3406 and
3497 cm−1 (N–H stretch). As expected, the C≡N stretches are close to those observed in similar
compounds. The N–H stretching frequencies are shifted from values in the region 3100–3200 cm−1
found in a number of similar network solids we have made containing protonated amines. Data on
infrared data on iminium cations in the literature are sparse, but reference [8] gives N–H frequencies
at 3427(s), 3325(m), and 3268(m) cm−1 for the unsubstituted guanidinium cation. A lower value of
3115 cm−1 was quoted for the asymmetric N–H stretch in methyl formimidate hydrochloride [11],
but the author commented that the low value was likely due to strong N–H . . . Cl hydrogen-bonding.
We synthesized the hydrochloride salt of 1,1,3,3-tetramethylguanidine, 2, by titration of this base with
HCl, since the iminium group in this salt should have a similar molecular environment to the iminium
cation in 1. The N–H stretches found for 2 were 3107 and 3281 cm−1. The significant differences in
N–H frequencies for 1 and the model compound 2 perhaps again reflect N–H . . . Cl hydrogen bonding
in 2 compared with the lack of hydrogen bonding to the iminium group in 1. The presence of the host
CuCN network could also affect the IR spectrum of 1.
Elemental analysis of 1 gave 32.59%C, 3.68%H and 25.19%N, which are comparable with the values
calculated for the new product, C9H14Cu2N6—32.43%C, 4.23%H and 25.22%N, and differ significantly
from values of 31.06%C, 5.21%H and 22.64%N calculated for the expected product C8H16Cu2N5,
which would have contained the conjugate acid of the dimethyldiaminopropane. Further confirmation
of the presence of the guanidinium cation in 1 was found in the density of the crystals, which was
found by flotation methods to be 1.692(8) g/cm3, the same as the value of 1.698 g/cm3 calculated from
the X-ray data for 1.
3. Experimental
Crystal Data for C9H14Cu2N6 (M= 333.34 g/mol), crystals cut from colorless rods, monoclinic, space
group P21/c (no. 14), a= 8.5598(14) Å, b= 14.825(4) Å, c= 10.853(2) Å,β= 108.570(13)◦, V = 1305.5(5) Å3,
Z = 4, T = 300(2) K, μ(MoKα) = 3.249 mm−1, Dcalc = 1.698 g/cm3, Dmeas = 1.692(8) g/cm3,
21,730 reflections measured from four crystals (2.4◦ ≤ Θ ≤ 27.67◦, cell dimensions averaged from
the four crystals), 3009 unique (Rint = 0.052), which were used in all calculations. The final R1 was
0.0340 (I > 2σ(I)) and wR2 was 0.0951 (all data) for 166 variables. The structure was solved by the
heavy atom method from a Patterson map calculated with SHELXS and refined with SHELXL Version
2017 [12]. The CN groups were modeled with 50% disorder in their orientation, and a disordered
model was also used for two of the three propane C atoms, with restraints on the geometry and
temperature factors for atoms at alternative sites; refined occupancies for the A and B occupancies
were 65(1)% and 35(1)%. Hydrogen atoms were constrained at idealized positions, riding on the
carbon atoms, with C–H distances of 0.96 Å for methyl groups and 0.97 Å for methylene groups,
and isotropic temperature factors were 50% larger than the Ueq of the bonded C atoms. Attempts
to refine the iminium H atoms were not successful, so they too were constrained in ideal positions,
with N–H distances of 0.86 Å, and Uiso was again 50% of the Ueq of the N atom. The cif file for this
structure is included in the Supplementary Material for this article and has also been deposited with the
Cambridge Crystallographic Data Center as CCDC 2035041. These data can be obtained free of charge
via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union Road, Cambridge
CB2 1EZ, UK; Fax: +44 1223 336033; E-mail: deposit@ccdc.cam.ac.uk).
4. Discussion
This study shows that an unexpected reaction between cyanide ion and
N,N′-dimethyl-1,3-diaminopropane occurred to form a cycle guanidinium cation under the
preparative conditions used. We have not found reference elsewhere to the preparation of this cation
or to the conjugate base. When syntheses were carried out at lower pH values, a different crystalline
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product was obtained, for which X-ray diffraction analysis showed an anionic 3D CuCN network,
not 2D, as in this case, the expected protonated diamine was a guest, rather than the guanidinium
cation found in the present work. This work will be published elsewhere. Further studies will explore
the conditions favoring the reaction described here, and a possible mechanism.
5. Materials and Methods
Chemicals were used as obtained from suppliers without further purification. Chemical analysis
was performed by Robertson Microlit (Ledgewood, NJ, USA). FTIR data were obtained with a Nicolet
iS50 FT-IR spectrometer (Thermo Fisher Scientific, Waltham, MA, USA), and thermal gravimetric
analyses were carried out under nitrogen with a TGA-Q500 instrument (TA Instruments, New Castle,
DE, USA). The X-ray structure was determined with diffraction data collected with a Nonius Kappa
CCD system (Bruker Axis LLC, Madison, WI, USA) using graphite monochromated MoKα radiation
with λ = 0.7107 Å.
Supplementary Materials: The following are available online. Figure S1: Checkcif Report, Table S1: MOL File,
Table S2: cif file, Figure S2: Infrared spectrum of title compound.
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